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CHAPTER 1 
 
INTRODUCTION 
 
STATEMENT OF THE PROBLEM 
 
Reproductive health encompasses the full range of the reproductive cycle (e.g., 
contraception, conception, pregnancy, childbirth, abortion) and includes various reproductive 
challenges (e.g., egg donation, surrogacy, reproductive technologies, etc.) (Ross 2006a).  It is a 
reflection of the lifelong health of the reproductive system and processes, setting the stage for 
health beyond the reproductive years and affects the health of the next generation (Roberts 1990, 
Rutherford 1992).  Throughout history African American1 women have had pejorative 
experiences with reproductive health through forced breeding during chattel slavery, medical 
experimentation, forced sterilization, unavailability of safe, legal abortions, forced use of birth 
control pills and other contraception methods, and coercive birthing process and hysterectomies 
(Nsiah-Jefferson 1989, Roberts 1997, Ross 1992, Ross et al. 2007).  Much of the work on 
reproductive health among African American women has been brought to light through 
recounting historical accounts of legal violations of reproductive rights with the intent to achieve 
retribution and legal footing.  Reproductive rights have been situated within the human rights 
and social justice paradigm as put forth by the Universal Declaration of Human Rights (1948) 
and subsequently, the United Nations International Covenants on Economic, Social and Cultural 
Rights (UNICESCR) and the United Nations International Covenants Civil and Political Rights 
(UNICCPR) to advance reproductive interests (Cook 1995, Okin 1998).  Additionally, 
reproductive health is most often discussed either (1) under the guise of the binary pro-choice or 
pro-life discourse, leaving other areas such as pregnancy prevention, family planning, birth 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The terms African American and Black are used interchangeably throughout this dissertation.  
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spacing, and health promotion neglected or (2) in reference to women in underdeveloped 
countries (Price 2011, Ross et al. 2007, Smith 2005).  Regrettably, women with sickle cell 
disease experience more gynecological complications than do those unaffected by the disease, 
including delayed menarche, dysmenorrhea, ovarian cysts, fibrocystic disease of the breast, as 
well as a high prevalence of vaso-occlusive pain associated with menstrual cycles (Creary, 
Williamson and Kulkarni 2007).  
Sickle cell disease (SCD) is a condition with a complicated clinical sequelae, 
accompanied by a myriad of health complications, unremitting, extreme pain, and frequent 
hospitalizations.  Consequently, much of the existing literature has focused on the experience of 
symptoms and clinical management rather than how those with this condition maintain their 
health (Abrams, Phillips and Whitworth 1994, Anie, Steptoe and Bevan 2002, Fuggle et al. 1996, 
Hurtig and Park 1989, McClish et al. 2005).  Indeed, the knowledge of symptoms and 
subsequent treatment are important components of ensuring optimal heath care provision, 
however, this narrow focus precludes gaining a broader understanding of the multifaceted 
experiences and identities women with sickle cell disease have regarding their reproductive 
health.  
Women with sickle cell disease also bring to fore a unique nexus of reproductive health, 
race, gender, and genetic illness.  As a sub-group of African American women, women with 
sickle cell disease may experience suboptimal reproductive health care or limited independent 
decision-making regarding reproductive issues due to race, class, or illness.  Seemingly, 
restrictions of reproductive choice and limited reproductive care are likely for this population 
through denied reproductive health information, coerced sterilizations and abortions, and 
discouraged pregnancies due to concerns of genetic transmission and pregnancy complications 
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(Fort et al. 1971, Fort and Morrison 1972, Horger 1971).  Although there has been continued 
anecdotal speculation to this end, recent, empirical evidence either supporting or refuting 
whether such violations continue is lacking.  Furthermore, studies exploring how women with 
sickle cell disease experience reproductive health care and choice embedded within multiple 
social, and often marginalized, identities are limited. 
 
STATEMENT OF PURPOSE 
Contemporary research concerning reproductive health care among African American 
women in general and women with sickle cell disease in particular is scarce (Daniels 1996, Gallo 
et al. 2010).  To date, much of the sociological literature on how women with sickle cell disease 
have been limited to (1) health beliefs of women with sickle cell trait (Anie, Berger and 
Asgharian 2003b, Gustafson et al. 2007), (2) care-giving experiences of families with a child 
with sickle cell disease (Brown et al. 1993, Hill 1994a, Moskowitz et al. 2007, Thompson et al. 
1993a, Thompson et al. 1993b), (3) financial burden of disease management (Barbarin et al. 
1999, Bediako 2010), (4) concerns regarding genetic and prenatal screening (Dyson 1997, Petrou 
et al. 1992), and (5) attitudes and experiences regarding the transition from pediatric to adult care 
(Baskin et al. 1998, Jordan, Swerdlow and Coates 2013, Telfair et al. 2004).  
To understand women’s health experiences it is important to understand women’s 
reproductive lives more broadly, with a broader focus than addressing only their bodily functions 
(Doyal 1995).  The specific aims for this study were to (1) explore and describe the reproductive 
health experience of women with sickle cell disease, (2) describe social, environmental, and 
cultural factors that influence their reproductive health experience, and (3) investigate the ways 
in which individuals who occupy these positions manage their reproductive health.  This study 
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will use qualitative in-person interviews with adult women with sickle cell disease with varied 
socioeconomic, parity, and marital status to capture a broad perspective of experiences.  The 
questions this research explored are: 
 
How do women with sickle cell disease think about and experience 
reproductive health? That is, how do they perceive the type and quality of care 
they receive concerning their reproductive health? What importance do they give 
to their reproductive health? What priority does their reproductive health have in 
their lives? What behaviors do women with sickle cell disease engage in that they 
believe help maintain their reproductive health? What impact does having sickle 
cell have on their reproductive lives including desires for motherhood and 
intimate relationships? 
 
How do race, gender, and genetic illness affect the reproductive lives of 
women with sickle cell disease?  
 
What social, environmental, and cultural factors influence the ability of 
women with sickle cell disease to either seek or receive reproductive health 
care? That is, what sources of information, advice and guidance do women with 
sickle cell use to learn about reproductive health?  
 
SIGNIFICANCE OF THE STUDY 
Nearly four decades ago the life expectancy of individuals with sickle cell disease was a 
staggering 14 years old; yet today the average life span reaches 42 years for men and 48 years for 
women (Lanzkron, Carroll and Haywood 2013, Platt et al. 1994). This dramatic increase in life 
expectancy is related, in part, to early detection, use of penicillin prophylaxis in young children, 
improved education regarding disease complications, and improved clinical management 
(Driscoll 2007).  Perhaps because of the limited number of individuals with sickle cell disease 
and the fact that it is only in recent generations that women with sickle cell disease live longer 
lives, it remains somewhat of an unknown illness.  Consequently, the short life expectancy 
caused much of the scholarship surrounding this condition to be limited to child and adolescent 
populations who were frequently considered asexual.   Their sexual and reproductive health was 
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discounted.  However, this population is now transitioning into adulthood, with increasing 
survival estimates well into middle-age; therefore knowledge concerning their attitudes and 
behavior toward reproductive health is becoming increasingly important to both social and health 
audiences.  
Reproductive health among women with sickle cell disease remains a critical gap in the 
literatures on sickle cell disease, reproductive health, and women’s health.  Most often, the 
reproductive health of this population has been relegated to biomedical examinations of 
pregnancy complications, risks and outcomes, primarily maternal and infant mortality rates, 
pregnancy complications, and appropriate methods of contraception and acceptance of prenatal 
genetic testing (Creary, Williamson and Kulkarni 2007, Dauphin-McKenzie et al. 2006, Hassell 
2005).  Yet to date, limited research exists exploring the experiences of women with sickle cell 
disease, and even less focusing on understanding how women with sickle cell experience 
reproductive health care and choice and the ways in they prioritize and exercise agency in this 
area of their lives.   
This study has been designed to explore the ways in which women with sickle cell 
disease think about and experience reproductive health and the factors that influence their 
identities and experiences.  The findings of this study have both clinical and sociological 
implications.  From a sociological perspective, this study may extend existing ideas concerning 
the availability of, and barriers to, information and appropriate reproductive health care, improve 
the understanding regarding the significance of reproductive health in general and within the 
context of illness, and assess the ways in which women with sickle cell disease perceive their 
ability to exercise agency in making informed and independent decisions about their 
reproductive lives. A better understanding of these concepts will help health care providers 
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understand how factors such as economic status, race, gender, and genetic illness may intersect 
to influence the reproductive health experience of women with sickle cell disease and inspire 
improved care for this population. 
 
ORGANIZATION OF THE DISSERTATION 
The first chapter has provided an introduction to the research topic, significance of the 
research and the purpose of the study. Chapter Two includes an outline of sociology of the body, 
which illustrates how individuals with sickle cell experience the condition.  Following this 
section of the literature is a review of the socio-historical research of reproduction health of 
African American women, disabled women, and women with genetic conditions.  This chapter 
also provides an introduction to sickle cell disease, which includes an overview of the clinical 
manifestations and disease management.  Chapter Three provides an outline of the theoretical 
and methodological approaches using Sociology of the Body as the conceptual framework for 
the study.  Chapter Four explains the use of Colaizzi’s phenomenology method for data 
collection and analysis and outlines the participants’ characteristics.  Chapters Five through 
Seven describe the findings of the dissertation.  Chapter Five focuses on the participants’ 
responses to various discouraging reproductive messages. Chapter Six focuses on the 
motivations and perceptions regarding genetic-related reproductive decision-marking. Chapter 
Seven focuses on participants’ reproductive health care experiences.  Chapter Eight concludes 
this study and presents the limitations of this study. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
REPRODUCTIVE HEALTH 
 
The most comprehensive conceptualization of reproductive health was developed during 
the International Conference on Population and development (ICPD) held in Cairo in 1994 and 
the International Conference on Women sponsored by the United Nations in Beijing in 1995.  
The World Health Organization, Chapter VII of the Programme of Action of ICPD, adopted this 
definition of reproductive health: 
Reproductive health is a state of complete physical, mental, and social well-being and not 
merely the absence of disease or infirmity, in all matters relating to the reproductive 
system and to its functions and processes.  Reproductive health therefore implies that 
people are able to have a satisfying and safe sex life and that they have the capability to 
reproduce and the freedom to decide if, when and how often to do so.  Implicit in this last 
condition are the right of men and women to be informed and to have access to safe, 
effective, affordable and acceptable methods of family planning of their choice, as well 
as other methods of their choice for regulation of fertility which are not against the law, 
and the right of access to appropriate health-care services that will enable women to go 
safely through pregnancy and childbirth and provide couples with the best chance of 
having a healthy infant (Germain and Ordway 1989).  
 
Additionally, reproductive health includes decisions rooted in mothering in the broadest 
context.  Regardless of whether a woman decides to have a child, not have a child, adopt a child, 
or submit her child for adoption, women are socially defined as mothers or potential mothers and 
ultimately make decisions about mothering (Hanigsberg 1995). Therefore, reproductive health 
involves access to information, the ability to interpret this information, and the freedom to make 
complex decisions that involve their ability and desire to become a mother.   
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Reproductive Health and African American Women 
Compared to women from other racial groups in the United States, African American 
women have experienced more incidents of coercive sexual encounters, unwanted pregnancies 
and abortions, and less social support for raising their children (Barbee and Little 1993, Hill 
2009).  Moreover, this experience extends beyond the biomedical domain into the unique socio-
historical context under which African American women have endured forced motherhood (e.g., 
slavery (re)production, lack of access to safe abortions), denied motherhood (e.g., legal 
regulation of conception, coerced or forced sterilization, subjection to contraceptive testing or 
use of long-term contraceptive methods), and disciplining of mothers-to-be (e.g., legal regulation 
of behavior during pregnancy) (Ehrenreich 2008, Ross 2006b). 
 
Forced Motherhood 
 Forcing women to become mothers forces them into a servant caste, which subjects them 
to a special duty to serve others and not themselves (Koppelan 1990).  Dating back to slavery, 
African American women have experienced a long history of racist and discriminatory behavior 
with respect to systemic efforts to control their sexuality and reproduction (Roberts 1997).  The 
slavery experience epitomizes the patriarchal use of a woman’s body for reproduction and the 
most brutal example of the denial of autonomy over reproduction. Limited access to health care 
resources serves to perpetuate restrictions of their reproductive health and emerges as a 
contemporary method of forced motherhood (Hooton 2005, Ross 2006c, Silliman et al. 2004). 
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Reproduction During Slavery 
Within the institution of slavery, Africans were kidnapped and sold, and women were 
forced to reproduce in order to provide a laboring population that fueled the slave-based mode of 
production (Davis 1983, Jones 1985).  During slavery, Black women experienced the most 
atrocious denial of reproductive autonomy.  Female bondage was severe because these women 
were often forced to bear children–to which slave mothers had no legal claim–and cope with 
sexual abuse in addition to doing the work assigned to them (Jennings 1990, Jones 1985).  This 
history is important because it suggests that controlling the reproductive rights of women of 
color extends beyond issues of fertility and also serves to reduce the importance of issues of 
chastity and virginity.  Once the female slave accepted that she did not have control over her 
body, the importance of her virginity was considerably reduced (Gubrium 2007).  Thus, not only 
did the concept of Black female sexuality develop out of the experience of slavery, but slavery 
also influenced later perceptions of Black female sexual morality (Roberts 1997).  Angela Davis 
(1983) claims the subjugation of the female slave was the slave master’s symbolic attempt to 
break her ability to resist.  Davis states:  
In confronting the Black woman as adversary in a sexual contest, the master 
would be subjecting her to the most elemental form of terrorism distinctively 
suited for the female: rape.  Given the already terroristic texture of plantation life, 
it would be as potential victim of rape that the slave woman would be most 
unguarded.  Further, she might be most conveniently manipulable if the master 
contrived a random system of sorts, forcing her to pay with her body for food, 
diminished severity in treatment, the safety of her children, etc. (1983:213).  
 
One way in which African American women have been made to feel dehumanized is 
through sexual denigration.  The system of slavery forced female slaves to serve as human 
subjects in scientific experiments resulting in significant contributions to scientific progress, 
usually without consent (Savitt 1982).  For example, painful experimentation on slave women 
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resulted in a cure for vesicovaginal fistula, a condition that allows urine to escape into the 
vagina–a procedure that came to be known as the ovariotomy (Washington 2006).  Slave women 
also played an important role in the perfection and development of the cesarean section (Byrd 
and Clayton 2000, Dula 1994, Washington 2006).  Openly deliberate and undisguised medical 
abuse of African Americans was possible because of the existence of ideals of White superiority 
and the inferiority of the Black body. Black bodies were also thought to be owned by Whites, 
thus furthering abuse.  The historical legacy of medical experimentation continues to influence 
the delivery of optimal medical care to African Americans (Byrd 1990, Chandler 2010, 
Washington 2006).  
 
Limited Access to Reproductive Health Services 
African American women experience some of the worst reproductive health outcomes 
when compared to women from other racial groups, particularly in the areas of low birth weight, 
infant mortality, maternal mortality and prenatal care (Anachebe and Sutton 2003, Parham and 
Hicks 2005).  African American women also have the highest risk of pregnancy-related death, 
including hemorrhage, pregnancy-induced hypertension, and pulmonary embolism (Anachebe 
and Sutton 2003).  According the Centers for Disease Control report of Safe Motherhood, this 
represents a four-fold disparity in maternal mortality risk when compared to White women – 
46.1 versus 12.4 per 100,000 live births – and is one of the largest racial disparities among major 
public health indicators (2008).   
Many socially disadvantaged minority women find that reproductive health care that 
promotes healthy mothers and babies is unavailable, leaving them without many available 
choices (Dehlendorf et al. 2010, Roberts 1993, Rutherford 1992).  Furthermore, poor women, 
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and especially poor women of color, find limited access to reproductive services and 
information, including information about the option of abortion since they disproportionately 
rely on federally funded family planning clinics for contraceptives and basic reproductive health 
services (Arons and Agenor 2010, Rutherford 1992).  Many poor women and women of color 
live under circumstances that make it difficult for them to obtain early abortions (Dehlendorf and 
Weitz 2011, Nsiah-Jefferson 1989).  Even with the availability of such clinics, one notable 
legislative policy, the Hyde Amendment, highlights the constrained choices that impede African 
American women’s access to abortion through the denial of Medicaid funds for abortion (Arons 
and Agenor 2010, Nsiah-Jefferson 1989, Ross 2006c).  This policy impacted significant numbers 
of women of color and disadvantaged women, causing delays in abortions while they raise the 
necessary funds to cover the costs (Arons and Agenor 2010, Boonstra and Sonfield 2000, Nelson 
2003, Nsiah-Jefferson 1989, Ross 2006b).  In cases in which women are required to raise the 
money needed for an abortion, the time they spend searching for funds makes it more likely that 
they will need a more costly and difficult second-trimester procedure (Fried 2000).  
Prenatal care includes the range of health care services provided by hospitals, clinics, 
trained medical professionals prior to the woman giving birth.  The functions of prenatal care are 
to improve pregnancy outcomes and decrease the likelihood of adverse events such as low birth 
weight and preterm births (Fiscella 1995).  African American infants are twice as likely as White 
infants to be born to mothers who received late or no prenatal care (Rutherford 1992, Spong et 
al. 2011).  Additionally, studies have found that White women are more likely to begin their 
prenatal care in the first trimester, whereas African American women tend to delay treatment 
until the second or third trimester (Alexander, Kogan and Nebukera 2002).  When African 
American women receive timely prenatal care it may still be inadequate and contribute 
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significantly to the disproportionately high infant mortality rate of African American babies 
(Goldenberg et al. 1996, Johnson et al. 2007).  Although prenatal care reduces these risks, 
limited health-care access and use cannot fully explain the disproportionate rate of maternal 
death for African-American women (Parham and Hicks 2005).  
Unrestrained access to medical knowledge is crucial to the optimum maintenance of 
reproductive health and the power to make genuine choices about their reproductive health 
which is the sine qua non of reproductive freedom (Jones 2010, Rutherford 1992).  Reproductive 
choice for financially disadvantaged women and women of color is hindered by numerous 
realities including lack of quality gynecological services, unnecessary reproductive surgery, 
including hysterectomy and other procedures resulting in sterility, inadequate informed consent 
to procedures, lack of information about sex, contraception and health, lack of culturally 
appropriate health service, as well as anti-abortion clinic violence and domestic violence (Jones 
2010, Nsiah-Jefferson 1989, Washington 2006).  Ultimately, the lack of access to proper 
reproductive health care and information enforces the right to have children, while denying the 
right not to (Roberts 1997). 
 
Denied Motherhood 
The systematic denial of reproductive freedom has stained African American women’s 
history in America.  When state legislators and judicial officials deny a woman the right to bear 
children or the ability to maintain control over her reproductive capabilities, she is deprived of 
part of her humanity (Roberts 1997).  The denial of reproductive freedom emerges through 
issues such as sterilization and limited access to reproductive health and decision-making.  In the 
1970s, between 100,000 and 150,000 poor women, half of who were African-American, were 
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sterilized annually under federally funded programs (Roberts 1997).  For women of color, the 
line between helping to control their reproductive lives and coercing them to reduce the number 
of children has never been a clear one and continues to be an area of conflict and compromise.  
 
Compulsory Sterilization 
Women of color have been subjected to systemic and widespread sterilization abuse for 
decades (Davis 1983, Nsiah-Jefferson 1989, Roberts 1997, Roberts 2000).  Sterilization is not a 
phenomenon of the distant past.  A recent study using data from the 2002 National Survey of 
Family Growth revealed that African American women were more likely than White women to 
have undergone tubal sterilization (Borrero et al. 2007).  Sterilization abuse has taken the form of 
both blatant coercion and trickery and the subtle influences on women’s decisions to be sterilized 
(Clark 1984, Nsiah-Jefferson 1989).  Forced sterilization refers to instances in which the woman 
is unaware that she will undergo a sterilization procedure at the time of the surgery and only 
learned of the sterilization after the fact (Lombardo 2008).  Forced sterilization has historically 
been used to enforce family caps under state welfare laws, and a history of racism that devalues 
women of color and portrays them as undeserving mothers (Hooton 2005).  Coercive sterilization 
refers to two particular instances in which sterilization takes place.  First, it refers to an 
individual who is legally unable to give informed consent, due to mental capacity or age.  
Secondly, it may involve an individual who is legally capable of giving consent but is deceived, 
compelled or coerced into being sterilized.  Coerced sterilization is one of the most extreme 
forms of control over a woman’s reproductive life and despite the repeal of sterilization laws; 
such coercion persists among advocates of sterilization for women requiring public assistance 
(Thomas 1998). 
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Because the victims of blatant sterilization have been primarily African Americans, 
Hispanic Americans, and Native Americans, this raises concerns that sterilization has eugenic 
overtones.  Some doctors refused to deliver the infants of African American Medicaid patients 
unless they agreed to be sterilized after delivery (Roberts 1997).  The Eugenics Movement as a 
whole was concerned with what was believed to be the “genetic fitness” of the population.  
Measuring genetic factors rather exclusively through social and behavioral characteristics, the 
Eugenics Movement sought to control reproduction of individuals of perceived inferior races, 
including African Americans.  The U.S. government attempted to reduce the number of people 
on welfare by taking action to limit the transference of poverty from generation to generation 
(Roberts 1990, Ross et al. 2007).  In particular, the Eugenics Movement centered around the 
goals of creating a supreme race, supporting the Birth Control Movement targeting African 
American women as unfit, and working to prevent their reproductive freedom (Lee 2000).  By 
permanently denying women the right to bear children, sterilization enforces society’s 
determination that a woman is unworthy of motherhood.  The end of slavery did not afford 
African American women any greater right to sexual autonomy and the disproportionate 
sterilization of this population was yet another manifestation of the dominant society’s 
devaluation of them as mothers (Roberts 1990, Roberts 1993).  
Another method of sterilization is the hysterectomy, a medical procedure that surgically 
removes the uterus.  Hysterectomies were performed on many African American women for 
non-medically indicated reasons and frequently without her knowledge or consent including 
ending a women’s childbearing potential.  Although the practice was performed across the 
country, these procedures were so common in the South they were referred to as “Mississippi 
appendectomies” (Roberts 1990, Rodriguez-Trias 1982, Wilcox 2002).  In efforts to link 
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contraception to welfare, African American women and economically disadvantaged women 
were disproportionately the targets of programs and legislative proposals in the United States 
promoting sterilization or requiring contraceptive use (Boonstra et al. 2000, Rodriguez-Trias 
1982).  Due to its long history, recommendations of hysterectomies may cause suspicion among 
African American women, even in more recent times.   
 
Long-Acting Contraceptives 
A common reproductive choice for women who attempt to avoid pregnancy is the use of 
female contraceptives.  Contraceptives are an empowering tool that women use to control their 
fertility as they deem appropriate.  Population control on the other hand strips women of the 
ability to make fully informed decisions about their fertility and instead subjects women to 
policies and practices that control her reproduction against her will or without her full consent.  
Where contraceptives can be a positive woman-centered experience, population control never is 
(Scully 2004).  
One of the most common long-acting contraceptives is Norplant.  Norplant was approved 
at the end of 1990 and quickly became popular among public policy makers because of its 
simplicity.  Specifically, for five years a woman only had to allow a health care provider to 
surgically implant the device in her arm to induce infertility (Gill 1994).  Furthermore, a great 
portion of the early Norplant users experienced irregular, heavy bleeding that sometimes lasted 
for months and others had no period at all.  Many suffered from severe headaches, nervousness, 
extreme weight gain, hair loss, menstrual bleeding, nausea, depression, and chronic blurred 
vision leading to permanent vision loss or blindness and tumors in the brain (Scully 2004).  
Similarly, Depo-Provera is a “set it and forget it” form of contraception because it regulates 
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fertility for three months, sending a constant stream of hormones throughout the user’s body 
(Scully 2004).  This method also has potential side effects including adverse effects on bone 
density (Pitts and Emans 2008, Westhoff 2003), irregular menstrual bleeding and weight gain 
(Berenson and Rahman 2009, Matson, Henderson and McGrath 1997), and a potentially 
increased risk of cervical cancer (McFarlane-Anderson et al. 2008).  Furthermore, the limitations 
of these two contraceptives are that neither provides any protection against sexually transmitted 
infections and both are associated with decreased condom use (Martin et al. 1998, Scully 2004).   
Much of the debate about Norplant and Depo-Provera use in the United States grew from 
concerns about racial bias in the provision of health care (Lee 2000).  The unique characteristic 
of Norplant is that it removes virtually all control over contraception from the woman (Albiston 
1994).  One of the most salient problems with Norplant was that many physicians were trained to 
insert Norplant yet lacked the skills to remove it.  While physician’s removal skills have 
improved, many state Medicaid policies provide support for insertion but not removal (Arnow 
1996, Scully 2004).  Thus when women desire to have the Norplant devise removed, if they do 
not have funds for the procedure, they are held hostage, often at the discretion of providers and 
politicians.  These long-acting contraceptives caused extreme controversy because they were 
perceived as a form of population control because of its targeting to African American, Latino, 
and Native American women (Albiston 1994, Roberts 1997).  Two examples support these 
claims: the regular use of Norplant among African American women prior to FDA approval and 
courts mandating the Norplant device to be implanted in women convicted of drug or child abuse 
or as a condition of probation (Albiston 1994, Roberts 1997, Watkins 2010).  With the exception 
of Asian American women, women of color have higher Depo-Provera usage rates than 
European American women (Volscho 2011).  Young, low-income, African American and Native 
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American woman with lower levels of education have also been found to be more likely to be 
currently using Depo-Provera than similarly situated European Americans, Asian Americans, 
and Latinas (Volscho 2011).   
Additionally, women frequently made the “choice” of using Norplant or Depo-Provera 
under pressure, thereby making these decisions not a choice but a consequence of coercion, 
particularly after giving birth (Roberts 1997).  Tactics limiting women’s choices to only a few 
methods of contraceptives (e.g., sterilization, Depo-Provera and Norplant) or pressuring the use 
of these methods despite significant health risks, or denying women choices altogether, are 
viewed as attempts of population control (Scully 2004).  Contraception decisions should be 
based on a woman’s health history, current health status, ability to access health care as needed, 
and lifestyle, rather than a health care provider in a position of power perceiving her as a 
problem because she is a woman of color or has an illness (Scully 2004).   
 
Conspiracy, Suspicion & Discrimination 
 While the early occurrence of slave breeding, rape, and sterilization laid a foundation for 
the distrust of programs directed toward sexuality, fertility and reproduction, in contemporary 
African American culture, belief in conspiracy theories may play a significant role in health care.  
Conspiracy theories influence a patient’s decision making in seeking health care, trusting 
providers, and making choices about health behaviors.  Bird and Bogart (2005) conceptualized 
conspiracy beliefs as beliefs about large-scale discrimination by the government and health care 
system against a group (Bird and Bogart 2005).  They explored conspiracy and discrimination 
beliefs in relation to contraception among a randomly selected sample of 71 African Americans.  
Specifically these authors explored (1) birth control conspiracy beliefs, (2) perceived group 
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discrimination, and (3) attitudes toward and perceived effectiveness of contraceptive methods. 
Among their sample, 36.9% agreed with the statement “doctors and nurses coerce African 
American women to use certain birth control methods” and 48.6% agreed with the statement 
“Whites want to keep the numbers of African American people down.”  Between five to forty-
nine percent endorsed the conspiracy beliefs regarding birth control.  They also found their 
respondents reported perceiving discrimination when seeking health care for family planning or 
contraceptive services.  Interestingly, those with stronger beliefs of conspiracy also held more 
negative attitudes toward contraceptive methods (Bird and Bogart 2005).  Finally, these authors 
contended that their findings of conspiracy beliefs regarding birth control were similar to beliefs 
found among African Americans over three decades ago.   
Actions and attitudes aroused suspicions among African Americans that family planning 
efforts were inspired by racist and eugenic motives, designed to eliminate African Americans as 
a race (Dula 1994).  Certain segments of the African American community mistrusted the 
underlying intention of both private and government efforts with respect to contraception.  Some 
African Americans in particular became skeptical of the increasing push for contraceptive 
dispersal in poor urban neighborhoods, accusing contraceptive proponents of promoting nothing 
less than “Black genocide” (Caron 1988).  The infamous Tuskegee experiment is one of the most 
notable medical atrocities in American history, in which this 40-year study the United States 
Public Health Service withheld treatment from 400 impoverished African American men 
diagnosed with syphilis.  However, little focus has been given to the women and children who 
were the invisible victims of the experiment.  At least 50 unnamed women and children 
contracted syphilis from the untreated men.  Their needs were ignored until 1975 when the 
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government approved treatment for 27 wives who tested positive for syphilis and 17 children and 
2 grandchildren with congenital syphilis (Gamble 1997).   
Additionally, negative interactions and counseling with health care providers have 
important implications for the health of individuals as well (Yee and Simon 2011).  Several 
researchers have found that a significant percentage of patients report experiencing 
discrimination based on their race, socioeconomic status, sexual orientation or other factors when 
receiving health care (Rouse-Amett, Dilworth and Stephens 2006).  It has also been found that 
experiences with discrimination can have adverse physical and mental effects (Bird and Rieker 
2008, Rouse-Amett, Dilworth and Stephens 2006, Williams and Williams-Morris 2000, Yee and 
Simon 2011).  In another study by Bird and Bogart (2005), they suggest that perceptions of 
discrimination may affect the interactions African American women have with the health care 
system and her receipt of family planning or contraceptive services.  In a telephone survey of 
500 African American women of reproductive age, the authors found that while the majority of 
women indicated they had seen a provider for family planning services, 2 of 3 women reported 
race-based discrimination when obtaining these services.  The respondents spoke of experiences 
with providers that reflected stereotypes of African American women, such as assumptions about 
multiple sexual partners.  They also touched on concerns of contraceptive safety and a broader 
historical view of birth control as a form of African American genocide (Thorburn and Bogart 
2005).  These authors suggest that future discussions surrounding unintended pregnancy, birth 
control, and HIV/AIDS risk in African American women should take into consideration the 
historical context of these issues, because African Americans may be more suspicious of certain 
contraceptive methods.  Thus, considerations should be made for historical and current policies 
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and experiences within the health care system that may explain ways in which African 
Americans access and receive health care (Dula 1994, Jupka et al. 2008). 
Dorothy Roberts’ seminal work, Killing the Black Body, brought to light the socio-
historical struggle for reproductive freedom by tracing the pathways from slave owner’s 
economic vested interest in bonded women’s fertility to the more contemporary attempts to 
coerce African American women and welfare mothers to accept Norplant and Depo-Provera 
(Roberts 1997).  The horrific history of oppression that African American women have endured 
through the brutal exploitation of their reproductive labor coupled with prior negative 
experiences with health care institutions and personnel have led many African American women 
to distrust institutional recommendations, thereby putting these women at risk for unintended 
pregnancy, sexually transmitted infections, and compromised reproductive health (Mullings 
2006).   
 
Reproductive Health and Disabled Women 
Although most chronic conditions are disabling, clear lines distinguishing between 
chronic illness and disability continue to be blurred (Gabe, Bury and Elston 2009).  Some have 
argued that society makes clear distinctions between the able-bodied and the disabled and that 
chronic illness and bodily states are separated from such structures (Gabe, Bury and Elston 
2009).  Nonetheless, symptoms and disability are indeed the principal outcomes of chronic 
conditions and become the focus of protracted personal and medical care (Verbrugge and Jette 
1994).  In short, in many instances, chronic conditions affect bodily functioning and daily 
activities and can lead to disability–conceptualized as the restriction or lack of ability to perform 
an activity in a normal manner (Nosek et al. 2001).  Disability is generally categorized into three 
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broad categories: (1) communication, (2) physical, and (3) mental (Waldrop and Stern 2003).  
For the purpose of this dissertation, disability is narrowly defined as bodily limitations that 
restrict physical activities.   
 
Discouraged Motherhood 
Medical providers treat disabled women as incapable of making their own choices, 
especially those choices involving sexuality and pregnancy (Kallianes and Rubenfield 1997).  
For most women choosing to bear a child is an unquestioned right, yet society insists that 
disabled women justify and defend their decision (Killoran 1994).  To assume that childbirth is 
not a concern for women with disabilities denies their normal desires (Jackson and Wadley 
1999).  It also underlies the serious lack of consumer and clinical information about risks and 
precautions of pregnancy, labor and delivery for women with disabilities (Nosek and Simons 
2007).  Women with disabilities have reported that their mothering rights have been denied 
through subtle discouragement by doctors, professionals, and family members due to the 
assumption that they will breed more disabled individuals (Kallianes and Rubenfield 1997, 
Romano 1982, Volz 2006, Walsh-Gallagher, Sinclair and McConkey 2012).  In extreme cases, 
providers have performed forced sterilization through unwanted and unnecessary tubal ligations 
or hysterectomies on disabled patients (Cole 1988, Volz 2006).   
As part of a study on maternity, motherhood, and disability, Carol Thomas (1997) 
conducted interviews with 17 women having Crohn’s disease, diabetes, asthma, Addison’s 
disease, cerebral palsy, and systemic lupus erythematosus to explore their reproductive 
experiences (Thomas 1997).  Participants were varied in terms of childbearing status, and 
included women who were currently pregnant, had no children, one child, and two or more 
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children.  Participants expressed their desires, decisions and experiences of childbearing and 
parenting as intertwined with additional concerns stemming from the physical limitations they 
encounter, personal experience of living with impairment, and their knowledge about the 
possible effects of reproduction on their bodies.  Secondly, women in the study spoke of the 
pressure they felt resulting from their disabled condition that often made them feel as though 
they had to demonstrate that they were, or could be, “good enough mothers.”  The third key 
finding was the women’s experiences of receiving “unhelpful help” from health care and social 
workers, imposing suggestions from health care workers that were neither solicited nor desired.  
Thomas suggested this process served not to simply manage the pregnancy, but more-so to 
manage the disabled woman (Thomas 1997).   
 
Denied Reproductive and Sexual Information 
Women with illness or disease are frequently deemed asexual; therefore they are prone to 
ignore considerations of reproduction or sexual activity (Curry et al. 2009, Matthews 1983, Ray 
and West 1984).  When a disabled female is denied her sexual needs and desires, she is being 
denied her basic humanity as well (DeLoach 1994).  Nosek and Simmons (2007) identified 
several sources of sexual and reproductive health disparities among disabled women.  
Misconceptions about disabled women include that they are not sexually active, asexual, 
uninterested in sex, unable to take part in sexual activity, or are sexual “monsters” unable to 
control their sexual drives and feelings (Anderson and Kitchin 2000, Nosek and Simons 2007).  
Another source of disparities for this population are the systemic barriers that ensue when 
physicians fail to offer reproductive health services or fail to consider women with disabilities as 
sexual beings or assume that sexuality is not a relevant or important issue.  Many health care 
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providers are unprepared to discuss issues of fertility, conception, and pregnancy for disabled 
women (Philips and Phillips 2006).  Again, numerous barriers exist that impact disabled 
women’s prenatal and reproductive care such as provider attitudes, poor communication, 
knowledge of the conditions, and physical, structural factors such as limited time and resources 
(Becker, Stuifbergen and Tinkle 1997, Philips and Phillips 2006, Piotrowski and Snell 2007).  
Regrettably, disabled women report they are not generally afforded legitimacy and are 
unrecognized as having sexual desire – these serious claims of discrimination warrant attention 
by health professionals.  Disabled women have also reported dissatisfaction with the lack of 
adequate counseling on sexuality, birth control, pregnancy, and childbirth from gynecologists 
and rehabilitation professionals (Asch and Fine 1988, Nosek et al. 2001).  
A study by Becker, Stuifbergen, and Tinkle (1997) focused on how reproductive care 
could be improved for women with physical disabilities.  These authors conducted in-person 
interviews designed to elicit information about birth control, pregnancy, sexually transmitted 
infections and barriers to quality services and suggestions for improvement.  Ten women 
between the ages of 28-47 with various disabilities participated: four women had congenital 
impairments, one was disabled at 16, the other five were disabled in adulthood, all were White, 
with some college education, all were employed or attending college.  The thematic analysis of 
the transcripts revealed barriers, facilitators, and issues regarding birth control, pregnancy, 
sexually transmitted diseases, menopause, aging, and sexuality.  This study suggested that 
individual barriers to receiving appropriate reproductive care among women with disabilities 
may be attributable to the lack of knowledge about their bodies and sexual function and their 
difficulty in obtaining reliable contraceptive information (Becker, Stuifbergen and Tinkle 1997).  
Other barriers impacting participants’ reproductive health included limited options for 
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contraception, health care providers’ insensitivity, inaccessible equipment and facilitates, lack of 
knowledge about disabilities, limited information tailored to their needs, and avoidance of 
regular gynecologic visits due to difficulty accessing these services (Becker, Stuifbergen and 
Tinkle 1997).  Women with disabilities have also reported experiencing doctors not providing 
them with information on sexuality and birth control because of assumptions that they did not 
need it (Nosek et al. 2001). 
For women with disabilities, the desire for freedom to bear children is no different than 
able bodied women and translates into the need for them to have equal access to reproductive 
services, including sexual health education and access to contraceptives (Kallianes and 
Rubenfield 1997).  The lack of access to sexual health information can prove to be dangerous in 
that women with disabilities who have not received adequate information may not obtain 
necessary reproductive and obstetrical care, or appropriate information on protecting themselves 
from sexually transmitted infections (Kallianes and Rubenfield 1997, Sheppard-Jones et al. 
2008).  Women with disabilities may also fail to receive crucial information about domestic 
violence and sexual assault, which affects the population with disabilities at a greater percentage 
than the general population (Healey, Humphreys and Howe 2013, Kallianes and Rubenfield 
1997).  Because of these assumptions, many disabled women are likely to be restricted from 
opportunities that are readily available to nondisabled women (Lonsdale 1990).  Some of which 
include dating, engaging in sexual behaviors, and experiencing motherhood (Asch and Fine 
1988, Piotrowski and Snell 2007, Rintala et al. 1997). 
Women with disabilities are often perceived as unfit mothers because some believe they 
are unable to cope with the demands of pregnancy, childbirth, and childrearing (Hwang 1997, 
Lonsdale 1990, Palombi 2012).  They are also considered unfit because they are viewed as 
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incapable of contributing either physically, emotionally, or financially to a family (Asch and 
Fine 1988).  This raises concerns for disabled mothers about maintaining their right to parent 
(Wates 1997).  Research found that parents with disabilities experience prejudice about their 
rights or abilities to parent.  In a national study of nearly 1,200 parents with disabilities, about 
15% of the parents reported experiencing threats to their right to parent by having their children 
removed from the home (Kirshbaum and Olkin 2002).  These threats contribute to a skewed 
sense of identity and promote feelings of mistrust of the health care system. 
Women with disabilities are also deemed unfit because they are perceived as casting the 
burden of their care upon their children-, who are required to work as young caregivers.  Being a 
young caregiver is portrayed negatively and is usually seen as the result of restrictions on the 
child’s freedom, for example to social activities, friendships, employment opportunities, 
recreation, educational achievement and person growth (Aldridge and Becker 1994, Bilsborrow 
1992, O'Neil and Platt 1992).  Children of disabled parents are sometimes seen as victims and 
their parents are scrutinized for their values, choices, and even their right to parent at all (Keith 
and Morris 1995, Prilleltensky 2004). 
Cultural stereotypes depict disabled women as asexual, unfit to reproduce, overly 
dependent, unattractive–traits that are generally removed from the sphere of true womanhood 
and feminine beauty (Garland-Thomson 2002).  A woman with a disability is often treated as 
asexual and then viewed as an unfit lover and also assumed to be an unfit mother (Nosek and 
Simons 2007).  The dominant stereotype of disabled women is the poster child, which refers to 
the practice of many disability-related charity organizations of using a child with a particular 
disability for charity marketing and medical campaigns (Blackwell-Stratton et al. 1988).  The 
poster child portrays the image of the individual as cute, but not sexy: always the cared for, never 
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the caregiver (Blackwell-Stratton et al. 1988).  These images are exploitive, designed to evoke 
pity in the nondisabled, and thus a desire to contribute money to the charity, while an unintended 
consequence extends the image from the philanthropic world into society-at-large (Ferri and 
Gregg 1998).  Joanna Weinberg (1988) also suggested that women with disabilities are ‘‘locked 
in a perpetual adolescence’’ because of the strong societal taboos attached to their sexuality 
(Weinberg 1988: p. 274).   
 
Reproductive Health and Women with Genetic Conditions 
Genetic risk has various consequences for women as bearers, carers and carriers of 
children (Hallowell 1999).  Risk is a pervasive concept in the social and medical context of 
reproductive health and a central concept surrounding genetics (Kelly 2009).  The concept of risk 
dominates the process of becoming a mother in the United States and is used to categorize 
women from the time of their first prenatal visit (e.g. high- and low-risk) (Lippman 1994).  
Women with genetic conditions are frequently compelled to engage in the medical “risk” 
discourse and are often told of the risks associated with motherhood and advised of these risks by 
health care providers (Hallowell 1999, Thomas 1997).  A woman’s decision to conceive, abort, 
or bear a child with genetic disorders may be subject to questions of personal and communal 
accountability.  As biomedicine tends to direct attention toward matters of prevention, popular 
standards suggest that a child is morally wronged when he/she is knowingly, deliberately, or 
negligently brought into being with a health condition likely to result in disability, suffering, or 
significantly reduced life choices relative to other children with whom he/she will grow (Davis 
1997, Green 1996, Purdy 1995).  So while a woman may have not have control over her own 
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genetic occurrence, women can control the birth of a child who may inherit the condition; she 
may be required to make choices in the face of the fetus’ genetic risk (Lippman 1994).  
 
Tentative Motherhood 
Prenatal Testing 
Prenatal testing affects pregnant women in various ways, but it especially affects those 
known to be at greater risk of genetic abnormality due to family history, age, ethnicity, etc. 
(Shakespeare 1998).  Prenatal testing is performed to detect any fetal abnormalities and 
procedures include amniocentesis, fetoscopy, and ultrasonography.  Prenatal testing provides a 
means to avoid the family distress and suffering associated with the unpredicted birth of babies 
with genetic disorders and malformations.  Prenatal testing allows geneticists and obstetricians to 
offer the choice for abortion covertly, if not overtly, when the fetus has been found to have 
particular a-typical characteristics (Lippman 1994).  Definitions and expectations of normal 
pregnancies intersect with developments in prenatal diagnosis and a growing “ideology of risk” 
surrounding pregnancy (Lippman 1994).  Autosomal disorders are of particular interest in 
reproductive planning as couples may be at increased risk for having a child with one of these 
disorders (Driscoll, Sehdev and Marchiano 2004).   
Prenatal testing requires that women make decisions and then live with the consequences, 
a process which Barbara Katz-Rothman’s interviewees described as tragic (1993).  Findings 
from her interviews revealed that the investment in pregnancy with the question of ‘genetic risk’ 
renders women’s relationships with their own pregnancies as ‘tentative and fragmented’ because 
the pregnancy cannot be fully accepted until “abnormalities” are ruled out by the tests (Katz-
Rothman 1993).  Rothman argued that prenatal diagnosis involved a process of “evaluating 
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disabilities, deciding which disabilities make life not worth living for the person, and also which 
disabilities demand too much or are beyond [the mother’s/parents’] competence” (1993:160).  
Unfortunately, the burden of choice based on information provided by a prenatal genetic 
diagnosis will be disproportionally borne by women, since it is the expectant mother who will 
physically live out that decision through her body, whether through continuation or termination 
of a “risky” pregnancy.  If the decision is made to have a prenatal diagnosis, and the fetus is 
shown to be affected, then a decision is made whether to terminate the pregnancy or to give birth 
to an affected child.  These decisions are far from straightforward as there is more than one type 
of prenatal test and various risks associated with different procedures including the threat of 
miscarriage (Kazazian, Boehm and Dowing 1985).  Moreover, women are faced with an 
interesting paradox in that the choice to undertake prenatal testing reinvests the very conditions 
and discourses (eugenic and obstetric) which may make screening seem necessary (Shakespeare 
2011, Steinberg 1996).  It has generally been assumed that women who reject prenatal testing or 
those who chose not to terminate following a positive result do so out of a priori opposition to 
abortion or a commitment not to devalue the lives of those with disabilities (Kelly 2009).  
Petrou et al. (1992) investigated the uptake of prenatal diagnosis in 170 couples “at risk” 
of having children with sickle cell disease.  They showed that the stage of pregnancy, type of 
sickle cell disease, and ethnic group influenced participants’ choices.  They described that half of 
the couples in which one partner had sickle cell disease chose to receive prenatal diagnosis.  
Participants also reported a greater acceptability of first trimester prenatal diagnosis.  Women 
who were pregnant for the first time were least likely to request prenatal diagnosis.  The direct 
experience of sickle cell disease within the family was also important: over 90% of the women 
who already had an affected child chose prenatal diagnosis.  A common statement made by those 
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mothers was that they could not cope with the increased anxiety associated with having two 
affected children.  Many of the women indicated that they would not consider terminating the 
current pregnancy because of sickle cell disease, but would have liked to know the diagnosis.  A 
common reason given for declining prenatal diagnosis was fear of the procedure and the risk to 
the pregnancy, since miscarriage is an increased outcome for these women (Petrou et al. 1992). 
Etchegary et al. (2008) investigated retrospective attitudes toward prenatal testing and 
screening decisions among 38 adult women who had recently delivered a healthy child at Ottawa 
Hospital.  Of these 38, 16 declined screening and 22 accepted (Etchegary et al. 2008).Their 
analysis categorized women into having two main influences on their decisions: empathetic 
knowledge and embodied knowledge.  In this study, embodied knowledge referred the personal 
experience with pregnancy or illness and empathetic knowledge drew upon family and friends’ 
experiences with raising a child with a disability or screening procedures.  They found that 
participants embodied and empathetic knowledge influenced their decisions about prenatal tests.  
However, those who declined screening placed more emphasis on empathetic knowledge and 
expressed not wanting to place any additional stress or grief on their family and friends.  The 
participants who declined also expressed a more negative attitude toward termination and had 
fewer embodied experience with serious illness.  
Chen and Schiffman (2000) also qualitatively explored attitudes toward genetic 
counseling and prenatal diagnosis among 15 adults with physical disabilities including spina 
bifida, muscular dystrophy, amyotrophic lateral sclerosis (ALS) and others (Chen and Schiffman 
2000).  The participants in this study viewed genetic counseling as either general information, a 
discussion of recurrence of risk/reproductive choice, or warnings about birth defects.  
Perceptions of prenatal diagnosis included preparation for having a child with special needs, 
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knowledge for pregnancy, detection of birth defects and confirmation of a healthy baby.  One 
participant indicated that prenatal diagnosis was a means of allaying fears and stated “knowing 
takes some of the fear away.  If you can get enough knowledge about something, it puts you in a 
better seat” (p. 146).  Finally, participants did not view genetics as a mechanism for advancing 
eugenic ideals.  Ultimately, these authors suggest that previous views on prenatal diagnosis have 
been primarily negative, and their findings suggest that while an individual may in fact oppose 
termination, she may still favor prenatal diagnoses and these two procedures are not mutually 
exclusive (Chen and Schiffman 2000). 
While individuals with genetic conditions make autonomous decisions based on their 
risk, not often enough is it acknowledged that they draw upon various experiences, from multiple 
contexts (family, community, society) and are influenced by various competing discourses on 
their health (clinical, media, family) all of which influence their personal experiences and 
interpretations of genetic risk and screening (Vahabi and Gastaldo 2003).  
 
Summary 
This section illustrates how various social locations and identities may work together to 
label women with sickle cell disease as unfit mothers for multiple reasons.  This section provided 
an overview of the historical foundations, economic limitations, and discrimination experienced 
by African American women that may give rise to suspicions in health care in general and 
reproductive health care in particular.  It also illustrates how women with disabilities may be 
discouraged from motherhood through the lack of reproductive information and how women 
with genetic conditions may experience pressure to terminate pregnancies.  Women with sickle 
cell disease are an ideal population to sociologically study the nexus of race, gender, and genetic 
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illness.  These social categories have rarely been considered together alongside issues of 
reproductive health care, particularly with regards to the woman's choice to be sexual, to bear 
children–even an illness-affected child–and to be seen as fit to mother (Kallianes and Rubenfield 
1997).  
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SICKLE CELL DISEASE 
Sickle cell disease (SCD) is an inclusive term for a group of autosomal recessive 
inherited blood disorders, called hemoglobinopathies.  There are four major sickle cell disease 
disorders: sickle cell anemia hemoglobin S (Hb-SS), sickle beta-zero thalassemia (Hb-Sß0), 
sickle cell anemia hemoglobin C (Hb-SC), and sickle beta-plus thalassemia (Hb-Sß+) (Platt and 
Sacerdote 2006).  The most common and severe form of sickle cell disease is sickle cell anemia 
(Hb-SS) (Brawley et al. 2008).   
The disease is named “sickle” cell because of the 
abnormally shaped red blood cells that resemble the sickle, a 
farm tool with a cured sharp edge that is used for cutting 
wheat.  Normal red blood cells (RBCs) are composed of 
hemoglobin A and are soft and round, which allow them to 
flow easily through blood vessels.  For those with sickle cell 
disease, mutations in the hemoglobin gene (the main iron-
containing oxygen-transport protein in blood) lead to the 
production of an altered form of hemoglobin–hemoglobin S 
(Hb-S)–which distorts the normal shape of RBCs into a 
sickle shape (Ballas 2002, Frenette and Atweh 2007).  
Sickled RBCs are rigid and exhibit enhanced adherence to vessel walls, which obstruct the blood 
flow from the heart to organs and extremities, causing pain, infection and organ damage (Ballas 
2002, Frenette and Atweh 2007, Platt and Sacerdote 2006).  
For conditions that are inherited in an autosomal recessive pattern, a person needs to have 
two copies of a gene change in order to have the condition and receives one gene change from 
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each parent (Nussbaum, McInnes and Willard 2004).  Those affected with sickle cell disease 
have a 50% probability of transmitting sickle cell disease to their children if one parent has sickle 
cell disease and one has sickle cell trait (Hb-AS), and a 100% probability of transmitting the 
disease to a child when both parents have sickle cell disease (Platt and Sacerdote 2006).  When 
one parent has the disease and the other parent has normal hemoglobin, all children will have 
sickle cell trait.  
 
Table 1. Genetic Transmission of Sickle Cell Disease 
Pattern Parent 1 Parent 2 Children 
1 Sickle Cell Disease 
(Hb-SS) 
Sickle Cell Disease 
(Hb-SS) 
100% Hb-SS 
2 Sickle Cell Disease 
(Hb-SS) 
Sickle Cell Trait 
(Hb-AS) 
50% Hb-AS 
50% Hb-SS 
3 Sickle Cell Disease 
(Hb-SS) 
Normal Hemoglobin 
(Hb-AA) 
100% Hb-AS 
 
 
The first introduction of sickle cell disease into the literature occurred in 1910 by Dr. 
James Herrick, a physician at the University of Chicago (Herrick 1910).  Since then, probably no 
other medical condition has been so strongly associated with the concept of race (Bediako and 
Haywood 2009).  Sickle cell disease currently affects more than 250 million people worldwide 
and includes people from a diverse range of racial and ethnic backgrounds (Bediako and 
Haywood 2009).  Globally, the disease is found throughout Africa, Asia, the Caribbean, the 
Middle East, Europe, and the United States.  In the United States, sickle cell disease is most 
common among African Americans and has long been perceived as a “Black disease” (Bediako 
and Haywood 2009, Elander et al. 2003, Nash and Telfair 1994, Wailoo 2001).  Many have 
speculated that the sickle cell gene migrated to the United States and the Caribbean as a 
consequence of slavery which explains the high prevalence among Afro-Caribbean ethnic groups 
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(Hendrickse and Williams 1966, Serjeant, Singhal and Hambleton 2001).  The exact prevalence 
of sickle cell disease in the United States is currently unknown, however, it is estimated based on 
2008 U.S. Census reports and national newborn screening records that approximately 100,000 
Americans have sickle cell disease and approximately 1,800 infants are born with the disease 
each year (Hassell 2010).  
Over the past 30 years, life expectancy has improved dramatically due to early diagnosis, 
improvements in effective and comprehensive treatment, and the use of antibiotics, (Barakat et 
al. 2009, Driscoll 2007).  Previously, the life expectancy estimate for individuals with Hb-SS 
was 14 years old; yet today the average life span reaches 42 years for men and 48 years for 
women (Platt et al. 1994).  For those with Hb-SC the median mortality age is currently estimated 
at 60 years for males and 68 for females (similar to the general population of African Americans) 
(Nash and Telfair 1994, Platt et al. 1994).  This data is somewhat dated and it is likely that 
advances in treatment over the last 19 years have improved survival rates even further.  Despite 
medical advancements, the condition continues to be debilitating and life-threatening with a 
shorter lifespan than those unaffected by the condition (Brawley et al. 2008, Platt et al. 1994).  
 
Sickle Cell Trait 
Those with sickle cell trait are healthy carriers of the sickle cell gene who have inherited 
one normal hemoglobin gene from one parent and the sickle gene from the other parent (Platt 
and Sacerdote 2006).  Those with sickle cell trait are generally asymptomatic, however the trait 
has been found to be associated with sudden death, organ problems, and loss of fetus during 
pregnancy, and complications during strenuous physical activity and exercise (Connes et al. 
2008, Mitchell 2007, Tsaras et al. 2009).  More than two million Americans, again mostly 
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African Americans, have sickle cell trait (Hb-AS) (Brawley et al. 2008, Creary, Williamson and 
Kulkarni 2007).  While sickle cell trait is not a disease, when both parents have the trait, there is 
a 25% chance with each pregnancy that the child will be born with the disease, 50% chance the 
child will be born with the trait, and a 25% chance the child will be born with a normal 
hemoglobin (Nussbaum, McInnes and Willard 2004, Platt and Sacerdote 2006).  If only one 
parent is a carrier, there is a 50% chance of a child inheriting only one abnormal gene and being 
a carrier, like the parents (Table 2) (Nussbaum, McInnes and Willard 2004, Platt and Sacerdote 
2006).  
 
Table 2. Genetic Transmission of Sickle Cell Trait 
Pattern Parent 1 Parent 2 Children 
1 Sickle Cell Trait 
(Hb-AS) 
Sickle Cell Trait 
(Hb-AS) 
25% Sickle Cell Disease 
50% Sickle Cell Trait 
25% Normal Hemoglobin 
2 Sickle Cell  
(Hb-AS) 
Normal Hemoglobin 
(Hb-AA) 
50% Sickle Cell Trait 
50% Sickle Cell Disease 
 
Clinical Manifestations & Management 
Sickle cell disease is a multifaceted disease with a complicated symptomology and 
pathophysiology and unpredictable clinical course.  The chief manifestation is intermittent and 
unpredictable episodes of severe pain, which occur when sickled red blood cells constrict blood 
vessels and capillaries and cause a reduction of oxygenated blood supplied to tissues (Steiner and 
Miller 2006).  The vaso-occulsive pain episode is the hallmark of sickle cell disease and is the 
most distressing symptom to patients and leads to debilitation and impaired functioning in 
school, employment and other social contexts (Driscoll 2007).  Pain episodes are also the most 
frequent cause of recurrent morbidity in Hb-SS and accounts for 70-90% of hospital admissions 
among those with sickle cell disease in the United States (Serjeant, Singhal and Hambleton 2001, 
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Solomon 2007).  A pain episode may occur in nearly every parts of the body, the most 
commonly affected are bones, back, legs, chest, and abdomen and can be exacerbated by minor 
infections, a cold, sore throat, stress, fatigue, high altitudes, and abrupt weather changes (Ballas 
2002, Danielson 2002, Yale, Nagib and Guthrie 2000).  While length and severity are uncertain, 
pain is often based on the patient’s general health condition, physiological and psychological 
state, pain coping mechanisms, and other medical complications or conditions (Smith et al. 
2005).  A single pain episode can last between 3 to 14 days and has been compared to that of 
terminal bone cancer pain (Elander et al. 2003, Smith et al. 2003).   
Although pain is the chief manifestation, sickle cell patients also suffer from acute chest 
syndrome, a combination of respiratory symptoms including fever, cough, chest pain, and 
shortness of breath and in some cases hypoxemia (Vichinsky et al. 1997).  Approximately 50% 
of patients who have sickle cell disease experience at least one episode of acute chest syndrome 
during their lifetime (Driscoll 2007).  Infections also occur frequently due to splenic dysfunction, 
which can be life threatening in children under the age of three due to their immature immune 
system (Schnog et al. 2004).  Lung disease (pulmonary hypertension) and the increased 
susceptibility to severe bacterial infections–meningitis, pneumonia, and septicemia–are all major 
causes of death among individuals with the disorder (Brawley et al. 2008).  
Nearly 10% of all sickle cell patients will have a stroke at some point during their life, 
with the peak incidence occurring between the ages of 4 and 6 (Claster and Vichinsky 2003, 
Schnog et al. 2004, Steiner and Miller 2006).  Strokes also occur within the blood vessels of the 
brain, limiting oxygen levels and causing weakness on one side of the body, headache, cranial 
nerve palsy, and speech impairment (Claster and Vichinsky 2003, Schnog et al. 2004, Steiner 
and Miller 2006).  Some strokes can be so small they may go undetected, leading to 
	  	  
37 
compromised cognitive and physical functioning.  Additionally, individuals with SCD have 
decreased height, weight and body mass index, delayed sexual maturation, delay in onset of 
menarche and pubertal development when compared to those without the condition (Cepeda et 
al. 2000, Singhal et al. 1994).  Other common manifestations of sickle cell disease include skin 
ulceration, aplastic crisis, silent cerebral infarcts, and organ damage (Platt 2008, Schnog et al. 
2004).  This disease can also lead to an increased risk of early death, failure to thrive, vomiting, 
liver disease, and mental retardation in untreated survivors of stroke (Lee et al. 2006).  
 
Clinical Management 
There is no cure for sickle cell disease and therefore the condition requires on-going 
treatment.  Treatment for this condition is complex and ripe with controversy as it mainly 
consists of opioids.  The main purpose for sickle cell management is the prevention of pain and 
other complications and treatment of pain. 
 
Pharmacologic  
Pharmacologic management of sickle cell pain includes three major approaches: non-
opioid analgesics (Tylenol, ibuprofen, aspirin, etc.), opioid analgesics (codeine, morphine, 
oxycodone, etc.), and adjuvants (e.g., antihistamines, antidepressants, etc.) (Ballas 2002, Jacob 
2001).  Opioids are the mainstay of treating moderate-to-severe pain and are often associated 
with addiction and illicit drug use (Ballas 2007, Pack-Mabien and Haynes 2009, Shaiova and 
Wallenstein 2004).  Antibiotics can be used to prevent infection in early childhood and treat 
infection in adults with sickle cell disease (Jacob 2001).  Management also includes treatments 
for pain episodes and dehydration by using supplemental oxygen, non-steroidal anti-
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inflammatory drugs (NSAIDs), and intravenous fluids (Smith et al. 2005).  One of the premier 
causes of increase life expectancy, oral penicillin, is now administered during early childhood 
and has done much to improve and extend the lives of children with sickle cell disease (Falletta 
et al. 1995).  
 
Hydroxyurea 
Hydroxyurea is currently the only FDA-approved disease-modifying therapy for sickle 
cell disease (Brawley et al. 2008).  Hydroxyurea is taken orally and stimulates fetal hemoglobin 
production, raises hemoglobin concentration, increases the size of the red blood cell, lowers 
white blood cell counts, and decreases red blood cell intracellular dehydration (Hankins et al. 
2005, Steinberg et al. 2003).  This therapy is most often used with patients who have moderate to 
severe disease, as indicated by the number of painful episodes or occurrences of acute chest 
syndrome (Platt 2008).  However, long-term use may lead to cancer, specifically acute leukemia, 
which may influence willingness to take the drug and adherence (Platt 2008).  While use of 
Hydroxyurea has been found to reduce hospitalizations and pain episodes, it is currently not 
recommended during pregnancy as it has been found to have teratogenic effects which may 
increase the risk of adverse effects and fetal abnormalities (Brawley et al. 2008, Hassell 2005, 
Lanzkron et al. 2010).  
 
Blood Transfusion Therapy 
Blood transfusion therapy is commonly used in sickle cell disease management in those 
severely affected individuals to lower the fraction of cells that contain the hemoglobin S and 
improve oxygen carrying capacity and/or prevent sickle-related vascular effects (Danielson 
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2002, Wayne, Kevy and Nathan 1993).  Transfusions also help minimize or prevent disease 
complications such as acute chest syndrome, stroke, cerebrovascular disease, vaso-occlusive 
episodes, and other organ damage (Josephson et al. 2007, Wayne, Kevy and Nathan 1993).  
While a life saving measure, if not used carefully, transfusions are associated with iron overload, 
alloimmunication and viral infectious complications (Wayne, Kevy and Nathan 1993).   
 
Bone Marrow Transplantation 
Bone marrow transplantation is the only potential curative treatment for sickle cell 
disease (Hoppe and Walters 2001).  While bone marrow transplantation has been successful for 
treating sickle cell disease in select individuals, the mortality rate and adverse long-term side 
effects with this treatment have been generally high, especially in adult patients (Walters et al. 
1996).  Unfortunately, locating sufficient matched donors significantly limits the number of 
candidate patients for this procedure and only 14% of sickle cell patients have indications for 
transplantation with a matched donor sibling (Driscoll 2007).  
 
Alternative Therapies 
Many alternative therapies methods are used to decrease the use of opioid and actually 
provide a more holistic approach to managing or eliminating the pain rather than simply riding 
patients of the perception of pain (Bodhise et al. 2004).  Continuous opioid use is associated with 
problems of over-sedation, acute chest syndrome, and paradoxical effects (Shafer and Vichinsky 
1994).  Cognitive strategies including hypnosis, imagery, and biofeedback can be effective 
methods for pain reduction (Chen, Cole and Kato 2004, Sibinga et al. 2006, Telfair et al. 2004, 
Yoon and Black 2006).  Some of the non-pharmacologic pain management options include heat 
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packs, relaxation, distraction, music, massage, therapeutic exercises, menthol cream rub, self-
hypnosis, acupressure, and acupuncture (Ballas 2007, Bodhise et al. 2004).  
 
Self-Management 
Those with chronic illnesses must assume a large part of the responsibility for managing 
their condition, which consists of self-care practices and routines that promote prevention and 
improve health (Thorne and Patterson 2000).  Individuals with sickle cell disease are encouraged 
to take health promotion steps to prevent the onset of pain and promote their own health status 
(Platt and Sacerdote 2006).  Some of these behaviors include drinking plenty of water, managing 
fever, getting enough oxygen, flying in unpressurized airplanes, getting plenty of rest, refraining 
from over-exertion, taking prevention medications appropriately, avoiding certain situations such 
as getting too hot or cold, and avoiding alcohol, tobacco and illicit drugs (Platt and Sacerdote 
2006).  These measures are just a few of the key principles of promoting health for a person with 
sickle cell disease.  
 
Reproductive Health Outcomes  
The two most researched areas of reproductive health in women with sickle cell disease 
are pregnancy complications and acceptable contraception methods.  Notwithstanding medical 
advances, women with sickle cell disease continue to experience worse pregnancy outcomes than 
women without the condition and there continues to be some degree of uncertainty concerning 
appropriate contraceptive methods.  It well established that women with sickle cell disease face 
numerous pregnancy risks, complications, and adverse outcomes (Barfield et al. 2010, Chase et 
al. 2008, Hassell 2005, Howard, Tuck and Pearson 1995, Smith et al. 1996).  Prior to 1972, 
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maternal and perinatal rates averaged 4.1% and 52.7%, respectively, however these rates have 
declined and in 2005 were reported as averaging 1.7% to 22.7% (Powars et al. 2005).  The 
decreases in maternal and perinatal mortality may be the result of advances in medical care, 
improvements in transfusion medicine, and more frequent prenatal care. The increased risks of 
complications and mortality caused providers to recommend that women with sickle cell anemia 
become sterile, terminate pregnancies when they occur, or avoid pregnancy altogether based on 
known health risks (Fort et al. 1971, Fort and Morrison 1972). 
There is an emerging body of evidence-based research on pregnancy outcomes for 
women with sickle cell disease (Serjeant et al. 2004, Mou Sun et al. 2001, Villers et al. 2008).  
Of note, these women are at increased risk for several adverse pregnancy outcomes.  Mou Sun 
and colleagues (2001) reported that women with sickle cell disease (hemoglobin SS) were 
significantly more likely to need antepartum hospital admission (62%, often as a result of sickle 
pain crises, pyelonephritis, and anemia), deliver by cesarean section (34%), deliver an infant that 
was premature (45%) or low birth weight (46%), and experience a postpartum infection (22%) 
compared to the control group (Mou Sun et al. 2001a).  Villers and colleagues analyzed data 
from the 2000-2003 National Inpatient Sample from the Healthcare Cost and Utilization Project 
to assess the maternal morbidity of pregnant women with sickle cell disease (Villers et al. 2008).  
The authors identified 17,952 deliveries to women with sickle cell disease in the United States 
during this time-period.  Similar to Mou Sun and colleagues, the authors reported a higher 
cesarean delivery rate in women with sickle cell disease as compared to controls (31% vs. 25%, 
p< 0.001).  Moreover, they experienced a higher mortality rate (72.4 vs. 12.7 deaths per 100,000 
deliveries).  Unlike previous reports, this study found that when compared with control subjects, 
women with sickle cell disease had higher rates of infections and pregnancy-related 
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complications such as preeclampsia, placental abruption, preterm labor, intrauterine growth 
restriction, and genitourinary tract infection (Villers et al. 2008).  
More recently, Barfield and colleagues (2010) conducted a retrospective study comparing 
pregnancy outcomes between women with sickle cell disease and women with no 
hemoglobinopathies (Barfield et al. 2010).  Both cohorts of women were of African descent and 
residents of the state of Massachusetts, with a live birth greater than 20 weeks and greater than 
350g.  The study used the Massachusetts Pregnancy to Early Life Longitudinal (PELL) Data 
System to examine perinatal outcomes for these populations between 1998 to 2006.  The study 
yielded a total of 663 deliveries and found that fetal demise was twice as likely among SCD 
deliveries relative to deliveries to women with no reported hemoglobinopathies.  The authors 
also found preeclampsia, lung disease, and heart disease were reported more often among 
women with sickle cell disease compared to deliveries to women with no reported 
hemoglobinopathies, while no differences were found for diabetes, hypertension, kidney disease, 
or eclampsia.  Over 58% of deliveries to women with sickle cell disease were covered by public 
insurance yet nearly 26% of the deliveries had less than adequate prenatal care utilization.  This 
study suggests that women in this population continue to experience major risk-factors for 
pregnancy and delivery-related complications including higher risks of fetal death, preterm 
births, low weight births, cesarean delivery and induction of labor (Barfield et al. 2010). 
Numerous concerns and misconceptions exist surrounding potential complications and 
disease exacerbations due to the use of contraception among women with sickle cell disease 
(Howard, Lillis and Tuck 1993, Legardy and Curtis 2006, Manchikanti et al. 2007).  Much of 
this uncertainty is due to the lack of useful and clear guidelines and conflicting messages 
regarding contraceptive use among this population (Chase et al. 2008, de Abood et al. 1997, 
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Foster 1981, Ladipo et al. 1993).  The use of combined oral contraceptive pill has found to be 
associated with increased thrombotic risks, while progestogen-only pills, injectables, and 
implantables have resulted in concerns for possible clinical or hematological complications.  
Other documented research cautions against the use of copper intrauterine devices (Howard, 
Lillis and Tuck 1993, Koshy and Dorn 1996).  In a recent Cochrane review of steroid hormones 
for contraception in this population, Manchikanti and colleagues (2007) state that Depo-Provera 
appears to be a safe contraception option and may reduce sickle pain crises, but that more well-
designed randomized controlled trials are needed.  The authors only included a trial by De 
Ceulaer that reported that affected women who were on Depo-Provera were 77% less likely to 
report a painful sickle crisis over a six-month period (DeCeulaer et al. 1982, Manchikanti et al. 
2007).  
This gap in knowledge of the complete reproductive health experience for women with 
sickle cell disease was further stressed in a small body of research on contraceptive choices for 
adolescents with chronic diseases.  Kimberly Heroux (2003) and Gittles and Strickland (2005) 
explained that there is a lack of information on identifying effective contraceptive options for 
medically ill adolescents who may be initiating sexual activity.  In a review of the literature, 
Heroux (2003) described the challenge of promoting contraceptive counseling in adolescents 
with the concurrent medical management of a chronic illness.  Some medications may alter the 
effectiveness of hormonal contraception; thus, Heroux reviewed the literature and clinical 
recommendations for this at-risk population.  For adolescent girls with sickle cell disease, 
Heroux stated that recommendations vary widely given the uncertainty on the magnitude of risk 
for venous thromboembolism in oral contraceptive users with sickle cell disease (Heroux 2003).  
Gittles and Strickland (2005) echoed these findings and argued that, while adolescents with the 
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disease may be chronically ill, there is evidence to suggest that their experiences with sexual 
activity mirror their healthy peers (Gittes and Strickland 2005, Suris et al. 1996). 
There is a paucity of evidence-based research on family planning practices for women 
with sickle cell disease (de Abood et al. 1997, DeCeulaer et al. 1982, Howard, Lillis and Tuck 
1993, Manchikanti et al. 2007).  Again, this gap is critically important as the unintended 
pregnancy rate for women with sickle cell disease may be higher than in the general population 
(Howard, Lillis and Tuck 1993).  Howard and colleagues first reported on this disparity in 1993 
in an analysis of 156 women with sickle cell disease in North London (Howard, Lillis and Tuck 
1993).  Interviewers asked participants about their menstrual, obstetric, and gynecologic history 
and current and past contraceptive use.  The authors found that the average age at menarche was 
15 years and that of the 207 pregnancies reported, 133 were unplanned (64%).  Moreover, 45% 
of participants had used a combined oral contraceptive at some time.  The use of the progestin-
only pill (20%), intrauterine contraceptive device (19%), and Depo-Provera (17%) was much 
lower but may reflect contraceptive patterns of that study period.  When asked about pregnancy 
counseling they had received, 36% of respondents indicated they were advised not to become 
pregnant by their medical provider.  However, only three participants indicated this advice had or 
would have influenced their pregnancy plans. 
Samuels-Reid et al. (1984) collected sexual and menstrual history, contraception 
behaviors, pregnancy, and general demographic data from 52 patients with sickle cell disease 
and 80 patients without sickle cell attending two family planning clinics at Howard University 
and George Washington University (Samuels-Reid, Scott and Brown 1984).  These authors 
found that 39% of the sickle cell group reported being sexually active compared to 81% of 
control group with age of first sexual relationship at 17 years old.  Thirty-three percent of sickle 
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cell group (SCD) reported use of some contraceptive method compared to 66% of controls and 
only 30% of sickle cell group had used any contraception during most recent sexual encounter 
whereas 64% of controls had used contraception.  Of the contraception methods reported 39% of 
sickle cell group used the birth control pill while 86% of control group used this method.  
Among the sickle cell group in particular, 23% used a diaphragm, 15.4% used an IUD, and 23% 
used foam.  Only 38% of the sickle cell group and 49% of controls reported unplanned 
pregnancies, while 55% of the SCD group reported using no contraception at time of unplanned 
pregnancy versus 35% lack of use among controls.  The method of delivery varied between the 
two groups with 46% of the sickle cell group and only 18% of control group having caesarian 
sections (Samuels-Reid et al 1984).  While this study is dated, the results indicate that while 
women in the sickle cell group reported less sexual activity, they were older at time of first 
encounter, which would provide additional time for reproductive health education.  
A much more recent study conducted by Knight-Madden and Barton-Gordon (2009) also 
explored the prevalence of contraceptives usage in women with SCD and factors affecting their 
use (Knight-Madden and Barton-Gooden 2009).  Similar to the Samuel-Reid study, they used a 
quantitative questionnaire to capture demographic, obstetric history, sexual activity, desire for 
pregnancy, contraceptive type, reason for non-usage, and beliefs about contraceptive use and 
pregnancy in women with SCD.  A total of 132 women between the ages of 20-28 were 
recruited; the median age was 24 years old.  The questionnaire results revealed that 83% reported 
having been told of the risks of morbidity and mortality associated with pregnancy.  Among the 
sickle cell group, 75% had been pregnant at least one time, of those 72% had at least one live 
birth, 25% had at least one miscarriage and 4% had still born infants or elective abortions.  
Forty-eight percent of women in the study had used at least one contraceptive method during the 
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past 3 months.  From greatest to least, women (or partners) used condom (39%), intramuscular 
depot medroxyprogesterone acetate injection (28%), oral contraceptive pill (22%), withdrawal 
(12%), tubal ligation (6%), the IUD (2%), and emergency contraception (1%).  None of the 
participants reported using an implant, rhythm method, or a diaphragm.  Among the 68 non-
contraception users, 52% reported they did not use contraception because they were not sexually 
active, 15% expressed a desire to become pregnant, 18% indicated a fear of potential side effects, 
16% had the belief that they were unable to conceive, 12% expressed that they did not like 
contraceptives, 10% had health concerns, and 2% had partners who did not like contraceptives 
(sum of percent greater than 100 because more than one selection was allowed).  Women in the 
study reported their use of contraceptives was associated with sexual activity, not desiring to 
become pregnant, and being in a relationship.  Women who declined to use DMPA cited 
excessive vaginal bleeding and the fear of injections as reasons for their choice (Knight-Madden 
2009). 
O’Brien et al. (2011) reviewed Michigan Medicaid claims of 250 adolescents with sickle 
cell disease, aged 13-21 over a period of 20 months.  In this review they abstracted data for 
procedures and pharmacy claims to establish pregnancy and contraception use.  They review 
found claims for hormonal contraception among 20 patients, the most common was DMPA 
(N=12).  They also found 64 patients had at least one pregnancy during the study time period and 
16 had two or more pregnancies, of these 59 were among patients aged 13-18 (O'Brien et al. 
2011).  These results indicate more pregnancies than contraception use among this insured 
population. 
The most recent practice bulletin on hemoglobinopathies in pregnancy issued by the 
American College of Obstetricians and Gynecologists (ACOG), and summarizing much of the 
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literature presented above, advocated for a multidisciplinary approach in the management of 
pregnancy for women with sickle cell disease (2007).  Specifically, they encourage an ongoing 
discussion between the obstetrician, hematologist, and anesthesiologist involved in the patient’s 
care during the perinatal period.  Given the presence for painful crises during pregnancy and an 
increased risk for adverse pregnancy outcomes, the ACOG stressed the need for coordinated 
care.   
 
Other Reproductive Issues 
The biomedical model of sickle cell disease perceives the condition as a major health 
threat to African Americans and a disease that should be avoided if possible (Meyappan 2001).  
Thus, biomedical discourses have focused on preventing the transmission of the disease by 
suggesting that statistical probability be used as the basis of deterring parents from passing the 
trait or disease onto their child (Fort et al. 1971, Kenen and Schmidt 1978, Markel 1992).  It also 
focuses on treatment and prognosis of the disease and the elimination of the disease through 
selective reproduction (Meyappan 2001).  Linus Pauling, the scientist who discovered the 
molecular basis of sickle cell disease (1968), suggested: 
There should be tattooed on the forehead of every person a symbol showing 
possession of the sickle-cell gene…[so that] two young people carrying the same 
seriously defective gene in a single dose would recognize the situation at first 
sight, and refrain from falling in love with one another. (1968:269)  
 
The issue of moral judgment has generally been confined to discussions of voluntary 
health risks, particularly people’s lifestyle choices or behavior (Hallowell 1999, Pauling 1968).  
However, more recently it has been observed that individuals not only have a responsibility to 
avoid voluntarily exposing themselves and others to health risks, but also may be seen as bearing 
some responsibility for their genetic risks (Kenen 1994, Lupton 1995a, Steinberg 1996).  Moral 
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judgment may also include issues of blame or causality.  Blame within the social construction of 
illness occurs, in some instances, whereby the disease is considered preventable or controllable 
yet still contracted.  Thus certain people are blamed for their own condition which may 
incorporate a moral judgment about how the condition was contracted and pre-existing hostility 
toward the group most affected by it (Bayer 2008, Deacon 2006, Scambler 2009).  The moral 
taint associated with a stigmatizing condition may cause some suffers to deny their health status, 
a situation that can lead to the further spread of a genetic condition.  
Responsibility and blame are both important concerns in the context of reproductive 
choice.  Downing (2005) illustrated the complexity of reproductive decision-making in families 
facing Huntington’s Disease and suggested that accepting, modifying, or avoiding genetic risk is 
an emergent and jointly negotiated process (Downing 2005).  Additionally, Steinberg (1996) 
argues that women in particular are seen as bearing the responsibility for genetics risks.  She 
observed that genetic discourses construct women as “the bearers of nature’s defects” or “genetic 
transmitters” and as such, they are seen as, almost single-handedly, bearing the responsibility for 
passing on their own and their partner’s genes (1996:267).  Previous research has found that 
mothers of children with sickle cell disease have been blamed for knowingly conceiving and 
giving birth to children who suffer physically (Burnes et al. 2008, Hill 1994b, Jenerette and 
Brewer 2010).  However, little work has been done exploring similar experiences among women 
with sickle cell disease rather than sickle cell trait. 
Genetic responsibility generally consists of three dimensions: (1) knowing about the self 
for self, (2) knowing about the self for others, and (3) knowing about the self to oblige others to 
know (Etchegary et al. 2009).  These dimensions have implications for test decisions, family 
relationships and other family members desire to know (or not know) and to act (or not act) with 
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respect to their own genetic risk (Arribas-Ayllon, Sarangi and Clarke 2008).  Moreover, several 
aspects of genetic responsibility arise within the context of the family: gendered responsibility, 
reproductive choice, and genetic testing of children (Arribas-Ayllon, Sarangi and Clarke 2008).  
Genetic responsibility has become a key factor for understanding how genetic risks reshape 
choice, identification, and obligation within families.  Women are traditionally viewed as 
gatekeepers and transmitters of family information (Richards 1996).   
Practices and belief systems that hold mothers fully responsible for the good of the child 
and the safety of the family go back at least to the Enlightenment (Badinter 1981).  In America, 
the Eugenics Movement embraced the theory that intelligence and other traits were genetically 
determined and therefore inherited.  Eugenicists held women directly responsible for the genetic 
make-up for their children. Eugenicists argued that unfit women would not willingly limit their 
reproduction because they lacked the mental ability to comprehend the issues and avoid 
seduction and, like the Jezebel, appeared incapable of exerting restraint on her capacity for 
impure breeding (Ettorre 2000, Ettorre 2002).  Proponents alleged that many social problems 
could be eradicated by using eugenics through the enforcement of sterilization laws, thereby 
preventing the reproduction of genetically unfit individuals (Allen 1999).  Eugenic goals 
concentrated on weaning out undesired characteristics by denying certain individuals with 
undesired traits the right to marry as well as the right to carry, birth, and rear children (Waxman 
1994).   
Society scrutinizes, judges, and censures decisions by parents who decide to bear children 
with potential genetic abnormalities.  Parents decide whether to be tested as a carrier or to 
conceive when there is a family history, or positive carrier status for certain genetic conditions, 
whether to submit to prenatal screening or to continue the pregnancy of a nonviable fetus 
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identified as having a genetic anomaly (Shepherd 1995).  When society determines that certain 
choices are irresponsible, it has a range of options, one of which is judging those parents to be 
morally irresponsible in their use of genetic information.  As a result, these parents feel their 
requests for assistance are not respected (Green 1996).  The goal of reducing genetic disorders in 
the population may be based on a desire to reduce human suffering or reflect an economic 
concern that the genetic disorder is costly.  An even more damaging script is one that elevates 
eugenics to a level in which the offspring are expected to reach an ideal level of human 
functioning (Charo and Rothenberg 1994).  Ultimately, the diagnosis of a disease-producing 
genetic trait suggests that those with the trait should avoid passing the disease on to a child by 
genetic screening of fathers, undergoing prenatal testing, selective abortion, or forgoing 
parenthood altogether. 
 
Partner Testing  
In the context of genetic conditions, both partners must be a carrier of the gene in order to 
reproduce a child with the condition.  Parents must first have access to an understanding of their 
genetic information.  Then they must seek to obtain the trait status of the prospective partner.  If 
the affected person has a partner who is a carrier, then she or he may have other choices when it 
comes to having children.  It may be complicated for a carrier to face her potential reproductive 
decisions because sexual and reproductive behaviors are governed by complex biological, 
cultural, and psychosocial factors. 
The balance of power within intimate relationships is linked to sexual and reproductive 
health in three primary ways: (1) directly, (2) through its relationship with violence between 
partners, and (3) through its influence on the use of health services (Blanc 2001, Gillespie 1971).  
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The power in sexual relationships refers to the relative ability of one partner to act 
independently, to dominate decision making, to engage in behavior against the partner’s wishers, 
or to control the partner’s actions (Pulerwitz, Gortmaker and DeJone 2000).  Gender-based 
power relations can have a direct effect on the ability of partners to acquire information relevant 
to their reproductive health, their ability to make decisions related to their health and the ability 
to take action to protect or improve their health of those who depend upon them (Blanc 2001).  
Women who discover their fetus may be disabled or will be disabled consequently face many 
pressures to terminate the pregnancy.  According to Tait (1986), the concept of “pro-choice” in 
the process becomes reduced to choosing between having a “healthy baby” or a “defective child” 
(1986:452).  The control women exercise over the risk or safety of their sexual practices is 
constrained by the confusion of their ideals of sexuality with their expectations of romance, love, 
and caring (Tait 1986).  Women’s strategies for engaging in safer sex develop within social 
contexts characterized by gendered power inequalities, sexual hierarchy, and male dominance 
(Holland et al. 1992).  
In a study of 34 adult women with sickle cell trait, 15 did not find out their partner’s 
status prior to becoming pregnant (Anie, Berger and Asgharian 2003a).  Reasons given for not 
finding out their partner’s status fell into two categories: the awkwardness and sensitivity of 
asking their partner to be tested and a lack of awareness of the availability and importance of 
testing.  One participant with the experience of sickle cell disease–through caring for a child with 
the condition–thought that testing was important and would expect her daughter to ask her own 
partner to be tested.  Women who found it difficult to ask their partner explained that discussing 
sickle cell trait was not considered part of “normal” conversation.  Some believed that asking 
could provoke problems within the relationship and it was viewed as “dangerous ground.”  Also, 
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participants suggested that asking or having a dialog would imply the woman wanted children 
with their partner and often women did not want to ask before reaching a natural state of 
discussing having children.  Reasons respondents gave for not having prenatal diagnosis were 
because of the risk of miscarrying and the thought of having to make a decision about abortion if 
they found that the fetus was affected.  Some women also mentioned that prenatal diagnosis was 
not an option because it was offered too late into their pregnancy.  Despite the risk of disease to 
offspring, none of the participants questioned their role as a mother.  Nevertheless, at least six 
women who previously had a child with SCD considered the possibility of not having any more 
children (Anie, Berger and Asgharian 2003a).  
One of the most relevant studies on this topic found that female African American 
carriers of the sickle cell trait tended to “obfuscate” medical information (Hill 1994b).  That is, 
they obscure, confuse and confound the information almost subconsciously in order to protect 
their reproductive autonomy.  Nonetheless, women in this study found that it could be very 
difficult for them to talk about their carrier status with partners in advance of becoming pregnant.  
It was often easier to take the risk of giving birth to an affected child than to initiate discussions, 
which could expose them to the risk of rejection and the possible loss of opportunity to 
reproduce.  Providing genetic information to these women did not limit the risk of transmission 
of disease to offspring.  African American women were seen by the author as placing a strong 
value on motherhood yet they were not in a position to make active empowered choices 
regarding it.  Furthermore, the postnatal implications for mothers include the additional 
responsibilities of attending to their own health and medication regimens, dealing with the 
physical symptoms of SCD that may impede parenting, preparing for future child care, and 
coping with guilt about passing the condition to the child (Hill 1994b).  
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Summary 
The literature outlined above illustrates the clinical complexities of sickle cell disease.  
The lives of individuals with this condition are punctuated with pain and they may often 
encounter multiple barriers to effective treatment, which may be fueled by racial, economic, and 
health-related stereotypes.  Having this condition may also limit perceived physical and 
psychological ability to maintain or pursue relationships, employment or education goals.  
Moreover, women with this condition face numerous reproductive health considerations and 
complications, and African Americans have a double burden since they are weighted by the 
intersecting identities of gender, illness and race.  
Recent increased life expectancy of individuals with SCD calls new attention to issues of 
the psychosocial aspects of reproductive health and choices that have previously been ignored in 
the literature.  The unpredictable and recurrent nature of sickle cell pain, sociocultural 
stereotypes, and the use of opioids for treatment present significant challenges in the delivery of 
health care (Jacob 2001).  The close association of African American women with sickle cell 
disease coupled with multiple sociodemographic factors may cause providers to develop 
preconceptions about patients based on their membership in racial and economic status groups, 
which may contribute to these women receiving less than appropriate health care.   
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CHAPTER 3 
THEORETICAL FRAMEWORK 
SOCIOLOGY OF THE BODY 
 
Sociology of the body emerged as sub-discipline of medical sociology to examine the 
role of the body in the social world by drawing attention to how bodies are assigned meaning, 
used to define the self, and are socially controlled and regulated (Nettleton 2001).  This sub-
discipline has been used to illustrate how the body has been commodified and used as form of 
personal expression and the development of identity (e.g., tattooing, cosmetic surgery, piercing, 
etc.) (Nettleton 2001, Pitts 1988). Sociology of the body involves the study of the embodied 
nature of the cultural representations of the human body, the social nature of performance, and 
the reproduction of the body and populations in the social structure (Turner 2004, Turner 2009).  
Turner (2004) argues embodiment is: 
not a static entity but a series of social processes taking place in the life course.  
Embodiment is a life process that requires the learning of body techniques such as 
walking, sitting, dancing, and eating.  It is the ensemble of such corporal 
practices, which produce and give a body its place in everyday life… 
Embodiment is the mode by which human beings practically engage with and 
apprehend the world (2004:71) 
 
Traditionally, three dominant approaches exist within of the sociology of the body 
framework: naturalistic, social constructionist, and phenomenological.  The naturalistic approach 
focuses on explaining human actions and social differences in terms of their biological 
predispositions (Nettleton 2006).  As a natural or biological entity with specific physiological 
characteristics subject to natural processes of aging and decay, the body is never just a physical 
object since it is shaped and influenced by society creating a unique relationship between the 
natural body and society (Shilling 1993, Turner 1996).  Chris Shilling (1993) suggested the body 
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“is not simply constrained by or invested with social relations, but also actually forms a basis for 
and contributes towards these social relations” (Shilling 1993).  He also suggested that the 
naturalistic body has been used as a justification for the subordination of women, minorities and 
other socially marginalized groups.  
The social constructionist approach challenged the naturalistic approach by 
demonstrating the role social forces play in the creation, organization, and regulation of the body 
and the ways through which social meanings are attached to human bodies (Nettleton 2006, 
Shilling 1993).  Based on this approach, bodies are socially constructed, no different from the 
evolution of historically changing modes of production and consumption, rather believed to be 
the culmination of key biological features (Freund 1998).  Bodies are also socially constructed 
through individuals’ perceptions and experiences which are based on cultural norms and mores 
which define appropriate behavior (Wainwright 2008).  Using this approach, bodies are assigned 
meaning based on social perspectives and norms in the society in which they live.  Furthermore, 
certain bodies have particular social or cultural meanings attached to them, which compel 
individuals to perceive meanings of an illness that are socially stigmatized, contested, and 
medically unexplainable which also influence the way they experience the illness (Turner 2009). 
The phenomenological view distinguishes between the lived body and the biological 
body. The concept of the “lived body” was developed by the French philosopher Maurice 
Merleau-Ponty in his Phenomenology of Perception, which argued that the body is a location of 
meaning and identity as well as a material entity, which is experienced within society (Merleau-
Ponty 1962). He indicated:  
We are in the world through our body, and … we perceive that world within our 
body. … [T]hus by remaking contact with the body and with the world, we also 
rediscover ourselves. (1962: 206) 
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Merleau-Ponty’s perspective involves two main aspects: body as subject and body as 
object.  The body-subject examines the individual’s negotiation of societal rules in dealing with 
the body and is understood as both active and passive.  The body actively questions the world in 
terms of the cultural schemas, which it has actively acquired rather than passively accepting 
messages from the world (Crossley 1995).  For example, perceptive of tattoos, beauty or what it 
means to be overweight (anorexia) etc. Research inspired by this idea of the lived body and lived 
experience has been important in demonstrating the intimate and necessary connections between 
body, experience, and identity (Crossley 1995, Nettleton 2006).  The body-object purports that 
the relationship between society and the individual is established through training, disciplining 
and socializing the body to adopt societal values concerning the body (Crossley, 1995).  Thus, 
society defines, shapes, and limits the body.  As both subject and object, the body is both a 
producer of society as well as a product of society.  
Besides these three approaches to sociology of the body, individuals find meaning in their 
experience. Meaning is embedded in our experience within the world and is not separate from 
either the embodied experiences or the world itself (Waskul and Vannini 2006). Betsy Fife 
(1994) posited that meaning consists of two fundamental and linked dimensions: self-meaning 
and contextual meaning.  Self-meaning refers to the perceived effect of the event on various 
aspects of one’s identity, while contextual meaning refers to the perception of an event based on 
social circumstances that surround it.  Fife states that meaning is not static.  Self-meaning will 
change as the individual grows and brings new experience to the situation.  Contextual meaning 
will also change as the individual moves in and out of social environments (Fife 1994).  
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The Body and Feminism 
Feminist scholars contend that the body is as much a cultural entity as a biological one 
and even physiological processes such as menstruation are frequently culturally constructed and 
assigned gendered meanings (Kuhlmann and Babitsch 2002).  Feminists consider the body to be 
biologically sexed which has been categorized and treated within a patriarchal society in a 
manner that limits a woman’s life chances (Lorber and Moore 2002).  The feminist perspective 
suggests that the body is a location of meaning and identity in addition to a material entity, with 
unique social and physical experiences (McDonnell et al. 2009).  Many feminist writings on the 
body have also adopted the work of Michael Foucault highlighting the construction and 
regulation of women’s bodies in and through medical discourse and health care settings by 
invoking his concept of power and the various ways individuals are constrained within society 
(Eckermann 1997, Harding 1997).  Foucault (1978) asserted that “power is not an institution and 
not a structure; neither is it a certain strength we are endowed with.”  Instead, he defines power 
as “a complex strategical situation in a particular society” (p. 93).  For Foucault, the body is a 
site of the manifestation of power relations and it is managed by ideological constraints and 
everyday practices (Foucault 1978).  
In the 2002 seminal work Gender and the Social Construction of Illness, Judith Lorber 
and Lisa Moore describe how menstruation has been socially constructed as a medical condition 
in a number of ways that include pathologizing women’s emotional and bodily states.  Using the 
biomedical model, menstruation transformed from a natural bodily process to an illness requiring 
treatment thereby providing justification for the production of medical intervention that either 
suppress or delay or suppress menstruation. The association of menstruation as a social problem 
and health concern served to maintain notions of idealized femininity during menstruation, 
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encouraged women to monitor their bodies through medical surveillance, and allowed 
pharmaceutical companies to promote medical treatment for menstruation (Lorber and Moore 
2002).  The modern trend of menstrual suppression represents an example of neo-medicalization 
of women’s bodies with two effects:  erasing female difference and promoting the patriarchal 
ideals of personhood as controlled and contained (Lippman 2004).  
Another area of focus of women’s bodies is pregnancy and childbirth.  Pregnancy is also 
an illustration of embodiment.  During pregnancy two separate entities exist, a woman and a 
fetus, within the body of the woman.  Thus, the pregnant body is not completely separate from 
the self and is different from but not inseparable from the self (Gadow 1980).  The physical 
growth and movements of the fetus within the mother’s body depicts a notion of separateness.  
The fetus’ presence is not detached from the mother, but is part of the mother’s lived experience 
of her pregnant body.  The view of a woman and her fetus as separate beings perpetuates the 
view of the fetus as patient and the woman as a mere container.  This realization causes the use 
of surveillance and monitoring at the expense of the mother’s self-determination.  
Barbara Katz Rothman (1998) argued that of the various stages of motherhood, 
pregnancy is probably the most intense form of mothering, as women host their babies inside 
their bodies and shape them with their bodies.  Much of Katz Rothman's work has illustrated how 
pregnancy affects women’s lives and how women develop a social and not just a biological 
relationship with their children even prior to childbirth (Katz Rothman 1998).  During pregnancy 
and childbirth, the primary medical assumption is that this is a time of risk and danger (Parry 
2008, Sagrestano and Finerman 2012).  This assumption shifts the view of pregnancy and 
childbirth from a natural and normal occurrence to one that requires scientific monitoring.  From 
a feminist perspective, the medical involvement during pregnancy can be seen as a form of social 
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control – an interruption to women’s bodily autonomy which entitles medical professionals 
access to the body (Westfall 2006). 
In a modern patriarchal society, the pregnant woman often experiences a loss of control.  
The medicalization of women’s bodies and experiences is perpetuated by removing the natural 
process from the comfortable home to the clinical hospital.  Prior to becoming a medicalized 
event, pregnancy was an entirely private and female matter that did not require medical 
supervision (Sagrestano and Finerman 2012).  When a woman enters the hospital to give birth, 
she is less likely to experience a purely natural childbirth, more likely to be offered/given drugs, 
and more likely to have an invasive medical procedure, such as an episiotomy or a Caesarian 
section.  
 
The Body and Risk (Embodied Risk) 
Risk and the body are important concepts in understanding reproductive health.  Two 
types of risk have dominated the risk literature, environmental and lifestyle risks (Gabe 1995, 
Lupton 1995b).  Environmental risks have traditionally included factors such as pollution, toxic 
chemicals and nuclear waste which externally imposed, and serve as an indication that an outside 
agent has influenced a person (Kavanagh and Broom 1998).  Lifestyle related risks include 
activities such as smoking, exercise and diet and are the result of certain activities in which 
individuals engage (Kavanagh and Broom 1998).   
Anne Kavanagh and Dorothy Broom (1998) suggest a third category of risks2: embodied 
or corporeal risk.  They distinguish embodied risk from lifestyle or environmental hazards in that 
this type of risk is located within the bodies of individuals. They further suggested that embodied 
risk simultaneously positions individuals either in a current illness state or as a sign of possible 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2 These categories of risks (environmental, lifestyle and embodied risks) are not mutually exclusive. 
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future disease.  Therefore embodied risks define who a person is rather than what they do or 
what is done to them.  With embodied risks, a part of one’s body poses a threat to the self, 
resulting in dissociation between body and self.  Imposing a threat from within the body, 
embodied risks have the potential to define who a person is as opposed to what they do (e.g., 
lifestyle-related risks) or what is done to them (e.g., environmental and occupational risks).  
Finally, embodied risk is most often managed via self-surveillance (Kavanagh and Broom 1998).  
Although risk discourse tends to deeply embedded in predictability and statistical 
principles, estimates remain inherently uncertain. In the case of embodied risk, the risk is 
internalized and experienced as a state of being (Gifford 1986).  Embodied people mindfully 
resolve pragmatic problems with intention and purpose in social encounters that are situated 
within broader social, cultural, and institutional settings (Koenig and Stockdale 2000, Waskul 
and Vannini 2006).  The embodied risk experience is similar to the experience of living with 
disease in that the ways in which a person experiences risk is dependent on her personal 
experiences and her familiarity with the illness (Chalmers and Thomson 1996).  In their research 
on the embodied risk and genetic burden, Barbara Koenig and Alan Stockdale (2000: 130) state:  
How will women understand “risks” that literally reside within them, in their 
genes, over which they have little control, and which they may already have 
passed on to their children?  Will breasts and ovaries be experienced as potential 
time bombs, harboring the early stages of cancer, in need of constant 
surveillance?  
 
As a phenomenological approach, embodiment helps us understand how individuals 
understand risk information and create meaning about risk. Further, with this approach, bodies 
are contextualized within the lives of individuals and the complex relations along a spectrum 
from the biomedical to the social (Roberts 2002).  For example, the biomedical approach to risk 
provides a rational and universal way of preventing unwanted outcomes fostering an individual 
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approach to lifestyle risk.  Conversely, social science examines the strategies developed by lay 
individuals to deal with risk and uncertainty in their lives (Burton-Jeangros 2011).  Genetic risk 
is an embodied risk and considers certain bodies as potentially dangerous and may result in a 
person to experience their body as “other” (Kavanagh and Broom 1998, Robertson 2000).  The 
knowledge of certain genetics may cause the person to perceive their body as possibly dangerous 
(Polzer, Mercer and Goel 2002).  This type of risk warns the individual of potential future 
illness, susceptibility to disease itself, and creates awareness that the body is separate from the 
self.   
In matters of reproduction, Barbara Rothman (1986) noted that the burden of risk 
disproportionally rests upon the female body, whose reproductive processes are already viewed 
with suspicion within dominant obstetric discourse.  The notion of genetic risk thus interfaces 
with already established notions of maternal risk (Katz-Rothman 1993).  Under this guise, 
although both the father and mother influence heredity, as bearers of children, women are 
constructed as the carriers of heredity, holding women liable for choosing to give birth to 
afflicted children, and allowing the deterioration of the population (Caplan 1989, Ettorre 2000).  
Concepts and ideas utilized in reproductive genetics appear to exert more limitations on 
women’s than men’s bodies.  The process of conception and gestation is internal to the female 
body, and the reproductive body represents processes that are unique to females (Ettorre 1999).  
Again, women also bear the burden for the decision to have children, especially when they are 
aware of genetic risks which may jeopardizing the quality of the life of potential offspring.  In 
this way, it is the mother who bears the ethical responsibility for society (Novas and Rose 2000).   
Embodiment can also enter into reproductive health discourse in an attempt to explain 
matters of risk assessment.  Emily Abel and C.H. Browner (1998) and Thomasina Borkman 
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(1979) provide the framework of experiential versus expert knowledge, which are used by 
individuals to assess risk and make health decisions (Abel and Browner 1998, Borkman 1979).  
Experiential knowledge has been conceptualized by Borkman (1979) as knowledge that is based 
upon the experiences of an individual and is highly valued because it has been acquired through 
the individuals’ direct interaction with the physical, social and intellectual world (Borkman 
1979: 450).  Abel and Browner further suggest there are two types of experiential knowledge: 
embodied and empathetic.  Embodied knowledge refers to personal perceptions of bodily 
experiences and sensations (e.g., pregnancy) and empathetic knowledge is derived from close 
association with others living with a particular experience.  Embodied knowledge also refers to 
the subjective perceptions of bodily experiences and sensations (Abel and Browner 1988).  
Empathetic knowledge derives from a close association of with others living with a particular 
experience perhaps through care-giving (Abel and Browner 1998).  Using this framework, 
research tends to draw a distinction between personal knowledge and expert (health care 
professionals) knowledge regarding perceptions of genetic risk, and unfortunately views 
individuals as passive recipients of risk information rather than active agents in their health care 
(Bakker et al. 2001, Cox 2003, Koenig and Stockdale 2000). 
 
Summary 
 The sociology of the body and embodied risk are important theoretical frameworks for 
this study because sickle cell disease may pose perceive themselves as having an embodied risk 
during times of reproductive health.  Focusing on a woman’s bodily processes and how others 
attempt to regulate her reproduction is a key contribution to the existing literature in this area.  
This study touches on matters of the body and how bodies with illness are viewed, as well as the 
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attempts by medical science to regulate, monitor, and place these bodies under surveillance.  To 
date, limited research exists exploring the experiences of women with sickle cell disease, and 
even less research focuses on how women with sickle cell experience reproductive health care 
and decision-making and the ways in which race, gender, and illness may influence the meaning, 
priority, and agency they give to this area of their lives and their approach to achieving optimal 
reproductive health.   
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CHAPTER 4 
 
RESEARCH METHODOLOGY 
 
The purpose of this research was to explore the reproductive experiences and identities 
among women with sickle cell disease.  This study will focus on reproductive health experiences 
with professional health providers, contraception usage, preparation for conception, navigating 
disclosure and testing conversations within intimate relationships and the trajectories of 
motherhood.  This chapter describes the methodological approach to this study including 
sampling, targeted population, data collection, and data analysis. 
 
Methodological Strategy–Phenomenology  
Phenomenological approaches to the body and embodiment use thick descriptions of 
lived experiences that reveal meaning in the life worlds of the individuals who live them 
(Waskul and Vannini 2006).  Phenomenology was founded by the German philosopher Edmund 
Husserl (1959-1938) and is a paradigm used to explore and describe the meaning of a unique 
experience (VanManen 1990).  It is based on an inductive approach that focuses on describing 
(rather than explaining) the life worlds of those being studied and the ways in which a 
phenomenon has been experienced and the meanings individuals construct of their lived 
experience (Creswell 2003, Omery 1983).  Phenomenological researchers are driven by the 
desire to understand the ways in which people experience their world, how they see a given 
phenomenon instead of preconceived theoretical constructs and research hypotheses (Creswell 
2003, Omery 1983).  Descriptive phenomenology focuses on descriptions of peoples’ 
experiences and the meanings attached to them, rather than the interpretations, rationalizations, 
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and speculations about the causes of their experiences (Koch 1995).  This method of inquiry is 
particularly suited for this study since participants report their perceptions when describing their 
lived experiences with reproductive health.  Further, this is one of the few occasions in which 
this topic has been examined among women with sickle cell disease. 
 
Black Feminist Standpoint Theory 
One of the most dominant qualitative inquiry approaches used in research with women is 
the standpoint perspective which according to Smith asserts that “the notion of a standpoint of 
women doesn’t stand by itself as a theoretical construct; it is a place to begin inquiry” (1992:91). 
This approach focuses on the everyday experiences of women not as universal but recognizing 
the diversity of women’s experiences (Smith 1992). 
Black Feminist Standpoint Theory is defined as ideas that are produced by Black women 
that clarify a standpoint for Black women (Collins 2000a).  According to Patricia Hill Collins, 
Black Feminist Standpoint Theory acknowledges that knowledge is the sum of two perspectives: 
first, the taken-for-granted knowledge shared by members of the group, and second the 
declarations from experts who are part of the group and express the group’s standpoint (Collins 
1986).  Black Feminist Standpoint Theory further asserts that African American women occupy 
a unique standpoint based on their subjection to both racism and sexism (Collins 2000a).  Indeed, 
women’s diverse social locations influences how they experience being a woman as they occupy 
multiple locations and identities, which shape their experiences, opportunities and decision-
making abilities.  However, while women share similar physical and biological events (e.g., 
menstruation, childbirth, menopause, etc.) that affect their health and well-being, they frequently 
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differ in how they experience and create meaning from these events based upon their social 
locations (Martin 1987).   
As a methodological theoretical construct, Black Feminist Standpoint Theory comprises 
four fundamental tenants: 
(1) Valuing women’s experiential knowledge through their lived experiences.  Collins 
argues that only those men and women who experience the consequences of a 
phenomenon can select topics for investigation and methodologies used.  Black 
feminist epistemology then begins with connected knowers, those who know from 
personal experience.   
(2) Using dialogue in assessing knowledge claims.  Collins suggests that when at 
least two subjects come together, knowledge is based on perception, there is no 
objective existence apart from lived experiences, and knowledge emerges through 
dialogs.  
(3) Implementing the ethics of caring. Collins argues that all knowledge is 
intrinsically value-laden rather than believing that researchers can be value-free, 
and would thus be tested by the presence of empathy and compassion.  She 
further asserts that it does not require the separation of the researcher from her or 
his own experience nor does it require or assume that it is possible to separate our 
thought from our feelings.  
(4) Implementing personal accountability.  Collins claims that because knowledge is 
built on lived experience, the assessment of knowledge is a simultaneous 
assessment that precipitates through the filter of an individual’s character, values 
and ethics.  This approach states that all knowledge is based upon beliefs, which 
implies personal responsibility.  
 
Black Feminist Standpoint Theory places the experiences of Black women at the center 
of analysis through interpretive frameworks that extend beyond demonstrating that African 
American women are capable of creating specialized knowledge, but they are also able to create 
new ways of thinking about that knowledge (Collins 2000b).  This framework also acknowledges 
that Black women in the United States are not a homogeneous group. Thus, it would seem 
appropriate that the reproductive health of African American women be rooted in this ideology 
which has long asserted its commitment to improving the position of this population (Collins 
2000a, King 1998, Nelson 2003).  Accordingly, much of the work of reproductive health among 
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women of color highlights how race and class work together to shape and restrict reproductive 
choices (Cook 1995, Pine and Law 1992, Ross et al. 2007).   
This study used Black Feminist Standpoint ideology as a point of inquiry which supports 
the use of qualitative methods as inviting African American women to share the stories of their 
experiences (Collins 1986).  It also aimed to give voice to the lives and expressions of African 
American women and position them as informants who are not simply talked to but speak for 
themselves (Collins 1986).  Several key dimensions ground Black Feminist Standpoint Theory 
including: (1) Black women in the United States participate in a dialectical relationship linking 
oppression and activism; (2) wisdom gained from experience is highly valued; (3) action and 
thought inform one another in ongoing dialogue; (4) Black women intellectuals from all walks of 
life (not only academia) have contributed to Black feminist theory; (5) Black feminist and social 
justice projects are intimately connected; and (6) Black women’s struggles are part of the wider 
struggle for human dignity, empowerment, and social justice (Collins 2000a).   This study was 
designed to uncover the voice of African American women, particularly those with SCD, in 
order to illuminate how the “web of stigmatization” works to shape their perception of and 
experience with reproductive health care.  In addition, this study was designed to explore how 
women with sickle cell disease approached health rather than illness, which also fits into this 
paradigm as it presumes an image of African American women with SCD as being empowered 
and healthy rather than victims who are sick. 
 
Research Questions 
How do women with sickle cell disease think about and experience 
reproductive health? That is, how do they perceive the type and quality of care 
they receive concerning their reproductive health? What importance do they give 
to their reproductive health? What priority does their reproductive health have in 
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their lives? What behaviors do women with sickle cell disease engage in that they 
believe help maintain their reproductive health? What impact does having sickle 
cell have on their reproductive lives including desires for motherhood and 
intimate relationships? 
 
How do race, gender, and genetic illness affect the reproductive lives of 
women with sickle cell disease?  
 
What social, environmental, and cultural factors influence the ability of 
women with sickle cell disease to either seek or receive reproductive health 
care? That is, what sources of information, advice and guidance do women with 
sickle cell use to learn about reproductive health?  
 
Method of Inquiry 
Data Collection 
Qualitative approaches are well suited for investigating the human experience and 
meanings individuals give to social events, situations and activities, and allow researchers to pay 
particular attention to the subjective nature of the experience (Denzin and Lincoln 2005).  The 
unique ability of qualitative research to focus on experience and meaning is central to 
exploratory studies, which focus on relatively understudied topic in new areas.  Qualitative 
research seeks depth rather than breath and is used to learn about how and why people behave, 
think, and create meaning.  Moreover, this method of inquiry provides a voice for participants, 
raises their consciousness, and advances an agenda for change that may improve the participant’s 
lives (Creswell 2003). 
This study used a qualitative approach of semi-structured in-depth interviews to explore 
how women with sickle cell disease experience reproductive health, which included various sub-
categories of sexuality and sexual behavior, motherhood, pregnancy, contraception use, and 
intimate relationships.  According to Seidman (1991), phenomenological interviews are 
structured in a three-stage process of (1) establishing the context of the participant’s experience, 
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(2) constructing the experience, and (3) reflecting on the meaning these experiences hold for the 
participant (Seidman 1991).  The semi-structured interview technique is optimal for collecting 
data on individuals’ personal histories, perspectives and experiences, particularly when sensitive 
topics are being explored, while allowing interviewees to answer direct questions and offering 
their unique perspective.  This interview style also provides the opportunity for synchronous 
communication and the ability for the researcher to provide comfort and react to visual and non-
visual cues of respondent distress (Opdenakker 2006, Sturges and Hanrahan 2004).   
These methods illustrate the common thread that exists among qualitative inquiry and 
phenomenology.  A qualitative approach is being used due to the lack of existing literature on 
this topic with the hope of shedding light on reproductive health among women with sickle cell 
disease.  These approaches emphasize include focusing on capturing the participants’ 
perspective, enlisting the participant as the expert knower, describing the participant’s 
experience from their own perspective and searching for the meanings individuals give to their 
particular experiences.   
 
Participant Sampling 
Lincoln and Guba (1985) suggested that sampling within a qualitative study should be 
“based on informational, not statistical, considerations…to maximize information, not facilitate 
generalization” (1985:202).  The inclusion criterion for this study was the following: identify as 
an African American, a medical diagnosis of sickle cell disease, female, and over the age of 18.  
The targeted population was not limited according to socioeconomic status, insurance status, 
marital status or parity.  The attempt was made to recruit a diverse sample through recruiting 
from multiple types of locations (e.g., medical clinic, community organization and the internet). 
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Participants for this project were recruited using the non-probability and snowball sampling 
methods.  The sampling method was non- probability in that I targeted participants from one 
gender (female), a specific medical condition (sickle cell disease) and from specific locations, 
rather than the general public.  Snowball sampling was used to generate chain referrals by asking 
members of the target population under study to provide names, and telephone numbers of other 
members of the targeted population (Adler and Clark 2003).   
Sampling in qualitative research does not attempt to meet requirements for 
representativeness and proportionality or achieving adequate numbers for “statistical power” for 
analyses, however the aims are to narrow sampling strategies in phenomenological studies based 
upon experiences of the phenomenon under investigation(Lincoln and Guba 1985).  This strategy 
is further supported by Colaizzi’s idea that in order to best understand a phenomenon it is 
important to include individuals who have actually experienced it (Colaizzi 1978).  
 
Human Subjects Approval 
I received approval from the Wayne State University (WSU) Human Subjects Review 
Committee prior to the implementation of this project (Approval # 104611B3E).  Women who 
were selected agreed upon a meeting time and location that allowed for privacy and the ability to 
allow the conversation to audio-recorded.  Before beginning the interview, women gave their 
permission for the interview to be tape-recorded.  I reminded every woman that their 
participation was limited to one interview, and they were informed that they were not required to 
answer any question that made them feel uncomfortable.  Women were reassured their identities 
would remain confidential.  Women were given an information sheet detailing the study as well 
as confidentiality guidelines and contact information for further and future informational about 
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the study.  To maintain confidentiality, random numbers were assigned to each participant’s 
demographic questionnaire.  Confidentiality was maintained by changing names to pseudonyms.  
These pseudonyms were used in all written records.  The electronic data collected for this project 
was stored on a password-protected computer and paper data (e.g., demographic questionnaire) 
was stored in a locked file in my home.   
 
Recruitment Locations and Strategy 
The primary recruitment location for the study was the University of Michigan sickle cell 
clinic, a pediatric clinic services over 200 patients with various hemoglobinopathies.  This clinic 
provides comprehensive care including psychology, nutrition, and access to social workers.  The 
recruitment process was facilitated by the Clinic Director who wrote a letter of support providing 
legitimacy to my study.  Based on the inclusion criteria, the Director mailed the recruitment 
flyer, introductory letter, along with a cover letter in November 2011 and then again January 
2012 to all eligible patients meeting the study inclusion criteria.  As further reinforcement, 
recruitment flyers were also distributed during weekly clinic visits and to any new patients who 
had not received either mailing.  A total of eleven women were recruited from this location, ten 
with direct contact with the location and one woman was recruited from another participant. 
The other primary recruitment location was the Sickle Cell Disease Association of 
American (SCDAA)–Detroit Chapter.  This chapter, under the direction of the legendary Charles 
Whitten, M.D.3, was one of the initial chapters to emerge into what has now become a national 
organization.  The SCDAA promotes awareness and education and provides free services to 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Dr. Whitten was among the first to develop and insist on newborn screening for sickle cell disease, which is now 
performed worldwide. In 1971, he formed the Sickle Cell Detection and Information Center in Detroit, the most 
comprehensive community program in the country. In the same year, he facilitated the creation of the National 
Association for Sickle Cell Disease, which now has over 80 member organizations. 
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persons with SCD and their families, such as genetic counseling and genetic testing.  I received 
approval from the WSU Human Subjects Review Committee to use the Association as an 
additional recruitment location in March 2012.  In April, interviews started to pick up due to the 
assistance of the SCDAA.  Prior to receiving this approval I experienced a lapse in recruitment.  
The SCDAA-Detroit Director extended her support based on their established relationships with 
the target population, interest in the topic, and available staff to assist with the research project.  
In addition to distributing my recruitment flyers, she also asked staff members to contact 
potentially eligible participants and provide them with my contact information.  Eight 
participants were recruited from this location; one contacted me via email, the other seven made 
contact via telephone. 
The Sickle Cell Warriors website (sicklecellwarriors.com) also served as a recruitment 
location. This is a supportive website with over 3,000 members. The site’s slogan is “A 
Community of those Living, Loving and Surviving Sickle Cell Disease” and is owned by a 
Registered Nurse who also has sickle cell disease.  While I sent her the flyer and approval 
notification in November 2011, after several attempts to re-contact her during December and 
February 2012, the announcement did not get posted until mid-February 2012.  The owner of the 
Sickle Cell Warriors posted information about the study as well as my contact information on the 
website.  Instead of posting the flier, she posted the contents of the flier, in narrative form, on the 
website under the “SC Research” section of the site.  However, no mention was made about in-
person interviews or state of Michigan residency.  Two participants were recruited from this 
location.  
Another recruitment location I used was a sickle cell support group sponsored by the St. 
Joseph Mercy Health System-Oakland.  Shortly after the support group moderator received the 
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flyer I contacted her again and she informed me that the support group took a hiatus for the 
winter and would not resume again until April 2012.  After receiving the flyers, the organizer of 
the support group distributed flyers at their monthly meeting and placed them in the Emergency 
Room.  This location did not yield any participants.   
All participants were given fliers and asked to pass them along to any other women with 
sickle cell disease over the age of 18.  I also obtained seven interviews through personal 
connections.  Professional colleagues and close friends were provided with flyers and my 
introductory letter in an effort to gain additional access to a wider network of women with sickle 
cell disease who may not be under the care of a physician or involved with the SCDAA.  A total 
of 45 women volunteered to be interviewed for this study, 28 were interviewed and the other 12 
were not interviewed because of hospitalizations, a death in the family, and several canceled to 
care for children who had become ill.  Follow-up with these women was difficult and I felt once 
the initial interview was canceled they may have lost interest.  The other five women who 
volunteered lived out of state and were unavailable for an in-person interview.  I responded to 
their emails letting them know that at that time I did not have approval to conduct telephone 
interviews outside of Michigan, yet if I did get approval I would like to contact them.  I kept 
them as possibilities if I could not obtain enough in-person interviews. I did not end up using 
those contacts.  Also, because I recruited women from locations that specifically target 
individuals with sickle cell−either seeking medical treatment or education and support−my 
sample is not representative of all individuals with sickle cell disease and may not be a complete 
description of the reproductive experiences of women with sickle cell disease, but a direct result 
of the recruitment locations.  
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Figure 2.  Recruitment Diagram 
 
 
The interviews were conducted during the period of November 2011 through May 2012.  
I traveled approximately 2,200 miles to and from the 28 interviews.  Women lived between 4.3 
and 143 miles away and the average distance was 44.3 miles.  Because of the distance, it was 
important that I confirm with women prior to departing.  Each of the 28 interviews lasted 
approximately between 45 minutes to 90 minutes, with the majority taking more than one hour.  
Twenty-three interviews occurred in participants’ homes, four at public libraries, and one at a 
local coffee shop.  On several occasions the interviews started before I turned on the digital 
recorder.  Women sometimes started telling me their stories either when we spoke on the phone 
to schedule the interview, or when I was getting settled into their home or on one occasion the 
ride to the coffee shop.  Within two months of completing the initial interview, I had conducted 
seven interviews.  There was a lapse in recruitment, which gave me time to reflect on the data I 
had collected and I believe improved the quality of the remaining 21 interviews.  During the last 
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four interviews I felt that I reached theoretical saturation–I used these final interviews to confirm 
previous findings.   
One of the difficulties I experienced in securing interviews was scheduling the interview 
too far in advance.  I realized that it was best to conduct the interview soon after talking to 
women.  When interviews were scheduled too far in advance, women would forget about it, their 
telephone number would no longer be valid, or they were may have been hospitalized.  While 
scheduling interviews soon after making contact worked in most cases, one attempt did not.  I 
had an interview scheduled with one woman, but when I called to confirm before departing for 
her home, she informed me she was out of town and asked if we could re-schedule, which we 
did.  Again, I called to confirm before departing and this time she didn’t answer.  Finally, I called 
her one more time and she asked if I could “come now” and I said yes, but it would take me 40 
minutes to get there.  I made it to her home in 30 minutes and her mother answered the door and 
said she was not there.  I explained who I was and I had just spoken to her daughter less than an 
hour ago, but her mother didn’t offer any additional information and I decided not to pursue this 
interview further.  On my way home I retraced my steps to see if there had been something 
during our conversations that would make me think she may not want to do the interview.  All I 
could think of was the voicemail she had left saying, “I saw your flyer, I want to do this.” 
Another strategy I used was not giving up after the initial attempt to reschedule missed 
appointments.  I realized that while this interview was at the top of my priority list, many 
participants had a different set or new set of priorities. For example, one woman had rescheduled 
the interview several times and after numerous unsuccessful phone contacts and voice mails, we 
finally made contact.  She apologized for not being able to be interviewed and explained that she 
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had recently been diagnosed with cervical cancer and was dealing with the psychological impact 
of this diagnosis and preparing for surgery in two weeks.   
Overall, the recruitment process was much more difficult than I imagined considering the 
multiple recruitment locations I had identified.  In the beginning recruitment was very slow and 
although participants contacted me, I stilled faced barriers to securing actual interviews (e.g., 
illness and cancelations).  However, in the end, the delay in interviewing actually benefited the 
quality of data I was able to collect.  
 
The Interview Process 
The interview guide was developed based upon key concepts identified during a 
systematic review of the literature on the reproductive health of African American women, 
disabled women and women with genetic conditions.  The questions were open-ended with 
follow-up probes to encourage elaboration and to ensure the full understanding of the experience 
has been captured.  During the course of the interview, more sensitive topics were introduced as 
rapport and trust were established.  I also used a feminist style of interviewing which seeks to 
minimize hierarchical nature of the research process.  I attempted to conduct interviews as 
conversations, rather than formal interrogations.  During each interview I maintained flexibility 
regarding the structure of the interview in order to record the context of their responses.   
 
Interview Guide 
Participants were asked questions to describe their past and present experiences of 
reproductive health within the context of socially excluded and marginalized groups (e.g., race, 
gender, and genetic illness).  Probes were used to extrapolate specific details of the experience.  
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Particularly, questions were asked regarding their experiences more broadly, as well as sources 
of knowledge of sexual health as well as identify sources of advice and information women with 
sickle cell disease use to learn about their reproductive health and how sexuality and 
reproductive health are understood and experienced.  Questions were asked to determine 
participants’ desires for motherhood and experiences with pregnancy (including abortion), 
including preconception desires for pregnancy, preparation and readiness (e.g., employment, 
emotional preparation, and readiness of other children), effort exhausted to either achieve or 
prevent pregnancy, desire for a child with their partner, and relationships with others.  I asked 
questions about access to reproductive health care, and their ability to exercise agency in their 
own reproductive health decisions.  Access and agency represent the social context in which 
healthy, sexuality, and reproduction are experienced and acted upon (Price and Hawkins 2007).  
Participants were probed about influential factors such as experiences with heath care providers, 
family and intimate partners.  Reproductive health and decision-making are embedded in social 
relations and social institutions that operate from the macro- to the micro-level (Price and 
Hawkins 2007).  Additionally, I asked questions regarding the participants’ life course 
considerations and social circumstances which included family dynamics and social support, and 
perceived life-chances (Santelli et al. 2003).  These questions were aimed at extrapolating 
experiences related to sexuality, fertility, reproduction and health that may be influenced by a 
range of race-, gender- and illness-specific factors, such as relations of power and control within 
intimate relationships, household and family structures, and economic and cultural ties.   
Although I collected over 52 hours of data on topics different than what is reported here, 
for the purpose of this dissertation I only present data from discussions related to reproductive 
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health care, messages from family and providers about reproduction, and participants’ 
experiences with prenatal and partner genetic testing.   
 
Demographic Questionnaire 
Participants were also asked to complete an end-of-interview questionnaire to capture 
sociodemographic information such as educational level, age, income, and use of hospital 
services, which were used to stratify participants.  The questionnaire collected general 
information on medical and reproductive histories to gather disease severity and parity.  Using a 
quantitative survey nested within a qualitative study enabled me to better describe between- and 
within-group similarities and differences based on demographic categories.  
 
Participant Motivations 
Women were appreciative that I was interested in studying sickle cell and specifically 
women with sickle cell.  For the most part, participants indicated they participated in the study 
because they were thankful that I was interested in or cared about sickle cell disease or they 
wanted to be supportive of someone furthering their education.  Specifically, one participant 
indicated, “If somebody is willing to put in the time and the effort, then I need to be willing to 
tell my story so that the next person doesn’t necessarily have to go through everything that I 
went through.” Another stated, “Here’s a young black woman trying to finish her doctor degree. 
Let’s do that.”  These sentiments caused quite a few participants to refuse to accept the $10 token 
of appreciation I offered them.  I began putting the $10 into a thank you-card so they would 
accept it.  Admittedly, only three participants informed me they participated simply because of 
the monetary incentive.  These three reported being in the lowest household income category on 
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the demographic questionnaire.  After I told one participant about the $10 incentive, she stated, 
“I wish it was $20!” I jokingly replied, “Me too!”  
 
Interruptions and Distractions during the Interviews 
The interruptions that occurred during the interviews were due to the environment, others 
in proximity, and participants’ emotions and fatigue.  Interviews in public places sometimes 
proved to be more difficult simply because of the personal nature of the topic. In one interview 
occurring in a public library on a Saturday morning, this facility was so small and busy we were 
forced to sit in a room where people frequently traveled in and out.  Another interview was in a 
coffee shop and I suspected this would keep her from speaking freely. 
Interviews were also difficult when other people were around.  For example, when 
participants had small children in the home who were curious about what “mommy was doing” 
or “who the lady was,” they would at times interrupt the interview or their presence would keep 
women from openly discussing their reproductive histories in front of them.  Younger 
participants were often compelled to invite their parents to sit in on the interview, probably 
because they were very much accustomed to having their parents around to assist in answering 
questions regarding their health.  In these instances, parents only stayed for the first few minutes 
of the interview during which questions pertaining to illness experiences were asked, which did 
not influence the data collection in any way. 
On several occasions participants became emotional when telling their stories.  One 
because of the burden of the illness, and another because of the emotions she felt when 
discussing her friends’ concern for her and her inability to attend school due to her illness.  When 
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participants became tearful, I stopped the interview and often offered compassion by touching 
their hand or forearm.  I paused the interview until they let me know they were ready to continue.  
With three interviews I got glimpses of fatigue when the participant’s speech slowed or 
their eyes became glazed.  When this happened I acknowledged that I thought they were 
becoming tired and asked if they could continue.  They always said they could, but I let them 
know I would attempt to wrap-up the interview and made sure to only ask pertinent questions.  
Because I ensured to ask pertinent questions this did not impact the data analysis.   
 
Leaving the Field 
Looking back, I realized that although the “interview” was officially over many 
participants remained engaged in the research process and continued to reveal very important 
information about themselves and their experiences.  In some cases I asked for permission to turn 
the recorder back on and in other cases I simply wrote detailed notes about these conversations 
immediately after leaving the interview location.    
Also, I found it difficult to abruptly bring such a personal and in-depth conversation to a 
close and sometimes the interview came to an end before the participants were ready for me to 
leave.  Once I realized this was happening I decided to linger for about 10-15 minutes for small 
talk and follow-up questions either the participant or I had.  The lingering would include women 
sharing articles about them in the paper, recent family portraits, wedding albums, old letters from 
previous physicians, or sharing stories about other interviews they had given about their disease.  
On several occasions, I received phone calls or text messages after I had left their homes, simply 
thanking me for talking to them.   
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It was important for me to have a journal in which to capture these post-interview 
conversations and to take time to reflect on how the interview went and unique occurrences 
(Ortlipp 2008).  After each interview I wrote about personal thoughts and initial impressions on 
what I had seen, heard, and felt during the interview.  I also recorded the time of day, who was 
present or within close proximity of the interview, and the characteristics of the room or 
environment. 
Upon reviewing these notes I began to realize that it wasn’t always what was said that 
told the story, but the manner in which the story it was told.  “Listening for voice” and “voice in 
conversation” are the additional components the researcher must address. In these steps, the 
researcher pays attention not only to what the research subject, the “actor”, says with words, but 
also to what the actor says with body language and with silences.  Sometimes women would use 
humor or a joking tone to talk about difficult situations or their voices would get low and sad and 
between their words I could hear them say, “It’s been hard, but I’m okay.”  Realizing this made 
me value the data I received even more, knowing that it came at the price of such difficult 
experiences. I left a resources sheet that included contact information for a support group and the 
Sickle Cell Disease Association of America (Appendix E). 
 
Data Analysis 
This study used a descriptive phenomenology approach which favors thick description 
and close analysis of the lived experiences to understand how meaning is created through 
embodied perception (Creswell 1998). My analysis followed the six steps of the Colaizzi’s data 
analysis method (Colaizzi 1978, Koch 1995).   
	  	  
82 
Step 1 Reading each transcript for accuracy and significant statements.  Each interview 
was fully transcribed by a hired transcriptionist and then I reviewed the transcript alongside the 
audio-file for accuracy.  I read each transcript in order to become familiar with the data. 
Step 2 Extracting significant and research relevant phrases.  This step consists of 
returning to the transcripts and extracting phrases or significant statements that pertain to the 
phenomenon under investigation.  I generated an initial list of concepts and themes by reading 
the data and creating as many relevant codes as possible.  I placed all transcripts into a 
qualitative software program, NVIVO©, to help with data management.  This allowed me to (1) 
further analyze the data units within each code and (2) review each data unit within each code 
organized by participant and specifically on the topic of reproductive health, health behavior, and 
activities.  When developing a new code in NVIVO© I also provided descriptions that explained 
what they represented to ensure accurate themes. This was the second phase of the analysis 
conducted to extrapolate common elements that described their unique experiences.  
Step 3 Formulating meanings and Step 4 Organizing formulated meanings into clusters of 
themes.  During these steps, Colaizzi says that meanings are derived and formulas developed 
which explicitly describe each significant statement; the data must be allowed to speak for itself.  
I then sorted the codes by participant, genotype, parental status and age group to explore whether 
these social locations were an indication of similar or disparate experiences. Each of the above 
steps were repeated for each data set and organized to illustrate an aggregated meaning.  
Step 5 Exhaustively describing the investigated phenomenon.  The descriptive step in the 
process emphasizes viewing a person as one representative of the world in which they live.  
Based on this step, three main themes emerged from the analysis of the interviews which focus 
on several reproductive stages and activities:  (1) reproductive health care experiences which 
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includes participants’ experiences navigating optimal care amid their provider’s knowledge in 
caring for women with sickle cell disease and illustrates how participants found themselves 
managing a gap in knowledge between their gynecologist and hematologist regarding their 
reproductive health care; (2) discouraging reproductive messages which described the ways in 
which participants were discouraged from having biological children; and (3) responding to 
reproductive risks in pregnancy and childbirth associated with having a genetic condition, 
particularly being categorized as high risk pregnancy and negotiations of prenatal and partner 
testing.  These themes and the theoretical foundations on which they were based are discussed 
and analyzed in the upcoming pages.  These themes were primarily derived from the questions: 
“In any ways do you think having sickle cell may impact any of these reproductive issues: Who 
do you see for your women’s health issues?  Things like pelvic exams, birth control, things like 
that? What kinds of conversations have you had about prenatal testing? What types of 
conversations have you had about genetic testing?”  
Step 6 Describing the fundamental structure of the phenomenon.  Colaizzi (1978) 
proposed formulating exhaustive descriptions of the investigated phenomenon.  He suggested 
that these descriptions be considered as an indisputable indicator that identified statements 
represent the fundamental structure of the data.  My analysis suggests that participants’ 
possessed an ongoing awareness of the influence having a genetic illness has on their 
reproductive behavior.  The analysis also revealed subtle differences in experience between 
symptoms, genotype, and parental status.  
One essential component of phenomenological methodology is believing that the 
consciousness is what humans share, an assumption that self-reflection and conscious “stripping” 
of previous knowledge, help to present an investigator-free description of the phenomenon, the 
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assumption that adherence to established scientific rigor ensures description of universal 
essences or eidetic structures, the assumption that bracketing ensures that interpretation is free of 
bias (Koch 1995).  To accomplish this, I maintained a journal of reflections about the 
interactions that I observed through the data collection process to create an audit trail and 
enhance the credibility of the findings.  I used this journal to capture my reactions to participants 
and collected data and to make explicit my evolving assumptions that might influence the 
analysis and interpretations.  With the journal, I also documented anecdotal impressions of the 
research sites, reactions to responses of participants, and the time lapse between each interview 
and reflections on the data collection process. 
 
Data Checking 
The findings of this research were confirmed using three validation methods as an 
assurance that the emergent themes represent the authentic expression of the participants (Miles 
and Huberman 1994).  First, I performed rich data collection, by conducting in-depth interviews 
that were detailed and varied to provide a full and informative picture of the participant’s 
circumstances and conditions and transcribe the interviews verbatim transcripts rather than 
simply depending on notes to ensure a full description is provided for analysis.  Secondly, I 
conducted an iterative analysis process, which involved repeated contextual reading of the 
original transcripts (Forman et al. 2008, Maxwell 2004, Strauss and Corbin 1990). Third, I 
maintained a journal of reflections about the interactions that I observed through the data 
collection process to create an audit trail and enhance the credibility of the findings.  This was 
used to capture my reactions to participants and collected data and to make explicit my evolving 
assumptions that might influence the analysis and interpretations.   
	  	  
85 
Even though I have a somewhat complete knowledge of sickle cell disease, I always 
remembered that the real experts in this study are the participants (Collins 2000).  For example, 
when during the eligibility phase I wanted to confirm that women had sickle cell disease and not 
sickle cell trait, or when I asked about what type of sickle cell they had, women attempted to 
educate me as if I was asking for information rather than clarification.  In these cases I simply 
listened rather than letting them know that I already knew what they were telling me.  
Understanding the different types of sickle cell disease and the genetic transmission patterns is a 
complicated process and I was also careful not to challenge what they told me, even if it 
contradicted what I believed I knew.  When I doubted what I was told, I simply asked them to 
repeat it to ensure they simply had not misspoken. 
I worked hard to establish rapport and to make women feel as comfortable as possible.  I 
was asking women to talk to me about very personal topics and had to get to that portion of the 
interview in a very short amount of time.  I am a 40-year old woman who does not have sickle 
cell disease.  I was never asked about my status and I never offered.  I simply informed women I 
interviewed that I was in graduate school in Sociology and this project was for my dissertation.   
 
Sample Characteristics 
Much of the demographic information on the sample derives from the demographic 
questionnaire each participant completed at the end of the interview about their social, medical 
and reproductive histories.  Specific information about their experiences was derived from 
conversations with participants before, during or after the interview and field notes taken after 
each interview.   
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Sociodemographic Characteristics 
The sample consisted mostly of women between the ages of 20 and 39, with ages ranging 
from 18 to 52 (see Table 1), and from two primary recruitment locations–the University of 
Michigan Sickle Cell Clinic and the Sickle Cell Disease Association of America. Women 
recruited from the clinic were younger, with ages ranging from 18 to 27.  The clinic primarily 
provides care to pediatric patients and has a limited adult patient population.  On the other hand, 
the Association provides services to parents of children with sickle cell disease or adults with the 
condition, therefore those recruited from this location were older, with ages ranging from 24 to 
44.  Women recruited from my social network were closer to my own age (40 years old), with 
ages ranging from 30 to 49.   
The household income of the sample was similar.  Over half of the participants reported 
household incomes below $25,000 and that they received Supplemental Security Income (SSI) 
(see Table 3).  SSI is a government program that aids people who are either over 65 or disabled 
and have low income and limited resources. Participants who did not receive SSI were employed 
full- or part-time, or were full-time students.  
There was limited variation among the sample in terms of marital status: 21 participants 
were single–20 never married and one divorced–five were married, and two lived with a partner 
(See Table 3).  Similar to marital status, the sample was quite similar in terms of their 
educational attainment.  The sample consisted of two current high school students, four high 
school graduates or equivalent, 18 with some college, and four college graduates, three with 
bachelor degrees and one with a graduate-level degree (see Table 3).  Many participants shared 
their challenges completing every level of education (elementary through post-secondary) due to 
frequent absenteeism and lack of understanding from educators of the nuances of the disease.  
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Participants who were successful in their educational endeavors benefited greatly from the 
attentive support of parents who ensured they received missing work from teachers, obtained a 
tutor when necessary, and advocated for their removal from situations that would impact their 
health (e.g., outdoor recess in the winter, excessive running in gym, etc.).  
The employment status among the sample was also very similar and most of the 
participants reported being currently unemployed (see Table 3).  Unemployment was most often 
illness related, either from the inability to secure employment should they inform potential 
employers about their condition during an interview or the ability to sustain employment as a 
consequence of frequent absence from work.  Furthermore, the lower household income of the 
majority of the sample may also be a reflection of unemployment and marital status since 21 
women were single (never married or divorced4).   
Living arrangements are often influenced by age, marital status and/or income.  The 
seven women who lived with their parents were younger and either high school or college 
students.  The remaining women in the sample had varied living arrangements: seven lived 
alone, eight lived with partner or husband, and seven lived alone with their children (see Table 
3).  The majority of women who lived alone received SSI and were unemployed (only one was 
employed).  The women who lived alone with children reported household incomes of less than 
$25,000, were between the ages of 30 and 39 and also received SSI.  Participants who lived with 
a boyfriend or partner (with or without children) had higher incomes, although most were 
unemployed, many still reported not having enough money for basic expenses (see Table 3).   
Based on these characteristics, the women in sample were relatively similar.  On average, 
the participants were single, had low household incomes, received SSI and had less than a 
college education.   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Of note, two women living with a partner reported household incomes of less than $25,000. 
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Table 3. Sociodemographic Characteristics 
 N (%) 
Age (Mean Age = 30.39) 
  18-19 2 (7.1) 
  20-29 12 (42.9) 
  30-39 10 (35.7) 
  40-49 3 (10.7) 
  50-59 1 (3.6) 
Household Income 
  Less than $25,000 19 (67.9) 
  Between $25,000 and $49,999 4 (14.3) 
  Between $50,000 and $74,999 1 (3.6) 
  Between $75,000 and $99,999 2 (7.1) 
  Between $100,000 and $149,999 1 (3.6) 
Supplemental Security Income (SSI) 
  Yes 19 (67.9) 
  No 9 (32.1) 
Marital Status 
  Single, never married 20 (71.4) 
  Single, divorced 1 (3.6) 
  Living with partner 2 (7.1) 
  Married 5 (17.9) 
Living Arrangements  
  Living alone 7 (25.0) 
  Living alone with children 6 (21.4) 
  Living with partner or husband 8 (28.6) 
  Living with parents or guardian 7 (25.0) 
Level of Education  
  High school student 2 (7.1) 
  High school graduate or equivalent 5 (17.9) 
  College student 5 (17.9) 
  Some college 12 (42.9) 
  Undergraduate college degree 3 (10.7) 
  Advanced degree 1 (3.6) 
Employment Status 
  Student (high school or college) 7 (25.0) 
  Unemployed 12 (42.9) 
  Employed part-time 7 (25.0) 
  Employed full-time 2 (7.1) 
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Medical Characteristics 
It was important to capture the medical history and illness characteristics of the 
participants in order gain some insight into the extent to which their illness may influence their 
daily lives and reproductive health experiences.  Of the 28 women interviewed for this study, 17 
had sickle cell anemia hemoglobin S (Hb-SS), nine had sickle cell anemia hemoglobin C (Hb-
SC), one had sickle beta-zero thalassemia (Hb-Sß0), and one had sickle beta-plus thalassemia 
(Hb-Sß+) (see Table 4).  The genotype of the sample may have been influenced by the higher 
prevalence of Hb-SS and Hb-SS in the population and the characteristics of two primary 
recruitment locations–UM Sickle Cell Clinic and SCDAA-Detroit Chapter.  Nine of the 10 
women recruited from the UM clinic had Hb-SS and five of the eight women recruited from the 
SCDAA had Hb-SC.  Because Hb-SS is considered the most severe form of sickle cell disease, it 
often warrants closer medical management through the care of a physician. However the primary 
aim of the SCDAA is to promote education, awareness and support, thus it not surprising that 
those with more severe forms were recruited from a medical clinic.  
While Hb-SS is known to be the most severe form of SCD, people with other types of 
SCD also experience illness symptoms.  I asked participants if they had any other illnesses in 
addition to SCD, as having multiple chronic conditions may impact their reproductive health.  I 
also asked participants during the past 12 months how many pain crises requiring hospitalization 
they experienced in order to gauge not only the frequency of their pain but also the severity of 
their illness experience.  People with sickle cell tend to exhaust every effort to manage their care 
at home before seeking care from a medical professional.  The frequency of pain episodes 
requiring hospitalization during the past 12 months varied among the sample, from 0 to 20, 
within the past 12 months.  The majority of participants reported having at least one other illness 
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(see Table 4). Those who experienced more pain crisis were mostly women with Hb-SS who had 
an illness in addition to SCD.   
Health insurance is an important factor in managing a chronic illness, particularly one 
that requires multiple medications and specialty medical care.  All participants possessed some 
type of insurance and only two reported a lapse in their insurance at some time during adulthood 
(see Table 4).  Notwithstanding insurance coverage, several participants lamented over the 
amount of their unpaid medical bills and the ensuing stress from their inability to pay them.   
Genotype and having another illness seem to have a role in the amount of pain and 
frequency of hospitalizations among this sample.  More women in the sample had Hb-SS, 
experienced 1-5 pain crises in the last twelve months and did not have another illness in addition 
to sickle cell disease.  Women who reported not being hospitalized for pain during this time 
period were mainly women with Hb-SC who did have another illness.  Because of the limited 
time frame in which I asked, I may have insufficiently captured the severity of illness during the 
participant’s lifetime.  Moreover, those with sickle cell disease have a high level of functionality 
while still in severe pain and therefore even what I observed may not have fully captured the 
severity of their illness.  
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Table 4. Medical Characteristics 
 N (%) 
Genotype 
  Hb-SS 17 (60.7) 
  Hb-SC 9 (32.1) 
  Hb-Sß0 1 (3.6) 
  Hb-Sß+ 1 (3.6) 
Other Medical Conditions (N=12) 
  Heart conditions (e.g., murmurs, CHF, etc.) 5 (41.7) 
  Lung conditions (e.g., pulmonary   
  hypertension, acute chest syndrome, etc.) 
4 (33.3) 
  Brain conditions (e.g., epilepsy, etc.) 3 (25.0) 
  Other 4 (33.3) 
Number of Pain Crises Requiring Hospitalization During 
Last 12 Months  
  None 6 (21.4) 
  1-5 14 (50.0) 
  6-10 5 (17.9) 
  11-15 0 
  16-20 2 (7.1) 
  21 or more 1 (3.6) 
Type of Insurance 
  Medicaid 18 (64.3) 
  Medicare 9 (32.1) 
  HMO Insurance 5 (17.9) 
  Private Insurance 4 (14.3) 
 
 
Reproductive Health Characteristics 
As previously stated, reproductive health encompasses the full range of the reproductive 
cycle (e.g., contraception, conception, pregnancy, childbirth, abortion) and includes various 
reproductive challenges (e.g., egg donation, surrogacy, reproductive technologies, etc.) (Ross 
2006a).  Therefore, to best capture the full spectrum of these experiences, I have divided this 
section into three disparate categories: bodily experiences, reproductive health behavior and 
pregnancy and childbirth. 
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Bodily Experiences  
There were only slight differences in how participants reported their reproductive bodily 
functions–menarche, menstruation, and menopause.  Monthly menstrual cycles among women in 
the sample varied, in regard to when they began, whether they continued, and the overall 
experience.  Participant’s age of menarche may provide some insight into the variation in 
reproductive bodily functioning.  Much of the existing literature reports individuals with SCD 
experience delayed sexual maturation, onset of menarche and pubertal development (Cepeda et 
al. 2000, Singhal et al. 1994).  Age of menarche among women in the sample ranged from 11 to 
20 and the average age was slightly older, 14.04 years old, than the average age for African 
American females, 12.09 (Anderson and Must 2005).  Genotype may influence age of menarche, 
since 14 of the 17 women with Hb-SS experienced menarche at age 13 and younger, while five 
of the nine women with Hb-SC experienced menarche the age of 11 and younger (see Table 5).  
The two women with Hb-thalessemia also experienced menarche over the age of 13. 
Twelve women reported they no longer had a monthly menstrual cycle, three of these had 
experienced menopause and one reported having a hysterectomy in an effort to resolve ongoing 
menstrual cycle difficulties (see Table 5).  Further, four women attributed the absence of their 
monthly cycle to the type of birth control they were using, and four women had no clear 
understanding about why they no longer had their cycle (see Table 5).     
I specifically collected data on pain associated with menstrual cycles, uterine fibroids, 
ovarian cysts, stillborn birth, infertility, and miscarriage because these are among the difficulties 
associated with sickle cell disease.  Only 11 women reported having at least one of these 
reproductive difficulties.  Of these women, nearly all had Hb-SS and over half had given birth to 
a child (see Table 3).  
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In summary, women in this sample who started their menstrual cycles at age 14 or later 
were more likely to have Hb-SS and were less likely to report a reproductive difficulty (see 
Table 5), while those beginning menarche between n the ages of 11-13 mostly had Hb-SC and 
reported having at least one reproductive difficulty.  Women who did not report any reproductive 
difficulties continued to have their monthly menstrual cycle (see Table 5). 
 
Reproductive Health Care Seeking 
I also explored the actions taken by participants regarding their reproductive health.  One 
key component of reproductive health is seeking care from an obstetrician/gynecologist 
(OB/GYN).  Of the 28 participants, 22 reported having an OB/GYN and 21 reported a recent 
visit to their OB/GYN (see Table 5).  Women gave various reasons for not recently visiting an 
OB/GYN: their reproductive health was currently being maintained by their primary care 
physician, they were a virgin and considered it unnecessary to see an OB/GYN, they simply had 
not “gotten around to it,” and one participant had recently undergone a series of negative 
interactions in her efforts to conceive and decided to “take a break” from reproductive health 
care.  
Among women with sickle cell disease, while the use of combined oral contraceptive 
pills has been found to be associated with increased thrombotic risks, progestogen-only pills, 
injectables, and implantables also raise concerns for possible clinical or hematological 
complications and others have cautioned against the use of intrauterine devices (Howard, Lillis 
and Tuck 1993, Koshy and Dorn 1996).  Women reported using a variety of contraceptive 
methods (see Table 5).  Of the 11 women reporting not currently using contraception, seven were 
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not currently sexually active, one wanted to have a child, and three believed they were unable to 
conceive due to failed attempts to become pregnant (see Table 5).   
Since contraception use is in part associated with sexual activity, I placed women in the 
following categories to explore their contraception use: women who were sexually active and 
single (N=12), sexually active and married (N=7), not currently sexually active (N=5), and never 
sexually active (N=4).  Single women who were sexually active, were more likely to always or 
sometimes use condoms, whereas married women used condoms sometimes or never during 
sexual intercourse.  Two of the women who had never had sexual intercourse explained that they 
used contraception for proactive reasons:  one to help regulate her menstrual cycle and the other 
had contraception impressed upon by her aunt in order to circumvent a teenage pregnancy.  In 
this sample, nine women reported using contraception as an intentional strategy to control 
menstrual cycle difficulties.  
Overall, the sample was similar in seeking care and consultation for reproductive health 
issues and the use of contraception.  Most women sought care from an OB/GYN for some aspect 
of their reproductive health and were using some type of contraception, although the specific 
type varied.  
 
Pregnancy and Childbirth 
Rather than simply looking at experiences of motherhood, I felt it was also important to 
capture the reproductive variations in the experience of pregnancy.  Therefore, I categorized 
women based on whether or not they had ever been pregnant, rather than their parenthood status 
(see Table 5).  This allowed me to acknowledge women who had been pregnant, yet had not 
given birth due to an abortion or a miscarriage–two potentially distressing reproductive 
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experiences.  Of the 28 participants, seventeen participants reported having been pregnant.5  Two 
women were pregnant at the time of the interview, one with her second child and the other with 
her third.  Six women reported terminating a pregnancy either voluntarily because of the lack of 
financial stability or due to emotional preparedness for parenthood or involuntarily due to parent 
enforcement.   
Among the 13 women with live births, the age of first child ranged from 17 to 35, with an 
average age of 22 years old (see table 5).  Three had one child, five had two children, four had 
three children, and one woman had four children, with children’s ages ranging from 16 months 
to 28 years old (see Table 5).  Of the 13 mothers in the sample, eight indicated they breastfeed 
their children.  Several women attempted unsuccessfully to breastfeed, others stated they did not 
breastfeed because of a medical condition, and a few never tried to breastfeed.    
As important as it was important to capture decisions to give birth, it was also important 
to capture decisions to purposefully bring an end to their ability to reproduce.  Six reported 
having planned tubal ligations, most to avoid future pregnancies and the physical “toll” of 
pregnancy on their bodies, and one indicated regrettably agreeing to a tubal ligation under duress 
following the birth of a stillborn child. 
Their pregnancy experiences varied based on genotype and age.  Of the 11 women 
without children who had never been pregnant, eight had Hb-SS and were mostly under the age 
of 29.  Additionally, more women with Hb-SC had live births and were younger at menarche 
than women who had never given birth (see Table 5).  
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 This number represents whether participants reported being pregnant (yes/no) and not the total number of 
pregnancies among the sample. 
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Table 5. Reproductive Health Characteristics 
 
 N (%) 
Age of Menarche  (Mean Age=14.04) 
  11-13 14 (50) 
  14-16 10 (35.7) 
  17-19 3 (10.7) 
  20 and above 1 (3.6) 
Regular Menstrual Cycles  
  Yes 16 (57.1) 
  No 12 (42.9) 
Menopause  
  Yes 4 (14.3) 
  No 24 (85.7) 
Reproductive Difficulties (N=12) 
  Vaso-occlusive pain associated with  
  menstrual cycles  
6 (50.0) 
  Dysmenorrheal6 5 (41.7) 
  Uterine fibroids  2 (16.7) 
  Ovarian cysts  1 (8.3) 
  Stillborn birth 2 (16.7) 
  Infertility 1 (8.3) 
  Miscarriage 5 (41.7) 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  Pain during menstruation that interferes with daily activities.	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Reproductive Health Care Seeking 
 N (%) 
Currently Have An OB/GYN 22 (78.6) 
  Yes 6 (21.4) 
  No  
Reason for Most Recent OB/GYN Visit (N=22) 
  Annual pap smear 15 (68.2) 
  Contraception consultation 5 (22.7) 
  Pregnancy care and delivery 2 (9.1) 
Types of Birth Control Ever Used7 
  Birth control pills 12 (42.9) 
  IUD 7 (25) 
  Contraception condom 11 (39.3) 
  Contraception patch 3 (10.7) 
  Contraception ring 1 (3.6) 
  Depo-Provera 16 (57.1) 
  Rhythm method 1 (3.6) 
  None 3 (10.7) 
Last Time Used Contraception During Sexual Intercourse (N=27) 
  Never 7 (25.0) 
  0-3 11 (39.3) 
  4-6 1 (3.6) 
  7-9 1 (3.6) 
  10-1 year 7 (25.0) 
Reason for Not Using Contraception (N=11) 
  I am not sexually Active 7 (25.0) 
  I want to have a child 1 (3.6) 
  I don’t believe I can conceive 3 (10.7) 
  I don’t like contraceptives 0 
Frequency of Condom Use During Sexual Intercourse (N=27) 
  Never 7 (25.0) 
  Sometimes 8 (28.6) 
  Always 12 (42.9) 
 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  Total number is greater than N=28, participants were able to check all that applied.	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Reproduction 
 N (%) 
Reproductive History8 
  Never Pregnant 11 (39.3) 
  Pregnant-Miscarriage or Abortion 4 (14.2) 
  Pregnant-Delivery 13 (46.4) 
Types of Delivery (N=13) 
  Caesarian Section 3 (23.0) 
  Vaginal 9 (69.2) 
  Natural 1 (0.7) 
Age of First Child (Mean Age =22.38) (N=13) 
  19 and under 7 (53.8) 
  20-25 3 (23.1) 
  26-30 2 915.4) 
  Over 30 1 (7.7) 
Number of Children (N=13) 
  None 15 (53.6) 
  1 3 (10.7) 
  2 5 (17.9) 
  3 4 (14.3) 
  4 1 (3.6) 
Breastfeed Any of Your Children (N=13) 
  Yes 8 (61.5) 
  No 5 (38.4) 
 
Summary 
Overall the sample is similar across sociodemographic categories. However, in terms of 
reproductive health experiences, behavior activities, and birth trajectories there is some variation.  
While the reproductive health diversity within the sample allowed me to make some assumptions 
about different types of reproductive health experiences, there was too little variation in 
employment, income or marital status to make any assumptions regarding the influence of these 
social characteristics.  Of note, two women were not officially diagnosed with SCD until they 
were adults, which also made the perceptions of their lifetime experiences and reproductive 
health decisions different from those diagnosed as a child. Since, the majority (N=17) of the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8	  Participants	  may	  have	  experienced	  more	  than	  one	  of	  these	  options.	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sample had Hb-SS and nearly all (N=20) experienced more than one pain crisis requiring 
hospitalization. I conclude that the women in this sample have a clear picture of what it is like to 
live with sickle cell disease.   
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CHAPTER 5 
RESPONSES TO DISCOURAGING REPRODUCTIVE MESSAGES 
 
I’ve heard we shouldn’t have kids.   
We’re still normal, regular women in my opinion. ~Jada 
 
The focus of this chapter is the discussion of participants’ resistance to discouraging 
reproductive messages and the various types of reproductive agency they used to pursue their 
reproductive desires for biological children.  Some of the agentic responses included seeking 
medical expertise, exercising their right to reproduce, becoming informed about their 
reproductive capabilities, and drawing upon personal experience. In this study, reproductive 
agency refers to the ability to exercise autonomous choice when selecting health care models and 
providers (Unnithan-Kumar 2004).  In the context of pregnancy and prenatal care, reproductive 
agency includes “ideas, actions, thinking and planning in the domain of human reproduction” 
(Unnithan-Kuman 2004: p. 6).  
This chapter specifically describes participants’ responses to three categories of 
discouraging reproductive messages: health concerns, genetic transmission, and misinformation.  
Nearly all the women in this study (N=23)9 encountered at least one discouraging reproductive 
message from family members or health care providers. Fourteen of the twenty-three women 
were discouraged from having a biological child because of the burden of pregnancy and 
childbirth on their bodies.  Eleven participants were discouraged from having a child with sickle 
cell disease.  Four participants were told they could not conceive children because they had 
sickle cell disease (See Table 6).  Only five of the 28 participants in the study were not 
discouraged from having biological children.    	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 Discouraging messages are not mutually exclusive and many participants received more than one discouraging 
message.  
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Message: Don’t Have Children, Its Too Dangerous 
Half of the women in the study (N=14) provided detailed descriptions of the discouraging 
reproductive messages they received from their health care providers or family members due to 
concerns of for their physical health associated with pregnancy and childbirth.  Nearly all of 
these women (N=13) had the more severe form of sickle cell disease (Hb-SS) and more pain 
crises requiring hospitalizations within the past 12 months.  The concern that these women may 
experience fatality is consistent with research, since apart from general health concerns related to 
sickle cell disease, pregnancy and childbirth are two contributors of mortality among women 
with this condition (Mou Sun et al 2001; Villers et al 2008).  Women with sickle cell disease 
have been found to experience higher mortality rates during childbirth than women without the 
condition (72.4 vs. 12.7 deaths per 100,000 deliveries) (Mou Sun et al 2001; Villers et al 2008).   
The sections that follow describe participants’ responses to the discouraging reproductive 
message not to have biological children because it was too dangerous: two participants decided 
not to have children out of concern of the chance they could die, the other 12 made other 
decisions and instead sought an alternate source of information, based their decision on their own 
bodily experience with sickle cell disease or decided to leave their fate in God’s hands.    
 
I Understand the Risks, But It’s Still My Choice To Make 
Seven participants indicated being told of a “50/50 chance” of death with childbirth.  
Two participants were unwilling to take this risk and decided to forgo having children.  Verlean, 
a 40 year-old woman, also decided not to pursue having a child because of the fear of fatality 
with childbirth, which she witnessed firsthand.   
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[PR:  Do you have children?] I was told not to, it was a 50/50 chance. [PR: A 
50/50 chance of what?]  That some women survive birth and some women don't 
when they have it [sickle cell disease].  There's a bunch of people with sickle cell 
that have been blessed with a wonderful, beautiful child and are still here in this 
world doing good.  My sister had a baby, she had sickle cell—the full one—and 
she gave birth.  The situation is kind of hurtful.  She passed when she gave birth.  
So it’s just like, if you have a child, you have that risk. How are you going to be 
there for that child when you’re gone?  I am blessed with a nephew and I'm 
blessed with four God-children.   
 
Verlean viewed becoming pregnant as making a choice between life and death and decided she 
was unwilling to risk death while attempting to have a child.  These odds of surviving childbirth 
were very real for Verlean because she knew women with sickle cell disease who had 
experienced both life and death during childbirth.  Verlean was concerned with her own fate and 
the fate of the child should she not survive childbirth.  She also considered the burden having a 
child would put on her family because she was frequently hospitalized and knew someone else 
would bear the burden for caring for her child.  Verlean lost both her sister and her mother, who 
also had sickle cell disease, due to other non-reproductive complications.  Because of her 
knowledge of these experiences and her close relationship with these women in her life, she 
decided to not bear children.  
Another participant, Mya, a 33 year-old woman, shared her experience of being told, “not 
to have none.”  
I was told not to have no kids, that it was 50/50 that you will die or the child 
might die so I was scared of having kids.  I was not even about to even set myself 
up for that type of failure.  I was like, no, no, no.  [PR: Tell me a little bit about 
that conversation.] I talked to him [her hematologist] about it a while back and 
they’re like, “You’re trying to have kids?” I’m like, “No, I’m just asking.” [PR: 
What were you asking about?] Like, would it be a hard time?  They said, “50/50 
and the older you get, we advise that you not, because it would just be harder on 
your body” and stuff like that.  So I’m like, “Oh, okay.”  I was just listening to 
what they [were] saying.  Now that I’m getting older, I know the older you get the 
worse the timing and everything and my doctor [hematologist] was like, ”No, I 
don’t think you should be trying to have any right now.” I’m like, “I’m not, I was 
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just seeing.”  Now, I don’t even want no kids for me.  I don’t want none.  I spoil 
my nieces and nephews.  
 
Mya’s reproductive decision was based on the worsening health she was told would come with 
age.  The information she received caused her to view pregnancy and childbirth as a choice 
between life or death and an activity that would jeopardize the adult life she had achieved.  As 
Mya got older, she remained curious about the possibility of having children and with some 
trepidation, she “checked to see” if her health had improved enough to pursue having a child.  
Thus, her decision to forgo having biological children was not necessarily a final decision and 
was contingent on the status of her health.  Upon having this discussion with her hematologist 
and with his words of discouragement, she resolved to end her reproductive pursuits.  Similar to 
women who delay childbearing or are infertile, not having children is typically a temporary 
decision and continues to be contemplated over their lifetime.  Like Verlean, Mya did not oppose 
the discouraging message that fatality may be an outcome of childbirth, and used it as a self-
imposed barrier to motherhood since both decided to forgo having children.   
The other twelve women who were discouraged from having children due to concerns for 
their health also recognized the potential risk of pregnancy and childbirth, yet made a different 
choice from Mya and Verlean.  Joyce, a 25 year-old woman, did not specifically inquire about 
her reproductive capabilities, but she was still discouraged from having children by her 
hematologist.  
When I was 15, he [hematologist] was like, “We can just do a hysterectomy right 
now,” when I was having all the issues with my cycle.  He was like, “Let’s just do 
a hysterectomy.”  I’m like, “Hold on. I might want to have kids at some point.”  
He was like, “Let’s just do the hysterectomy now.  You won’t have a cycle 
anymore and then we don’t have to ever worry about it again.” He’s like, “Well 
you’re not going to have kids.”  This was my doctor who at the time felt like he 
was my father.  Because when you have sickle cell anemia you and your doctor 
are talking every day.  So this doctor said, “You’re not going to have kids.  If 
something happened to you because you got pregnant, I would never be able to 
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live with myself.  You’re not having kids.”  Me and my mom were like, “No.  At 
some point I may be healthy enough to bear a child, so we’re not going to kill that 
whole dream.”  
 
Recognizing the finality of a hysterectomy, Joyce exercised agency by readily rejecting her 
provider’s recommendation and held on to the hope that she would be able to have children.  
Instead of following this recommendation, Joyce decided that her health during adulthood would 
determine whether or not she would have children.  When I asked her how she felt about the 
recommendation not to have children, she stated: 
I didn’t take it badly because you have to realize that I had a long relationship 
with this individual.  Like I said, having sickle cell anemia I have to be “there” 
with my doctor.  I have to be one-on-one. I have to know that you care more than 
just about your paycheck.  This is a doctor who asks me about my family.  He 
says, “Oh, what do you have going on?  Oh, what do you need?”  You know, even 
outside the medical part of it.  I didn’t take it badly.  He really thought that he was 
looking out for me.  But at the end of the day that’s my choice.   
 
Joyce felt this particular physician was committed to maintaining her health and their 
interactions had been filled with compassion allowing her to trust his intentions.  Her trusting 
relationship with this provider allowed the message to be received and rejected without 
animosity.  In this situation, her trust was the result of cooperative behavior that had developed 
over time and through frequent interactions.  Joyce respected her provider’s concern for her 
beyond sickle cell disease; however, she believed the decision of whether or not to have children 
was hers to make.   
I have friends who have sickle cell and have children.  My one friend, she had a 
really hard time.  She was never sick before she had her baby.  Once she got 
pregnant, she got super sick and she has been that way ever since.  It all depends 
about your own personal experience with the illness.  As far as I’m concerned, I 
feel like I’m too sick to physically carry a baby.  I do want children and I am 
thinking to myself that adopting may be my best strategy for doing that.  In fact, I 
was just talking to my mother about that yesterday.  I think that I want to do that 
sooner, rather than later.  I think that I’m ready now.   
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Over the past ten years, Joyce’s menstrual cycle problems had been resolved.  Now at the age of 
25, she still questioned her physical ability to bear a child and was considering adoption as a 
route to motherhood.  Like Mya, Joyce based her decision of whether she would be able to bear 
children on her embodied experience living with sickle cell disease and continued to hope her 
health would improve.  Joyce was determined not to allow her health condition to prevent her 
from becoming a mother.  Her mother had adopted five children, family members who originally 
were destined for foster care; therefore the idea of adoption was a familiar solution for her 
maternal desires.  
Jada, a 23 year-old woman, was looking forward to having a child.  Unfortunately, she 
experienced a long and disappointing journey securing medical assistance to fulfill her 
reproductive desires.  Jada was born with a ribcage that was not fully closed and with a heart that 
contained three holes, she had her first grand mal seizure at the age of seven, and her blood was 
98% sickled.  Her reproductive agency began with her initial step toward conception when she 
stopped using birth control, saying “[I want] to get it to get out of my system.  I wanted a kid.”  
Jada also experienced several miscarriages and estimated having a total of “five or six” in the 
past three to four years.  Thus she determined the condition of her health would dictate whether 
she would have a successful pregnancy and exercised agency by seeking advice from several 
obstetrician/gynecologists to learn what she could do differently to improve her health.  
I went to this one doctor and I’m like, “I want kids. I’ve always wanted them and 
I should be able to have them.”  That’s how I feel.  She asked, “Well are you 
taking any preventative measures to keep from getting from getting pregnant?” I 
told her “No.”  She goes, “Are you trying to kill yourself?”  She said, “You know 
this is a death sentence, right?” I was like, “What?”  She goes, “This is a death 
sentence and if you get pregnant I will write a prescription for an abortion.”  I just 
grabbed my stuff and walked out because I didn’t know what else to do.  [I 
thought,] “You’re not going to touch me.  You’re not going to continue to talk to 
me like this.”   
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Despite having numerous miscarriages and being told that having a child was a “death sentence,” 
Jada remained determined to have her own child.  This physician attempted to assume control 
over her right to have a child and instead Jada was seeking a physician that would work with her.  
Ultimately, Jada felt that the physician’s perfunctory response was simply another rejection of 
medical assistance because of her health condition.   
After such a negative encounter with an extremely strong message of potential fatality, 
Jada continued to resist this message and maintained her pursuit for having a biological child and 
found another obstetrician/gynecologist.  
I scheduled another appointment and this doctor was even worse.  I went in, same 
thing [as with the first doctor]. [As a] new patient, he [physician] goes through the 
medical history.  He goes, “Wow! This is a lot…” Before we could finish he goes, 
“This is a lot! How many medicines do you take?”  At the time I think I was 
taking like 21 pills a day.  He goes, “Well you do know that all of this will kill 
your child, right?”  He goes “Hmmm.”  Like he didn’t believe me, like, 
“Hmmm.” I was just like, “What the?”  He got to the question, “Why are you 
here? Are you using any protection?”  I said. “No!  Because I want a baby.”  He 
said, “Do you know how much it’s going to take to have a baby?  We’re going to 
need a team of 20-some-odd doctors.”  I said, “And your point is what?  I’m 
coming to you beforehand to see what I need to do to make sure that I am as 
healthy as possible.”  This is him, he killed me literally, [he said,] “Well I don’t 
feel comfortable being your OB/GYN, but I can be your primary care doctor.”  I 
said, “Why is it that you’re not comfortable?”  He said, “Because this isn’t a case 
I’m willing to take on. It’s too high of a risk.”  So, now you’re worried about your 
reputation instead of helping somebody?  That’s the impression I got from it.    
 
This attempt to find a health care provider willing to help her have a biological child was also 
unsuccessful.  While the message she received from this physician was that having a baby was 
possible, he was unwilling to put forth the necessary effort and take the risk to make it happen.  
To Jada, the benefits of having a biological child far outweighed the risks and by seeking 
preconception care she felt she was taking the necessary steps to minimize these risks. 
Additionally, because of this physician’s unwillingness to provide her with reproductive health 
care, Jada refused to allow this person to have authority over any aspect of her health care.  In 
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neither encounter did the physicians appear to take into consideration Jada’s desire to pursue 
having a child.  While it was within the physician’s right to decline to assist Jada in her pursuit 
due his knowledge of her case, it was the manner in which the message was delivered that caused 
her to have such negative feelings.   
Nonetheless, Jada continued to assert her right to have a child despite having sickle cell 
disease.   
I’ll find a doctor that will help me eventually.  I feel like it’s something wrong 
and if it was any other regular woman that has been trying to get pregnant for this 
long they would consider saying “Well you need infertility treatment” but they 
won’t do that with me. [PR:  Have you asked for those?]  Yes.  [PR: What 
happened?]  The doctor said that she doesn’t feel comfortable doing it.  She 
doesn’t feel comfortable!?  That’s what I get a lot. [PR: What about infertility 
treatment doesn’t she feel comfortable helping you with?] Because she doesn’t 
feel like I should be pregnant. [PR: How does that make you feel?] I get so mad 
and it takes a lot for me to get mad.  How dare you tell me that I don’t deserve to 
be a mom!  I told Dr. [hematologist] and he goes, “Just hang in there, we’ll find 
you a good doctor to help you out.”  He’s like, “It’s crazy. You’re going to have a 
baby, so don’t worry about it.”   
 
Being told not to pursue having biological children caused Jada to question whether she received 
the same reproductive support that she would if she were a “regular woman.”  She also 
specifically resisted any notions of the opinions of others regarding who should be able to 
reproduce and who should not, but felt it was her decision to make.  This is very similar to what 
was presented in Chapter 2, that physicians often fail to offer women with disabilities 
reproductive health services.  For example, these physicians were unwilling to suggest 
alternatives that would increase her odds of bearing children, such an infertility treatment which 
could in some sense be considered the denial of treatment.   
Although Joyce and Jada were both discouraged from having children, they had disparate 
reactions to this message. Joyce had a long relationship with the doctor who told her “not to have 
kids” and felt this statement was made purely out of concern for her health and genuine concern 
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for her.  Therefore while she opposed his recommendation, she still paid close attention to his 
concerns for health and years later recognized that she might not be healthy enough to endure 
pregnancy and childbirth.  Unlike Joyce, Jada was interacting with new physicians with whom 
she had not established a relationship and who only knew about her “on paper”.  Thus their 
recommendation that she forgo having biological children caused her to become very upset.  She 
interpreted this message as being told she did not “deserve to be a mom” rather than a doctor’s 
genuine concern for her health. Also, because Jada was purposefully inquiring about ways she 
could improve her health, she further concluded that this message was not related to her health, 
but their opinions of who should be able to reproduce.  It is important to note that Joyce received 
the discouraging message at the age of 15, when she was not actually pursing pregnancy, while 
Jada received this message during her current pregnancy pursuit.  
Both Joyce and Jada were close in age, lived independently with the emotional support 
from their families, had health problems beyond sickle cell disease, and experienced various 
health problems throughout their lives.  Both women stated they wanted their providers “to be in 
the war” with them, and exhaust every possibility in managing their care.  In particular, Jada 
recalled her mother telling her “it took a team of doctors to keep her alive” at birth, yet her 
current providers were unwilling to take these measures.  
Another agentic response to this discouraging message was to seek information to 
confirm validity.  Faith, a 19 year-old high-school student, described being discouraged by her 
hematologist from having children while seeking his advice about her ability to survive 
pregnancy.  
I went to the doctor because I wanted children and I don’t just want to get 
pregnant and end up dying giving birth.  I asked, “Am I allowed to reproduce?” 
They told me no. [PR: Who told you no?]  Dr. [hematologist] and a couple more 
doctors that I don’t know.  [PR: What did they say?]  That I shouldn’t because of 
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my chronic sickle cell disease and the things that come with it, like severe chronic 
chest problems or whatever I could die from going through labor. [PR: How did 
that make you feel when they told you that?] I was a little upset but I wasn’t 
worried about it because I wasn’t ready for no kids. [PR: How long ago did they 
tell you this?] About three years ago. [PR: What did they suggest you do?] Not 
have kids.  I've looked it up myself. [PR: Where?] Online. I looked up my disease 
and if I can have kids or not and what should I do and stuff like that.  I just 
wanted to know with my disease how should I take care of it [pain crisis] if my 
medicine doesn’t work when I’m pregnant. That was the hard part. [PR: What 
was hard?]  Finding stuff on what you can do.  
 
At the age of 16, this message held little meaning for Faith because she was not ready to have 
children.  However, as she got older she was unwilling to allow her reproductive desires to 
remain unfulfilled and exercised reproductive agency by investigating her reproductive 
capabilities.  Information is one way to individuals regain control over their lives to compensate 
for physical limitations.  Faith did not accept the definitive response to her inquiry about having 
children and sought information online about how to manage her condition while pregnant.  
Nia’s mother, Vivian, was concerned about her health and discouraged her from having 
biological children by suggesting she adopt instead.  Nia, a 23 year-old woman, resisted her 
mother’s message and exercised reproductive agency by taking Vivian with her to the 
hematologist to hear first-hand that it was safe for her to have a child.  Nia was very close to her 
mother and referred to her as “the hero of everything.”  Her mother was a constant source of 
support and encouraged her to overcome the barriers of her condition and pursue her life goals.  
Therefore Nia earnestly sought her mother’s approval when she decided to have a biological 
child.  
When I was younger I was told, “If you have sickle cell you shouldn’t have kids.  
You need to adopt.” [PR:  Who told you that?]  My mom.  Dr. [hematologist] 
made her feel a little more comfortable about it [having biological children]. So I 
think it [talking to her hematologist] was only to make her feel a little more secure 
about my life and me wanting to bring kids into the world.  I do want my own 
kids.  Me and Dr. [hematologist] and her [her mother] talked about it a lot because 
he’s delivered babies from sickle cell patients and it’s been such a success, 
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everything’s OK, so that’s good to know.  [PR:  Whose idea was it to talk to Dr. 
[hematologist]?]  Mine.  I brought it up because me and my mom were just 
having a conversation and she’s like, “Oh, I think you should adopt.”  I said, “No, 
I’m not adopting.  I don’t want to adopt.”  She’s like, “Okay, if it comes down to 
it, I’m saving you, not no baby.”  
 
Understanding the risks to both mother and child, Nia’s mother would choose to save the life of 
her daughter at the expense of her grandchild.  Her mother’s perspective was shaped by Nia’s 
long family history of sickle cell disease.  Both Nia’s mother and her grandmother had milder 
forms of sickle cell disease with fewer symptoms.  In some cases, the death of a family member 
from the disease brings to bear the possibility of death and caused participants to be discouraged 
from pregnancy, as with Verlean above.   
It’s only because her brother passed when he was young and she saw him always 
in pain and he died at a very young age.  He had sickle cell.  She saw him suffer 
every single day.  He was in pain every single day, every holiday, every birthday.  
Everyone she has known–as far as her family and friends–didn’t make it long 
once they had a child.  
 
Here Nia also acknowledged multiple sources of reproductive influence, her mother as well as 
other family members.  Nonetheless, like Faith, Nia decided to use information seeking as a 
strategy to confirm her safety during pregnancy and childbirth.  I also interviewed Nia’s mother, 
Vivian10, a 52 year-old woman, who stated that she told Nia to adopt.  I asked Vivian about this 
advice, and she replied not only from the perspective of Nia’s mother, but also as a woman who 
had experienced having her own biological children.  
I told Nia to adopt because it’s a strain on your body.  With Nia having SS, which 
is the chronic disease, I tell her no.  There are medications out there that can help 
you–especially the Hydroxyurea they say is really good.  Even though I know the 
medications are more advanced, I would just adopt.  Even though you might 
marry somebody who don’t even have trait or disease and it’s a 50/50 chance, I 
would consider adopting first.  If that’s not what you want to do, then you have to 
look at your life span.  Are you going to have time to spend with your child?  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 This was the only mother-daughter pair I interviewed, making them fairly unique in my sample. 
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Vivian was quite concerned that Nia’s chronic condition would worsen due to pregnancy and 
childbirth and wanted Nia to carefully consider the possibility of fatality.  By suggesting 
adoption, Vivian felt she was suggesting an alternative and safer path for Nia to become mother.  
Vivian had apparently already heard Nia’s refutations–that there were advanced medications and 
she would not purposefully seek a disease- or trait-free partner–nonetheless, she remained 
adamant that Nia should adopt.   
Well, the only reason why [I felt it was fine for me to have a child] is [because] 
my fetal hemoglobin is high and Nia’s [hemoglobin] is low [and] I did not have as 
many crises as she does.  She started off [having crises] at 12 months on up. I’m 
healthy.  
 
Vivian attributed her belief that Nia should not have biological children to Nia’s more severe 
experience with sickle cell disease.  Vivian emphasized the chronic nature of Nia’s symptoms, 
which suggests that when women exhibit more severe forms of sickle cell disease, family 
members may suggest foregoing pregnancy as a precautionary measure.  
Whether or not participants decided to forgo having children, pursue having children or 
postpone having children until they felt they acquired better health, they still made these 
decisions themselves and exercised agency in ensuring they made the most informed decision 
possible.  
 
It’s in God’s Hands 
Three participants indicated that their safety throughout pregnancy and childbirth had 
already been determined by God.  Sydney, a 24 year-old mother, was discouraged from having a 
child by her mother and hematologist because they felt it could jeopardize her life.  Because of 
these discouraging messages, she was hesitant to tell her mother about her pregnancy.  
I’m sitting at the table and my momma started yelling real loud and I just started 
crying. I’m like, “Oh, my gosh.”  Then she pulled the sickle cell thing in.  [She 
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said,] “You don’t know how it’s going to affect you.” Dr. [hematologist] said, 
“You shouldn’t have no baby because you might not make it. You can’t take these 
medicines while you’re pregnant.”  I’m like, “Oh, my gosh, this is really…this is 
a big risk.”  She just made me feel so bad.  No, no one decides whether you 
should have children no matter what.  When I was 18 they [her doctors] told me 
they didn’t want me to have a kid. [PR: Why not?]  Because of the sickle cell 
[and] the problems that could happen.  I believe there is a God and that we don’t 
have the last say.  So even though the doctors said that, it did scare me a little 
because I was like, “Dang!”  But they don’t got the last say.   
 
Sydney’s mother was concerned that she would be unable to take the necessary pain medication.  
Sydney’s mother attempted to reinforce what she heard from Sydney’s hematologist about the 
risks associated with pregnancy, to support her discouraging message by saying, “Dr. 
[hematologist] said.”  This statement drew upon the physician’s medical expertise as a source of 
valued and trusted information and reaffirmed the medical risks associated with pregnancy and 
childbirth.  Sydney was very much aware of the “problems that could happen” during her 
pregnancy, yet she recognized her right to make her own decision whether or not to have 
children.  Sydney turned to faith to support her decision to continue her pregnancy by explaining 
that because she was able to conceive, a “higher being” had destined a safe pregnancy and a safe 
birth.  Sydney’s narrative illustrates the multiple sources attempting to influence her reproductive 
behavior, including her provider whom she respected and her mother whose opinion she valued 
was her own perspective for her reproductive behavior.  
Similar to Sydney’s mother, Zora’s father had been told of the dangers of childbirth with 
sickle cell disease.  Zora, a 37 year-old participant, had numerous health problems brought on by 
sickle cell disease including a coma, brain damage, temporary memory loss, and nine grand mal 
seizures.  
My father was one that would definitely ask questions if he didn’t know which 
route to take.  He did a lot of questioning because he wanted to understand it 
[sickle cell disease]. I'm thankful for that.  He was there.  My daddy was told that 
if I ever got pregnant I would die. [PR: Who told him that?] He was told that at 
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the [Hospital’s] Sickle Cell Clinic when I was younger because of how much I 
had gone through.  
 
Zora, and six other women in my sample, explained that their parents had no prior 
knowledge of sickle cell before having a child with the condition.  Zora, for instance, said, “They 
never heard of it until they were told I had it.”  With parents’ unfamiliarity with the medical 
trajectory of sickle cell disease and the ongoing health challenges, participants’ parents paid 
particularly close attention to providers’ recommendations and were protective.  
When I got pregnant, my father didn’t want me to have the baby because of all the 
complications that can occur.  I understood that but still I’m going to do what I 
want to do, because I just believe that our life is already mapped out for us and if 
it’s meant for me to die then it’s going to happen. He wouldn’t even talk to me for 
the whole nine months he was so scared. I wasn’t really worried. I didn’t know 
my mother and father had so much fear. I didn’t know but he came down to the 
ICU when I opened my eyes and I saw him and that was when they were first 
taking the tube and everything off and he ran in and said, “My baby!”  That’s 
when he held my hands and told me, “I didn’t want to lose a daughter to gain a 
grandchild.”  I said, “Daddy, you should have told me that. You could have talked 
to me about this.”  I didn’t know why that was why he was being so mean to me.  
 
Zora’s father became withdrawn when she shared the news of her first pregnancy with him.  
Similar to Sydney’s mother, Zora’s father did not want her to continue the pregnancy and for 
both of the parents of these women their pregnancies were tentative.  Not until after her son was 
born−following a coma, nine blood clots, and a stay in intensive care−did Zora came to 
understand the reason behind her father’s reaction.  While her father and others were afraid, 
Zora’s belief that her destiny had already been determined offered her comfort about her decision 
to have children.  Zora’s story illustrates her first realization of the origin of her father’s fear.  
Despite knowing how involved her father had been in her medical care and had been told about 
the medical risks of childbearing with sickle cell disease, Zora did not understand (or had not 
consciously thought about) the deep impact this would have on her father.  
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Gwen, a 22 year-old woman, was discouraged from having children by her mother and 
sister due to their concerns for fatality.   
They [her mother and sister] said I can die from giving birth and then it’s nine 
times out of ten that the child wouldn’t make it.  They didn’t try to boost me up.   
I’d rather experience it for myself than to go by what somebody is telling me.  
They tried to bring me down.  I don’t listen to it because God got a plan for 
everybody.  I don’t listen to it.  If it’s not meant for you to have kids, you’ll find 
that out.  But I know one day I want to be a mother.  So it’s like I can’t listen to 
them. I have to go by my own feelings.  
 
Gwen’s reproductive desires were in opposition to her mother and older sister’s recommendation 
that she not have biological children.  She acknowledged the potential fatality of sickle cell 
disease and childbirth, yet felt that her mother and sister should have encouraged her to pursue 
what she wanted in life, perhaps because they served as a source of support in other aspects of 
life (e.g., caring for her when she is sick, motivating her to get back in school, etc.).  Even 
knowing the odds and having important adults in her life instructing her that pregnancy was 
medically unwise, Gwen believed this decision would be determined by the status of her health 
and God–not her family.  These three women made it clear that God would determine their fate, 
not family or health care professionals. 
Family members and health care providers’ concerns for participants’ lives were apparent 
throughout the interviews.  One participant, Sophia, provided a clear illustration of how in times 
of crisis, health concerns may be given priority over women’s reproductive desires.  
One thing that tends to happen with sickle cell females is pregnancy really takes a 
toll on our body.  I was engaged once and I had gotten pregnant.  Actually that 
was one of the things that sent me into the coma about five months into the 
pregnancy.  It was just really weird waking up and I knew something was 
different.  They [her family] told me that the doctor told them it was between me 
or the baby.  My whole thing was I believe in life choice.  I said, “What am I 
going to tell God when he asks me about this?”  And she [her mother] said, “Well, 
I’ll be standing right there and I’ll tell Him I chose life for her?” [PR: What are 
you saying?] Well, when my mother was saying that she chose life for me it was 
her decision. [PR: What happened?]  When I was in a coma they took the baby.  
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My parents signed for it.  I'm Catholic, and in the Catholic faith they don't believe 
in abortion. [PR: Is that how you view that?] Yeah, I did.  
 
In this instance, Sophia was denied the opportunity to exercise agency and achieve her 
reproductive desires and regulate her pregnancy while unconscious.  Sophia questioned her 
mother’s decision because it was in opposition to her preference for “life-choice.”  Not only did 
the health professionals prioritize Sophia’s life over her child’s, so did her mother.  For Sophia, 
this experience brought to light the importance of having a living will to ensure her reproductive 
and life decisions, are honored when she is unable to make them for herself.  
If you're going to have children and you have this disability, you need to have a 
[living] will.  You just have to.  Somebody needs to know your wishes if you're 
incapacitated. It's telling them to resuscitate you; it's telling them who’s going to 
be taking care of your affairs while you're out.  
 
Summary 
The 14 participants who were discouraged by their family members or health providers 
from having biological children were among those who experienced more pain and had multiple 
comorbidities (e.g. stroke, acute chest syndrome, seizures, etc.).  This suggests that, while in 
many cases the individual voicing discouragement was speaking out of legitimate concern for the 
participant’s life, that person still did not give enough attention to the participant’s reproductive 
desires and her freedom to decide for herself.  Most participants resisted the message that they 
shouldn’t have children because of their health; however, only four of these women had made 
the decision already and actually delivered children at the time of the interview.  Participants 
without children and who had decided to forego having them also spoke about their close 
relationships with nieces and nephews and god-children who may indicate a form of alternative 
mothering, replacing that of having biological children.  
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Although being discouraged from reproduction because of their health caused 
participants great angst and some tension between their family members and providers,  
participants still employed reproductive agency to pursue their desires and do what they felt was 
right for them.  Participants believed the decision whether or not to have children should be 
made based on the condition of their health and belief in God’s will rather than having sickle cell 
disease alone.  These women recognized and accepted the risks and even potential danger to their 
lives amid pregnancy and childbirth, but felt they were being responsible by doing their own 
research, seeking health clearance with physicians, and paying close attention to their bodies and 
health status to guide their decision-making.  Ultimately, those that opposed the message did so 
based on their desire to make an autonomous and informed choice.   
 
Message: Don’t Have a Baby by Nobody with Sickle Cell 
In addition to being discouraged from having biological children out of concern for their 
health, nearly one third (N=7) of the participants indicated they were discouraged from 
reproducing with a man with sickle cell disease or sickle cell trait.  This message was a more 
implicit way of ensuring these women would not transmit sickle cell disease to their child.  For 
example, Mya indicated that while growing up, her hematologist “didn’t like us [patients] to 
associate with other sickle cell patients in the office because he thought we might start dating.”   
 
Of Course I Wouldn’t Have a Baby with a Man with Sickle Cell 
Six women indicated that this message influenced their relationship formation and they 
exercised agency by intentionally avoiding having a partner with either sickle cell disease or 
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sickle cell trait.  As a young woman Gabrielle, a 36 year-old mother, used this message as a 
guide for her future reproductive behavior.  
I didn’t think I would have a baby with sickle cell of course because I didn’t think 
my husband had the trait.  Of course, I would not have mated up with anyone that 
had the trait.  Two bad genes is only going to give a bad gene. I can’t give off a 
good one because I only have two bad.  [PR:  How did you even know to ask your 
husband about it?] Because my family told me, “Don’t have a boyfriend with the 
sickle cell trait or disease.”  So I knew that much.  Because I knew my mother and 
father both had the trait and that’s how I ended up with the disease.  So they did 
teach me that.  Like, “You can’t have a boyfriend [with sickle cell].  You have to 
find out their medical history, if they have sickle cell” and stuff like that.  So that 
I did know.  I knew I was going to have kids.  Nobody said I couldn’t have kids, 
they just said that I couldn’t have kids with someone else who had sickle cell.  
 
Her family instructed her not to have a boyfriend with sickle cell disease–with the understanding 
that casual relationships have the potential to escalate into intimate relationships.  Through her 
family’s careful explanation of the genetic transmission process, Gabrielle interpreted her 
reproduction as contingent upon making sure her partner did not have either sickle cell trait or 
disease.  Gabrielle followed this instruction and was diligent about not dating a man with sickle 
cell.  For instance, she asked her ex-husband to be tested at the local hospital while they were 
still dating and before pregnancy.  However, once her son was born with sickle cell disease, they 
discovered her husband’s test result was a false-negative.  This experience caused Gabrielle to be 
even more agentic with her next partner’s genetic testing by taking him to the sickle cell clinic 
where they “test for everything.”  
In her youth, Jada had also been instructed to discover her partner’s sickle cell status 
prior to reproducing.  
I understood really early that if I wanted to have kids it should not be by a person 
that has sickle cell disease and that my child is going to be born with the trait.  
[PR:  Who told you that?]  Dr. [hematologist].  They of course have to tell us that 
you need to make sure the child’s father doesn’t have the trait or sickle cell 
disease.  If he has sickle cell trait and you have sickle cell disease, do you want to 
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take that risk?  Because you know you have to pass on one of your genes and one 
of his genes, so if I have the disease of course I’m going to pass it on.  
 
Similar to Gabrielle, Jada framed her reproductive future based on whether or not her partner had 
sickle cell trait or disease.  For Jada, this message was simply a form of necessary patient 
education for her as a woman with sickle cell disease not to have a child with the condition.  
Therefore she viewed it positively and willingly internalized this message as a road map used for 
reproductive partner selection.  
Joyce, her family, and her doctors had discussed in great detail how she came to have 
sickle cell disease.  Having this knowledge she refused to date men who had sickle cell disease to 
ensure she would not pass the disease onto a child.  
I have actually had guys with sickle cell try to talk to me and I’m looking at them 
like, “You do realize that there is no way possible for us to be in a relationship 
past a friendship?”  They’re like, “We can be together. We just won’t have kids 
together.” I’m thinking to myself, well, that’s part of what I want.  I don’t want a 
relationship and not be able to have a child.  Then it won’t work either because 
you’re sick [and] I’m sick, so when you’re sick I’m going to be taking care of you 
[and] when I’m sick, you’re going to be taking care of me.  What type of life are 
we really going to have?  Somebody has to be well at some point.  So, that 
doesn’t work.  
 
Due to these influential conversations with her family and providers and her own embodied 
experience, Joyce was willing to limit her partner selection, but she was not willing to limit her 
relationships to those in which having a child was not an option.  In her mind, taking care of a 
child was an experience she desired; however she fully realized the effort and energy required. 
Additionally, her decision not to dating men with sickle cell disease extended beyond having a 
child with sickle cell disease.  She expressed concerns about the quality of life she and her 
partner would have and questioned their ability to physically care for the child in times of 
sickness. 
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Joyce and Jada are participants who received different discouraging messages, from 
different sources, yet still exercised agency in pursuing their reproductive desires.  All three of 
these women were very knowledgeable about how sickle cell is transmitted and the likelihood of 
their children having the condition. Much of what they learned came about because they were the 
only ones in their families to have the condition and their parents had taken the time to education 
them.  This reproductive information was therefore viewed in large part as a form of education, 
as evidenced by Jada’s comment that “they did tell me that” and Gabrielle’s comment “I knew 
that much.”  This information was presented as a road map of how not to proceed and each of 
these women, along with three others, indicated they were determined not to follow in this 
direction. 
 
You Can’t Help Who You Love  
Only one participant was resistant to the message not to enter into a relationship with 
men who had sickle cell disease or sickle cell trait.  Yvonne, a 23 year-old college student stated, 
“My mom told me, ‘No! Don’t marry nobody with sickle cell!’”  However, Yvonne believed that 
love cannot be controlled by a set of rules. 
You can’t help who you meet and who you love and I guess that if I met 
somebody and I did find out that they had the trait of sickle cell, then, depending 
on how much I love that person you just have to make it work.  
 
In Yvonne’s opinion, adhering to this message would be based on the type of relationship and 
the feelings she may have developed for the other person.  Yvonne held very specific ideals 
about love, marriage and family.  She was planning to remain a virgin until marriage and had not 
seriously dated.  
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Message: Don’t Bring No Baby Here with Sickle Cell Disease 
In addition to the more implicit discouraging message not to have a child with a man with 
sickle cell trait or sickle cell disease, one quarter (N=9) of the participants indicated they were 
discouraged from having children because of the possibility that the baby would be born with 
sickle cell disease.  For example, Raven, a 39 year-old mother of two son’s with sickle cell 
disease, indicated that “people be like, ‘With sickle cell why would you want to have a baby 
anyway?’  Who wants to have a baby with sickle cell?”  Raven had two sons with sickle cell 
disease and did not believe that having sickle cell disease was a tragic occurrence and felt happy 
to have them.  
In addition to her concerns for Nia’s health, Vivian was also concerned about Nia 
genetically transmitting sickle cell disease to her child.  
I just don’t think it’s fair for you to have a child and you have sickle cell and it’s a 
chance that they will have it too.  I just don’t like it. Wasn’t no way Nia should 
have been here. I got my tubes tied right after Nia came out.  I’m like, “I’m not 
bringing another baby here with sickle cell.” I said [to her obstetrician], “Do you 
know how bad it is having sickle cell?”  I’m not going to say that now because 
she’s a blessing.  I had my brother [die from sickle cell disease].  I didn’t want to 
bring [another] baby here with sickle cell disease.  So that was my choice.   
 
Vivian indicated that she didn’t believe it was “fair” for someone to knowingly have a child with 
sickle cell disease.  Prior to her pregnancy, Vivian was under the assumption that her husband 
was not a carrier of sickle cell trait and therefore she did not knowingly make the decision to 
have a child who may have sickle cell disease.  Vivian illustrates her commitment to not having 
another child with sickle cell disease by taking the preventative measure of having a tubal 
ligation.  Vivian’s story highlights the delicate balance of family members telling their children 
not to have children who may also have sickle cell disease.  
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That’s the Way It Has to Be  
Six participants responded to the message not to have a child with sickle cell disease by 
enacting their own diligent behavior, three of whom decided to forgo having biological children.  
Gina, a 25 year-old woman, grew up in foster care and referred to herself as “a ward of the 
state”.  Due to her experiences with multiple foster care homes, she never received appropriate 
guidance or instruction regarding reproductive issues and stated, “With the foster parents that 
I've dealt with, they didn’t teach me anything. I guess.  They assumed that I already knew it so it 
wasn’t like a mother sitting down or a grandmother sitting down teaching you.”  Throughout her 
life she only maintained contact with one of her three siblings, her oldest sister, who continued to 
visit and inquire about her well-being.  Her sister was also the person who discouraged her from 
having a biological child.  
A couple of years ago when I was undecided, we [she and her sister] were 
debating about it, like spatting about it, and she thinks, it would be torturous to 
put someone else through this [sickle cell disease]. My sister thinks that it would 
be a disjustice [sic] to my child because I had the pre-knowledge on what his or 
her life is going to be like and it’s not good, so why would I go ahead and do that?  
So at first I was against it and I was like, “Well, why should I have to not have 
kids just because I have this disorder?  That takes away my chances at being a 
parent?  That’s not right.”  But now I agree.  Now that I am older, I understand 
that sometimes that’s the way it has to be.  
 
Gina’s initial response was to reject this message as an imposition of her right to become a 
parent, yet later she viewed this message as her responsibility to prevent the “disjustice” of 
knowingly passing along sickle cell disease to someone else.  As the one person in her life who 
provided her with any reproductive guidance, Gina was influenced by this message and later 
decided not to pursue having biological children. Gina’s sister felt that because Gina had the 
experiential knowledge of living with sickle cell disease, this should have sufficiently deterred 
her from taking the chance of having a child who could possibly also have this condition.   
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When I started becoming sexually active at 20, and I'm like, “I can't be like 
everybody else because I'm not like everybody else so I have to take extra 
precautions. I can't have accidentally have a baby.” [PR: What were the extra 
precautions?] I have took all the precautions in the world, even taking the 
morning after pill. I have took that about three times, you know, with accidents 
and things. So, yeah, I have not had to get an abortion.  
 
Upon making the decision to avoid having a child with sickle cell disease, Gina began to view 
herself as being different from other sexually active women.  Once she became sexually active, 
Gina held that her reproductive capacity was overshadowed by her genetic responsibility.  
Therefore, she exercised reproductive agency by taking extra precautions to avoid having a child 
with sickle cell disease, and even considered termination.  
For Imani, a 49 year-old woman, the message she received from her mother included 
various reasons why she should avoid having a child with sickle cell disease.  
My mother said, “Don’t date a man if he has sickle cell or if he’s a carrier because 
that’s going to be a huge weight on your child.  That can determine whether your 
child is going to suffer for the rest of their life or it’s going to determine whether 
your child is just a carrier.”  Now my cousin [who also has sickle cell disease], 
she has four children.  Me, I chose the…I guess I would say the coward’s way 
out, because I didn’t want to cause the baby suffering. I’ve got enough nieces and 
nephews.  I wasn’t going for that ‘cause I had suffered so much. I couldn’t see 
rolling the dice and saying, “Oh, guess you got it.  Now you got to suffer through 
just like I had to suffer through.”  I couldn’t see it and had my mother known, she 
wouldn’t have gotten pregnant.  
 
Imani viewed her decision of not having children as the “coward’s way out,” suggesting that to 
have a child would require a level of bravery she did not possess.  Neither of Imani’s parents was 
aware they were carriers of the sickle cell trait and Imani was told if her mother known that 
sickle cell could be passed to her offspring, she would have opted not to have children.  Having 
been told this, Imani felt that those who know they have the potential to have children with 
illness should forego having biological children.  Similar to Mya and Verlean above who were 
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unwilling to risk their health for childbearing, Imani redirected her maternal efforts toward her 
nieces and nephews and chose not to have her own children. 
Mya worked at a clinic for people with chronic illnesses and met a woman with five 
daughters, all of whom had sickle cell disease. 
I met a lady that came through my job with five daughters with sickle cell disease.  
She’s like, “When one is sick, the other is sick.”  I’m like “Duh!”  I’m like, “You 
and your husband know ya’ll got the trait and you sat here and had five daughters 
and one may be sick and the other one may be sick.” She’s sitting there 
complaining, “When one gets out the hospital, I have to go because another one is 
in there.”  I’m like, “What did you think was going to happen?”  They are sick 
and they are so cute.  I’m like, “You don’t understand the pain they go through. 
You have the trait. Ain’t nothing really happening to you on a regular basis.  Yea, 
they’re going to be sick back to back to back.”   
 
Mya decided not to have children because of the risk of fatality and childbirth, even though she 
wanted children.  She thought it was irresponsible for this mother to choose to have five 
daughters knowing she and her husband were both carriers of the sickle cell trait.  Mya attributed 
this decision to the woman’s lack of the embodied experience or a physical understanding of 
what it is like to live with sickle cell disease.  Mya’s strong opinion of this mother demonstrated 
her belief that those with genetic conditions should exercise responsibility in their reproduction 
and not have children who will have sickle cell disease and may explain how she arrived at her 
decision not to have children.  
 
I’d Rather Be Here Than Not Be Here  
Only three participants resisted the discouraging message of having a child due to genetic 
transmission.  In addition to Gwen’s family concerns about her having a child because her 
health, they also discouraged her from having a child that may be born with sickle cell disease.  
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My mom and my older sister, they told me I shouldn’t try to have a child when I 
got sickle cell because I wouldn’t want my child to grow up with sickle cell.  So 
they tried to talk me out of it.  
 
Growing up, Gwen’s said her parents told her “that I was the gifted child because when I was 
born, I was supposed to die.”  Having received this message of being “gifted” and surviving to 
the age of 22, it may have been difficult for Gwen to then accept being told not to have a child 
who would have sickle cell disease–since she beat the odds, her child would beat the odds.  
Similar to Gwen, Yvonne was another woman in the study who received discouraging 
reproductive messages for more than one reason.  In addition to concerns of reproducing with a 
partner with sickle cell disease, Yvonne’s mother also instructed her to avoid having a baby with 
sickle cell disease.   
She [her mother] said, “You received sickle cell from your father and I because it 
was a genetic thing.  I had a trait, he had a trait and if you marry someone who 
has a trait or you marry someone who has sickle cell itself your children could 
potentially have it.”  The reason why I said I thought it would be selfish is 
because, some people may say like, “Well I’d rather not be here than be here 
doing all this suffering.”  But, I know me and personally I would rather be here 
regardless. Then again it’s like we [she and her siblings] wouldn’t be here.  
Surprisingly I’d rather be here with my life than be like, “Oh, my God, he has the 
trait, let’s not have kids!”  I’d rather be here than not be here.  You’re here 
because somebody gave you a chance.  I wouldn’t want nobody to think I’m 
selfish.  Like, “Wow, that’s really selfish of you knowing that your child could 
have this disorder but you still want to have kids.”  And people who impose their 
opinions and judgments on us [people with sickle cell disease], I don’t think that’s 
right. So, regardless if I have sickle cell or not, it’s just a blessing to be here.  I 
don’t look at sickle cell disease like, “Oh, my God, it’s just the worst thing ever.”  
 
Yvonne viewed having a child with sickle cell disease differently than her mother. While 
Yvonne did not intend to have a child with sickle cell disease, she stated she would not allow this 
possibility to deter her reproductive desires.  Yvonne anticipated she would face social scrutiny 
and moral judgment if and when she should she have a child with sickle cell disease.  She felt 
somewhat guilty for wanting her own children, regardless of whether they have sickle cell 
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disease or not.  Yvonne based her desires for a biological child on her own gratitude for having 
the “chance” at life–even with sickle cell disease.  
 
The Strength of the Discouraging Reproductive Message 
As the above narratives illustrate, the message that women “shouldn’t have children” 
arises from a variety of important sources–physicians, parents, and other close family members.  
It is so commonplace during participants’ upbringing that it colors their reproductive decision-
making.  This message not only influenced some women (N=3) to forgo having biological 
children, it also influenced women to express a sense of relief over a spontaneous miscarriage 
(N=1) or consider terminating their pregnancy (N=2).  Jewel, a 41 year-old mother of four, 
highlighted how being told that she should not have children influenced her immediate reaction 
to her first pregnancy and while she had originally believed this to be true, an unplanned 
pregnancy caused her to realize the myth behind the message.  
I found out that I was pregnant and it was a scary feeling. I wanted to get an 
abortion because I knew the stories about people with sickle cell having kids.  
They would say you’re not supposed to have kids when you got sickle cell. [PR: 
Who told you that?]  That’s what I remember hearing as a kid when it came to 
sickle cell, [that] I’m not supposed to have kids. It’s one of the things that you’re 
not supposed to do.  My [older] cousin [who also has sickle cell disease] didn’t 
have any [kids] and a lot of people I know with sickle cell disease don’t have 
kids.  Even when I go down to the Sickle Cell Center, I hardly ever see anybody 
come to the clinic with kids. [PR: How did you decide you weren’t going to have 
an abortion? That you were going to have the baby?] I never got the money to get 
rid of it. Actually I had no choice but to have it at that point. After so long it was 
just too late to do anything. [PR: How did you feel after you gave birth to your 
first son?] I felt like a lot of things they say about sickle cell is a myth because I 
know a lot of people with sickle cell that don’t have any kids, none whatsoever, 
and want kids, wish they had kids. So I feel like I’m blessed.  
 
Unfortunately, Jewel did not realize the rumor she had heard was not true until after she had her 
first child.  While Jewel did not explicitly state the meaning she gave to hearing that she should 
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not have children, she internalized this information by seeking termination because of this 
message.  Ultimately, because of the lack of financial support from the father of the baby, Jewel 
was unable to have the initially desired abortion.   
 
Summary 
Twelve women received the discouraging reproductive message concerning genetic 
transmission.  These findings mirror existing literature that has found that women with 
disabilities have reported that their mothering rights have been denied through subtle 
discouragement by doctors, professionals, and family members due to the assumption that they 
will give birth to more disabled individuals (Kallianes and Rubenfield 1997, Romano 1982). As 
a social body, there is a collective interest in ensuring the future health of society, which makes 
the issue of reproduction and more specifically the connection between genetic disease and 
reproduction a matter of importance. 
In this study, participants received two separate messages aimed at preventing them from 
having a child with sickle cell disease.  The implicit message was to avoid having a partner with 
sickle cell disease and the explicit message was to avoid having a child with sickle cell disease at 
all costs.  Eight of the participants agreed with either of the two messages and four women 
agreed with both messages about avoiding genetic transmission.  More women in this study 
agreed with the explicit message mainly due to their embodied experiences living with the 
condition and their desire to avoid subjecting another person to their own experience.  These 
participants illustrated that even agreeing with this message was a form of reproductive agency 
in that they adopted specific strategies to ensure they did not have a child with sickle cell disease.  
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Two participants, neither of them had children, opposed this message and contended that while 
sickle cell disease is difficult to live with it was not a horrible fate.   
 
Message: Women with Sickle Cell Disease Can’t Have Children 
Four women in the study were told they could not have children as a result of having 
sickle cell disease.  Rather than being told they should not have children, which suggests a moral 
decision, the message that they are unable to have children is suggestive of a physical inability.  
 
I Believed Them 
Only one participant, Ivy, a 27-year-old mother of three, initially believed the 
misinformation about her ability to bear children.   
I was always told because I had sickle cell I couldn’t have children so I was kind 
of confused in the beginning [of her first pregnancy] because I thought I couldn’t 
have children.  [PR: Who told you that?]  My grandmother told me that and I 
remember while we were at my appointment at [Hospital], the same nurse who 
used to give me information, she also told me there was a chance that I would not 
be able to have children. They were wrong. [PR: How did you feel when you 
realized you were pregnant?] I was more nervous than excited. [PR: About what?] 
Just about everything because I really thought I couldn’t have children so it was 
more what is going to happen? [PR: Before your first pregnancy, was there any 
reason why you weren’t on birth control?]  I was always told I couldn’t have kids 
so there was no need for me to be on birth control. [PR: Any other reason?]  No.  
I was told I couldn’t have children so I never even thought about birth control, 
that’s the only reason.  
 
Ivy was the only person in her family with sickle cell disease and her grandmother was 
unfamiliar with the condition and depended on health care providers to educate her on how to 
care for Ivy.  Having received this misinformation from her grandmother, who raised her as well 
as a health care provider, Ivy initially believed she was unable to have children and therefore did 
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not use birth control. Since this was her first pregnancy, she was confused and nervous after 
realizing she was pregnant, which hindered her ability to be excited about her pregnancy.   
 
I Knew That Was Horse-Monkey 
Unlike Ivy, who did not realize she could have children until she became pregnant, three 
women in the study rejected the message that they could not have children.  As women with a 
physically-imposing condition, they had some doubt whether or not they were physically capable 
of becoming pregnant or bearing a child.  Hope, a 25 year-old woman, was told by her mother 
that women with sickle cell disease could not have children.  
I wish she [her mother] had of talked to me about pregnancy instead of telling me 
that sickle cell patients can’t have kids.  [She told me] that I can’t have kids 
because I have sickle cell.  That’s what she told me.  Instead of telling me that, I 
wish she had talked to me in a sensible way, like, “Well, you can have kids. It’s 
fine to have kids.”  Instead of me going to my doctor and asking my doctor, 
“Well, is it alright for me to have kids and what will happen if I have kids?”  I had 
to get it from my doctor.  My mom should have told me all the information that 
Dr. [hematologist] told me. I dropped the subject and I never brung [sic] it up 
again until when I had got pregnant with my son. [PR:  What did she say when 
you told her?]  She was like, “Okay. Are you sure you want to have the baby?”  
And you know, she just asked me stupid questions at the time, but I said, “Yeah.”  
Then she just dropped the subject.   
 
Hope had also been given misinformation about her reproductive capabilities as a woman 
with sickle cell disease.  Because she desired to have children, she decided to confirm this 
information with her hematologist.  Young African American women often look to their mothers 
as reliable sources of information about reproduction and reproductive health care (Warren-
Jeanpiere 2006).  However for many parents of children with sickle cell disease, they do not 
always share the embodied experience of sickle cell disease (most have sickle cell trait) and thus 
may not possess the sought after information or a comprehensive understanding of reproductive 
abilities or limitations.  While the intent of Hope’s mother’s message is unclear, even after 
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receiving clearance from the hematologist, her mother continued to question her decision to 
continue with the pregnancy perhaps out of an underlying concern of her health. 
For these three women, knowing another woman with sickle cell disease who had 
children served to counter the message that they physically incapable of having children.  Gwen 
indicated, “I know TBOZ from TLC11 got sickle cell and she got kids.”  Pearl’s mother also had 
sickle cell disease, not trait, which provided her with evidence to counter the message that she 
could not have children.  
All the time I heard we couldn’t, not shouldn’t. I heard we could not. [PR: From 
who?] It didn’t matter.  My mother had sickle cell disease so I knew they [people 
who said she couldn’t have children] didn’t know what they were talking about.  I 
heard it from just people in general and people in the medical profession.  I heard 
a lot of nurses say, “I thought sickle cell people couldn’t have kids.”  So I didn’t 
hear “shouldn’t,” I heard “you could not.”  But there wouldn’t be all these people 
out here with sickle cell if that was the truth, so I knew that was horse-monkey.  
 
In addition to hearing from laypeople that women with sickle cell disease could not have 
children, Pearl heard this message from health care professionals.  However, unlike most other 
women in the study whose mothers had sickle cell trait, Pearl’s mother had sickle cell disease, 
which provided her with the evidence that what she was being told was untrue.  
Katrina, a 30 year-old mother, had another female family member with sickle cell disease 
who had given birth. 
I have one cousin, she’s in her forties and she does have two kids.  Other than that 
I’ve never talked to anyone until I was pregnant and it was a nurse who assisted 
me and she was like, “You’re going to get through this. You’re going to be fine.”  
She had sickle cell and she was like, “I didn’t think I could have kids so I adopted 
and then I had three of my own.”  That really encouraged me.  
 
Katrina’s conversation with another mother with sickle cell disease offered her reassurance about 
her own pregnancy.  The women above illustrate that believing the message caused them to 1) 
not use contraception and 2) contemplate adoption.  Yet, knowing another woman who had 	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  TLC is a well-known R&B group.	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already gone through the experience served as a source of social support.  Researchers have 
specifically advocated social support interventions for individuals with sickle cell disease based 
on the observation that ethnic minorities tend to rely more on respected lay-persons for health 
information than medical professionals (Holmes, Hatch and Robinson 1991). 
 
Summary 
Only a few women in the study had been told they were unable to bear biological 
children because they had sickle cell disease. One woman believed this message to be true 
because it came from two trusted sources–her health care provider and her grandmother.  For the 
other women who were given this message, having personal knowledge seemed to help them 
disregard the misinformation they received, give them the power to overcome fear and doubt, 
and pursue their desire of having children.  While this message was based on misinformation, 
even among health care providers, it illustrates how women must be able to validate the 
information they are given, regardless of the source.   
 
Conclusion 
This chapter illustrates the multiple discouraging reproductive messages participants 
received as well as their resistance to or accommodation of the message and a range of agentic 
responses.  This chapter also highlights the complexity of the discouraging messages in that they 
were delivered at varying stages of reproduction, from multiple sources and for different reasons.  
Some participants received multiple discouraging messages throughout their reproductive lives-
from the time they reached reproductive age until their mid- to late-thirties.   
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The fourteen women in the study who were discouraged from having a biological child 
due to concerns for their health were also among those who experienced more pain requiring 
hospitalization during the past 12 months.  At the time of the interview, only two of these women 
decided they were unwilling to risk their own lives to have biological children.  Participants were 
physically unable to ignore having sickle cell disease, as they often experienced symptoms, thus 
instead of being influenced by the advice or guidance of others, participants used their embodied 
knowledge of living with sickle cell disease to determine whether or not to have children.   
Eight of the women without children indicated their plans to have children in the future 
because they were unwilling to sacrifice the experience of giving birth and having a child.  Aja 
explained this by saying,  
I’ve been told that I could harvest my eggs but then I was told that there was not a 
guarantee that they would survive the freezing, nor can I afford to do it.  And that 
if I do a bone marrow transplant, chances are that I won’t be able to have kids at 
all, so I decided to at least having a baby first and then do it.  Because I feel like I 
give up so much being sick, but that’s the one thing that I’m not willing to give 
up.   
 
Women in this study were not as concerned about the fatality associated with pregnancy 
and childbirth as they were about passing sickle cell disease on to their children.  Six of the 
seven women in the study who were told they should not partner with someone with sickle cell 
trait or disease used this message to influence their relationship formation and choose their 
partners accordingly.  Six of the nine women who were told not to have a child with sickle cell 
disease agreed with that message and were diligent in ensuring this did not happen.  Of the 
eleven women who received either of the discouraging genetic messages, seven were the only 
member of their family with sickle cell disease.  Thus, participants were willing to be selective in 
their reproductive partners in an effort to avoid having a child with sickle cell disease−even to 
the point of avoiding dating men who had sickle cell trait or disease altogether.  Whether 
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warnings about the potential risk to their lives originated from a close family member or from a 
provider, most all women in this study were determined to have children if they desired them.  
Interestingly, women in the study were occasionally unable to identify the specific source of 
their discouraging reproductive message and simply stated that a generic “I heard it” or “they 
said,” which suggests the normative nature of these messages. 
Sickle cell disease is an illness with very unpredictable symptoms and for these women 
reproduction was one aspect of their lives that many felt they could control. This attitude is 
reflective of Rotter’s idea of locus of control that refers to the degree to which people perceive 
that the outcomes of the situations they experience are under their control (1966).  This control is 
influenced by either the effort one exhausts or environmental forces that are beyond one’s 
control (Rotter 1966).  Thus some participants believed their decisions whether or not to have a 
child and whether or not they would have a child with or without sickle cell disease was within 
their control; however their survival of pregnancy and childbirth was not a situation in which 
they had as much control.  Some participants also expressed spiritual locus of control, which 
reflects the belief that a higher power has control over one’s health outcomes (Debnam et al. 
2012).  The type of spiritual locus of control described by some participants in this study favors 
the passive dimension and consists of a belief that, because only a higher power is in control of 
health outcomes, there is no reason to engage in health promoting behaviors (rather than the 
active dimension which suggests that a higher power affords an individual to be empowered 
about health behavior or collaborate with a higher power to stay in good health) (Debnam et al. 
2012).  
Only four participants were told that they were incapable of having children and they 
soon realized this to be misinformation, either from a personal experience knowing a woman 
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with sickle cell disease or by inquiring about their reproductive capacity with a medical 
professional.  Nonetheless, as Ivy illustrated, this message has the potential to place women at 
risk for unplanned or unwanted pregnancies. 
Women in the study were particularly vulnerable to the influence of others through the 
power of discouraging messages.  Suggesting that participants should not have children suggests 
an ideal outcome and the expectation that these women will make “responsible” choices by 
foregoing childbearing or limiting their intimate relationships with men who had sickle cell 
disease or trait.  Several women had medical comorbidities in addition to sickle cell disease (e.g., 
heart disease, kidney disease, acute chest syndrome, etc.), which further encouraged family 
members and providers to question their ability to physically endure pregnancy and childbirth. 
Some even were told that they were incapable of having children. Women’s reproductive 
decisions could be affected in various ways, depending on the strength and source of message. 
Most participants resisted the discouraging messages they received at least in part and 
exercised agency in pursuing their reproductive desires in varying ways.   Importantly, the 
agentic responses of women in this study were sometimes in opposition to the message and in 
other times their response was in agreement to the message.  Hollander and Einwohner (2004) 
suggested that resistance takes a variety of forms ranging from overt to none at all.  The 
everyday resistance behavior participants exhibited was intended to claim power over their 
reproductive lives (e.g. seeking medical expertise and becoming informed about their 
reproductive capabilities from alternative sources) and illustrates the agency women were able to 
exercise in their own reproductive decision-making (Hollander and Einwohner 2004). This 
chapter also illustrates that decisions regarding reproduction are not always definitive. While at 
one stage of life or health status, a woman may resist the message to have children but at another 
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stage she may be more amenable to the messages.  Five participants were not discouraged from 
having biological children for any reason.  While it is difficult to explain why family members, 
providers or others did not discourage them all women in this study, health status, cultural or 
religious background, and educational level could affect message transmission. For instance, 
Clem and Chloe had few symptoms and sickle cell disease may not have been a concern for their 
families.  On the other hand, Dana was from Ghana, and perhaps discouraging women from 
reproducing is not culturally acceptable.  Throughout her interview Aja also indicated that her 
family was not educated about sickle cell disease and she was not always comfortable talking 
about sexuality with her providers. Aja also noted that in her religious family, it was more 
important that childbearing occur within the sanctity of marriage than whether childbearing 
should be affected by sickle cell status. 
This chapter specifically addressed participants’ reports of discouraging reproductive 
messages and their agency in the face of these messages. In the next chapter I will describe how 
participants arrived at reproductive decisions based on their genetic identities and the 
internalization of these discouraging messages when confronting genetic testing.   
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Table 6. Participants’ Responses to Discouraging Reproductive Messages 
Participant 
Did Not 
Receive 
A 
Discouraging 
Message 
N=5 
Shouldn’t Have Children Messages 
Couldn’t 
Have 
Children 
Message 
N=4 
Do Not 
Have 
Children, 
It’s Too 
Dangerous 
N=14 
Do Not 
Reproduce 
with a 
Partner 
with SCD 
or SCT  
N=7 
Do Not 
Have a 
Child with 
SCD 
N=9 
Jada  X X  X  
Joyce  X X  X  
Nia  X X  X  
Sophia  X X    
Mya  X  X  
Gwen  X  X  
Ebony  X    
Faith  X    
Jewel  X    
Verlean  X    
Lynn  X    
Sydney  X    
Zora  X    
Tia  X    
Imani   X  X  
Yvonne   X X  
Gabrielle   X   
Gina    X  
Raven    X  
Hope     X 
Ivy     X 
Katrina     X 
Pearl     X 
Aja X     
Clem X     
Chloe X     
Dana X     
Vivian X     
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CHAPTER 6  
REPRODUCTIVE DECISIONS AND BEHAVIOR 
 
They wanted to do an amniocentesis on me to see if [her son] was going to have 
sickle cell disease or not and I’m like, “No. I’ll wait until I have him to find out.   
It ain’t that serious to me to know if he got sickle cell.” ~Raven 
 
In the last chapter I indicated that nearly all of the women in the study exercised agency 
to pursue their reproductive desires.  This chapter describes participants’ perceptions and 
motivations regarding genetic-related reproductive decisions.  Although reproduction is not a 
gendered experience, as the bearers of children, women are often considered the carriers of 
heredity, good or bad, placing more of the reproductive burden on them.  Also, having a genetic 
illness placed an additional burden on participants not only to disclose their condition to potential 
reproductive partners but also to inquire about their genetic status as well.  
Genetic testing is a technique used to identify a particular genotype.  It may be offered to 
individuals on the basis of ethnicity, family history suggestive of a genetic disorder, presentation 
of symptoms suggestive of a genetic disorder, and existence of a disease with known genetic 
components (Natowicz and Alper 1991).  Prenatal testing is performed to detect any 
abnormalities that are suspected because of (1) advanced maternal age, (2) previous pregnancy 
that resulted in the birth of a chromosomally abnormal child, (3) parent known to have or carry a 
chromosomal abnormality, (4) a family history of chromosomal abnormality, (5) history of three 
or more miscarriages, and (6) previous children (with multiple malformations on whom 
chromosomal analysis were not conducted) (Abram et al. 1983: p. 4).  Thus genetic and prenatal 
testing are methods of gathering medical knowledge about reproductive partners and “unique” 
pregnancies and are presented as part of standard prenatal care alongside other measures 
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pregnant women take to protect their unborn child, such as seeing a health care provider, taking 
prenatal vitamins, and even stopping unhealthy behaviors. 
In the following sections I describe participants’ motivations for asking their partners to 
be tested, their own decisions whether or not to undergo prenatal testing, and how responsibility 
for genetic testing remains a gendered burden. 
 
Why I Asked My Partner to Undergo Genetic Testing12 
As indicated in Chapter Two, women with sickle cell disease have a 50% probability of 
transmitting sickle cell disease to their children if their partner has sickle cell trait, and a 100% 
probability of transmitting the disease to a child if their partner has sickle cell disease (Platt and 
Sacerdote 2006).  When one parent has the disease and the other parent has normal hemoglobin, 
all children born by that couple will have sickle cell trait (Platt and Sacerdote 2006).  Given these 
facts, participants reported that determining whether partners were carriers of the sickle cell trait 
was an important element in their reproductive decision-making.  
Twenty-two women in the study asked their partners to be tested; of these, nineteen 
partners agreed but three refused to be tested (See Table 7).  Six participants had not been in a 
relationship serious enough to warrant a conversation about genetic testing.  Participants 
described three key stages of reproduction in which they asked their partners to be tested: before 
intimacy, before pregnancy, and after pregnancy.   
As discussed in Chapter Five, most women in this study had a clear understanding of the 
implications of reproducing with a partner with sickle cell trait, which strongly influenced their 
decisions to ask their partners to be tested.  Nearly all of the women in the study (N=22) thought 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12	  In	  wider	  society,	  people	  often	  use	  the	  terms	  genetic	  counseling	  and	  genetic	  testing	  synonymously.	  	  However,	  this	  dissertation	  specifically	  refers	  to	  testing	  –	  in	  which	  an	  actual	  procedure	  is	  performed.	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getting their partners tested was important enough to ask them to do so because of their 
embodied experience living with sickle cell disease (and the need to prevent children from living 
with the same experience), however not all participants identified the same sources of motivation 
for asking their partners to be tested.  For instance, eight did not want their child to suffer the 
way they had.  Another eight were motivated by their father’s lack of awareness of his sickle cell 
trait status.  Six were motivated due to a previous experience with an unplanned pregnancy with 
an untested partner.  Most of the partners mentioned in this study had not been previously tested 
before being asked by a participant.  In the few instances where partners said they had been 
tested already, women in the study (e.g., Aja and Nia) wanted them to be re-tested to confirm 
they were not carriers of the sickle cell trait.  
 
I Don’t Want My Child to Suffer Like Me  
Although pain is the hallmark of sickle cell disease, individuals with this condition are 
impacted socially, financially, and psychologically, greatly influencing their overall quality of 
life.  Therefore over one-third (N=8) of the women I interviewed indicated that their motivation 
for asking partners to undergo genetic testing was to prevent having a child who would suffer 
from the disease as they had.   
Zora, a 37 year-old mother of two, had experienced numerous health problems brought 
on by sickle cell disease including a coma, brain damage, temporary memory loss, and nine 
grand mal seizures.  She admitted having moments in her life when she wanted to “give up.”  
He [her husband] was everything I had asked God for. I made sure Dr. 
[hematologist] met him and she got him tested, when we got engaged.  She took 
his blood and he didn’t have the trait.  It was important that my husband was 
tested because I wouldn’t want to see a child go through a lot of the suffering that 
I went through. You see, a lot of the suffering is not just physical, it’s emotional, 
and it’s spiritual because I had times I wanted to just give up.  One thing I would 
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have done, if [her husband] would have had the trait, I would not have had a child 
by him and both of us had already discussed that actually. My mother and my 
father didn’t even know they had the trait and when they found out I had the 
disease it really hurt them.  
 
Zora was currently married and emphasized the importance of having her husband tested because 
she didn’t want to bring a child into the world who would experience the same suffering.  Not 
only did Zora ask her husband to be tested, but she also facilitated the testing with her 
hematologist.  Additionally, Zora pointed to the hurt her parents felt for having a child with 
sickle cell disease and she did not want to experience that same feeling.  So having her partner 
tested was a strategy for protecting her child from suffering as well as protecting herself from 
guilt.  Both her parents lacked the embodied experience of sickle cell disease as asymptomatic 
carriers of the sickle cell trait.  Zora also highlighted that the suffering is not limited to the 
physical symptoms and includes emotional as well as spiritual aspects.  Having this disease was 
a burden she carried throughout her life and fueled her motivation for having her husband tested 
to discover his sickle cell trait status.  This perspective influenced her reproductive decision-
making so much so that she indicated her willingness to forgo having children if her husband 
would have had the trait. 
Faith, a 19 year-old woman, described having sickle cell disease as being as “hard as ever” 
and was motivated to ask her boyfriend of two years to be tested specifically by her ongoing 
experience living with chronic pain. 
I just asked him [her boyfriend] just straight up if he had sickle cell trait because I 
got it and I don’t want no kids with it. I wouldn’t want them to go through that. 
[PR: Go through what?]  Just having pain like I have, constantly, every day, 
chronic. That’s harsh right there. A child shouldn’t go through that.  [PR: You 
went through it and you're surviving.] Yeah, I have it, but it’s not like I had a 
choice. If I had a choice, I wouldn’t want to go through it. [PR:  How did testing 
come up?] How does that come up? I just asked [her boyfriend] if he had the trait 
because I want kids later on and he said he didn’t have it and I told him the next 
time you go to the doctor to make sure and he did and he doesn’t have it.  
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She was very direct about asking her boyfriend to be tested and considered part of her role as a 
woman with sickle cell disease.  Faith saw having a child with or without sickle cell disease as 
an outcome she could control and prevent.  She reported being able to “handle” her own 
condition because she had no choice but to deal with it.  However she vowed not to recreate the 
same suffering in her own child.   
Aja, a 30 year-old single woman, also recounted a conversation with her current 
boyfriend about genetic testing.  She informed him that she wanted him to be tested and provided 
additional contextual information to support her position. 
I said, “I just want to let you know that if we were to ever have children that you 
would have to get tested first because we want to make sure that we aren’t going 
to pass this disease on to our children.”  I said, “I won’t have that.”  When you 
look into the future, you don’t want to pass this disease on. I feel like people don’t 
realize how bad it is.  Talking about it can only tell you how bad it is, but until 
you live it… I would never want my child to live this disease and to live the life 
that I have lived.  I know times are changing, but they’re not changing fast 
enough.  I have been stereotyped.  I have been looked at as a drug-seeking fool. I 
have sat in pain for hours waiting for treatment.  I have been literally poked, 
prodded, had everything stuck in me, shoved up me, and shoved down me.  I 
would not wish this on my children. If anything, I would adopt before I gave this 
[sickle cell disease] to a child. [PR: Why do you think you’re stereotyped?]  It’s 
hard to say because sickle cell affects predominately Black people and it’s 
predominately seen in Black people in the United States. So, it’s hard to separate 
the two [being Black and having sickle cell disease].   
 
For Aja, her future reproduction with her boyfriend was contingent on him getting tested.  This 
was the first person she had asked to be tested because, prior to this relationship, she “never felt I 
was going to marry anyone or that I wanted to marry anyone.”  Aja held firm beliefs that 
childbearing should only occur within marriage. She also indicated her motivation for asking him 
to be tested was not only to avoid passing the disease on, but also to avoid the social judgments, 
stereotyping, and poor medical treatment she had experienced from having this condition.  Aja 
also emphasized the mental work that goes into having sickle cell disease, and stated that 
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“everything you do, every thought that goes into your day…goes into dealing with it.” For Aja, 
the sheer weight of sickle cell disease symptoms made having her partner tested very important 
to her. 
Similar to Zora, Aja described her experience having sickle cell disease as an all-
encompassing condition.  Aja talked about not only having pain (i.e., the physical symptoms) but 
also the embodiment of sickle cell disease. That is, living with this disease meant that Aja was 
forced to deal with questionable care, poor medical interactions with providers, countless 
procedures, and drug stereotypes.  Having to navigate all of the everyday experiences she 
suggests occur because she is living with a disease that is debilitating, life-threatening, invisible, 
not completely understood, and racially marked is not something she would wish on someone 
else.  To both Faith and Aja, asking their partners to be tested was an agentic strategy to prevent 
having a child with sickle cell disease who would also have similar physical and social 
experiences.  
 
Daddy Didn’t Know He Had It 
Nearly one-third13 (N=8) of the participants indicated that their motivation for 
determining their partner’s sickle cell trait status was because while their mother was aware of 
her disease or trait status, “Daddy didn’t know he had it.”  For instance, Nia’s mother knew she 
had sickle cell disease but her father did not know he had the sickle cell trait until her mother 
was five months pregnant with her.  
I was so proactive about [partner testing] because my father told my mom that he 
didn’t have it.  She found out [my father had sickle cell trait] when she was five 
months with me that he did have it when he ended up getting surgery for his foot. 
She knew she had sickle cell disease, but all that time she thought that he didn’t 
have it.  That’s why I was so proactive about [my boyfriend] getting tested.  That 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 This includes women who favored genetic testing, yet had not had the opportunity to ask a partner to be tested. 
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was more secure for me to know considering that she believed what he said, but 
he had the trait.  So that’s why. Some people don’t know until it’s too late and 
you can’t do nothing about it at that point.  That’s why I think it’s so important for 
me. [PR: How did that conversation go?] Just one day we were talking about it 
and I said, “I would like for you to go get tested just to see if you have a trait.”  I 
had to explain to him why and since I have the full blown anemia, of course the 
kids are going to have the trait.  He did get tested [and] it came back that he didn’t 
have anything.  Dr. [hematologist] actually wants to test him again just to make 
sure.  
 
Nia made it clear that she was being proactive by asking her boyfriend to be tested, before it was 
“too late.”  She specifically attributed her request to her father’s unawareness of his sickle cell 
carrier status.  Nia also believed that testing was the only reliable way to make sure the pattern 
(and result) of her parents was not repeated with her and her boyfriend.  She was determined to 
make sure that what happened to her mother did not happen to her.  Her hematologist also 
wanted to re-test Nia’s boyfriend to confirm his negative test result.  Nia’s story emphasizes the 
layered emotions that are experienced by a woman in this situation:  empathy (toward her 
parents’ situation years ago), hope (that the test results were accurate and that children free from 
sickle cell disease were possible), worry (not to pass on disease), and courage (to live with the 
disease and pain). 
Joyce explained a similar situation, in which her mother was aware, but her father was 
unaware, of trait their status.  Knowing of her parents’ experiences and the consequences, Joyce 
was motivated to ask her sexual partners to be tested.  
My mother knew that she had the trait and she asked my father, he didn’t know he 
had the trait.  Then when I came out with sickle cell disease, he found out [he had 
sickle cell trait] and that plays into him feeling really guilty about me. He feels 
terrible about it.  My mother, my father, my doctors, we talk about how it 
happened.  I’m not having a child with sickle cell anemia.  So if you want to have 
sex with me there are things that you are going to have to do.  That’s why both 
people that I have had sexual relationships with have been tested because I don’t 
go into that situation not knowing like my mother.  I’m not like females who say, 
“Well, he said… Oh, he didn’t want to wear a condom because it was 
uncomfortable.”  I say, “Oh, well, then you don’t really want to have sex with 
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me.”  That’s the same way that I feel about getting [my partners] tested. My 
mother went on “He said,” which I don’t blame her for.  Because back then it 
really wasn’t as much knowledge.  It’s 2012 and you can go get a blood test for 
anything that you would like to get a blood test for. They [her partners] weren’t 
jumping at the idea, but when I said, “If you really want to have sex, you’ll do 
what is necessary.”  They need to have the blood test because I’m adamant about 
why bring a child into the world who is going to have health problems?  I’m not 
just talking about a cold.  I’m talking about strokes and serious things.  It’s 
preventable.   
 
Knowing that her father was unaware of his sickle cell trait status made Joyce very adamant 
about having her sexual partners tested for sickle cell trait prior to intercourse.  Like Nia, Joyce 
was unwilling to go on “He said”−trusting their partners who said they were not carriers of sickle 
cell trait−without confirmation.  Joyce’s narrative suggests that she did not feel as though her 
parents were behaving irresponsibly; rather, she attributed her father’s lack of testing to the 
scarcity of the necessary information and technology that would have aided their decision-
making at that time.  Joyce believed that with modern medical advancements there is no reason 
why her partners cannot get tested.  She feared carrying the guilt of having a child with sickle 
cell disease, the way her father had for all these years, if she failed to confirm her partner’s trait 
status.  According to Joyce, genetic testing is inherently linked to reproductive health.  She 
compared her requirement that her sexual partners were tested to her stipulation that her sexual 
partners wear condoms, drawing clear connections between genetic testing and condom use in 
describing responsible sexual behavior.  
Jada had also been told that her father was unaware of his trait status before she was born, 
yet her mother was aware of her status.   
My mom knew she had the trait, but my dad didn’t know anything until I was 
born.  Then it was too late.  I tell my mom and dad this all the time and not just if 
I get mad to my breaking point I’m like, “You guys were just reckless.  Like 
nobody knew nothing?”  So I made sure my boyfriend got tested.  To me it’s an 
easy cure to this, get your partner checked beforehand.  That’s just the easiest way 
to me to stop sickle cell. Because in my mind that’s just disastrous and reckless.  
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Because you don’t bring a child in the world [to] have to deal with the same thing 
you’re going through already.  That makes no sense to me. That makes no sense 
at all. It’s perfectly fine with me if they have the trait.  Now that leaves it up to me 
to educate them, like, “Don’t go and be stupid and have sex with somebody that 
has the trait or sickle cell and risk getting pregnant, or getting someone pregnant, 
and now you’re carrying a baby with sickle cell disease.”  I don’t believe in 
abortion.  I just don’t, but I couldn’t imagine bringing a child in this world to have 
this stupid disease.  
 
For Jada, the importance of partner testing before conception was further reinforced via a game 
she described developed by the Director of the local Sickle Cell Disease Association of America 
(SCDAA) chapter, comparing reproduction without being tested as a roll of the dice.  
Dr. [hematologist] made up this game with cubes with the different types of sickle 
cell on them and told the kids [at the SCDAA], “Go ahead take a pair of dice and 
roll them and see what you get.”  The majority of them got a baby with sickle cell 
disease because they didn’t have their partner tested.  That was very important to 
me because I get so sick and tired of seeing these little kids have strokes and heart 
attacks and this and that because of sickle cell.  It’s just like, “Let them have a 
normal life!”    
 
Much of Jada’s motivation for partner testing came from having the embodied experience of 
living with sickle cell disease symptoms as well.  Like Joyce and Nia, Jada also attributed having 
sickle cell disease to her father’s lack of knowledge of his carrier status.  Knowing about their 
fathers’ lack of awareness of trait status and their mothers’ not insisting their fathers be tested 
served as a source of motivation for participants to be absolutely certain about their partners’ 
sickle cell status.  She also discussed the burden she had of educating her own children, who 
would have sickle cell trait, about inquiring about their own reproductive partner’s status.  
Interestingly, similar to the participants whose fathers were unaware of their sickle cell trait 
status, an equal number of participants indicated neither of their parents knew they were carriers 
of sickle cell trait.  In the latter scenario, participants did not express the same motivation for 
asking their partners to be tested.  Also, in some cases (for example and Jada), both not wanting 
their children to experience the symptoms and their father’s lack of awareness served as 
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motivation, thus these categories are not mutually exclusive.  Blaming of their fathers for not 
knowing their sickle cell status and viewing their mothers not as proactive as they should have 
been is also a gendered perspective in that this suggests that women have a responsibility, more 
so than men to confirm their partner’s status. 
Joyce, Nia and Jada parents were all divorced and held their mothers in higher regard 
than their fathers.  Also, they described very open and detailed conversations with family 
members and providers about how they came to have sickle cell disease.  In Nia’s narrative it is 
clear that she and her mother placed blame on her father for being unaware of his sickle cell 
status.  As bearers of children, women experience a gendered burden in regards to reproduction.  
These women also expressed that the lived experience of sickle cell disease is also a burden. 
Thus these women experienced a third burden-to ensure their partners are tested.  In carrying out 
the gendered responsibility of getting their partners tested, some women in my sample were also 
empowered to take control of their reproductive lives.  Perhaps because sickle cell disease is 
such an unpredictable, uncontrollable, and difficult illness, these women were aware of the need 
to control the transmission of the disease many approached their partners in a very specific and 
direct manner.  These women felt responsible not only for themselves, but also for their partners 
and potential children; some of these women took this responsibility very seriously. 
In their attempt to understand their parents’ lack of knowledge about genetic 
transmission, many participants referenced a lack of technology, awareness, or knowledge about 
sickle cell screenings within earlier generations and their parents’ age groups.  Some parents did 
not know or understand genetic testing, and believed access to testing was limited.  In addition, 
during the time when participants’ parents would have come of age−approximately 30-35 years 
ago−early genetic screening programs had just been launched, having begun in 1972 (Markel 
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1992).  At the time when genetic screening programs were launched, tests unfortunately fueled 
racial prejudice and discrimination by simply reiterating that the largest prevalence of sickle cell 
trait resided among African-Americans (Markel 1992).  This race-based context may have 
initially minimized parents’ interests in or understanding of the value of genetic testing.  It may 
be that women may be able to convince their partners to undergo genetic tested now that there is 
less stigma and more understanding attached to sickle cell trait.  
Asking their partners to be tested was a form of reproductive agency participants used to 
ensure their children would not have sickle cell disease.  Women in the study recognized that 
their actions could be the difference between their children having the trait or having the disease.  
Among people with sickle cell disease, having the trait is considered as a far less serious 
condition and was reportedly acceptable for participants.  For instance women in the study often 
referred to it as “just trait” rather than the “full blown” disease.  Having a child with the disease 
was a much more serious issue and cause for concern in their minds.  As women with the 
disease, they make reproductive decisions within the context of their experience living with the 
disease.  This behavior illustrates the ways in which mothering begins even before conception, as 
participants looked at their behavior as a method of protecting their children, not only once 
conceived but even prior to conception.  
 
Learning from Unplanned Pregnancies 
Six participants indicated becoming more proactive about asking partners to be tested 
after having an unplanned pregnancy in which the father of the baby had not been tested for 
sickle cell trait before conception.  It was not until after Sophia became pregnant did she ask her 
fiancé about his sickle cell status and took him to the Sickle Cell Disease Association of America 
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(SCDAA) to be tested.  
He [her fiancé] was tested.  I took him to the detection center.  I was like, “Come 
on, let's go.” I had known him since high school and he would go with me to the 
different events that the Sickle Cell Center would have.  It was funny, because he 
was like, “I want to see.  I asked my mother and she said she didn’t know.”  I'm 
like, “Really?  Come on, I got to volunteer at the Sickle Cell Center anyway, you 
know, you can get tested.”  His [test] came out that he had the trait.  We both 
looked at each other, and he's like, “Wow,” and I'm like, “Oh, no.” [PR: Oh no, 
what?]  The reason why I was saying “Oh, no” is if he has the trait and I have the 
disease, that brings a higher percentage of the child, you know, the probability of 
the child having it.  That was my fear and after I lost the baby I had to break it off.  
He didn’t understand that.  
 
Sophia was pregnant at the time she asked her fiancé about his status and discovered he was a 
carrier.  Because of her work at the SCDAA she was surprised that her fiancé and his mother 
were unaware of his status.  Until this point, although she had known him since high school, she 
had not discussed the implications of carrier status with her fiancé.  Nearly having a baby with 
sickle cell disease caused Sophia to give serious thought to the consequences.  After she lost the 
baby she became adamant about not having children with this partner.   
Pearl’s first pregnancy ended in a miscarriage when she was 19 years old.  Similar to 
Sophia, Pearl’s first pregnancy was with a man whom she was unaware was a carrier of the 
sickle cell trait.  She decided to dissolve the relationship once it was revealed he was a carrier of 
sickle cell trait.  
Actually what he [father of the baby] didn’t know, and never did find out, and is 
the reason why I let that [the relationship] die off, is I found out that he had the 
trait.  [PR: How did you find that out?]  His mother told it.  I was in the hospital 
and she said, “You know, [the father of the baby] has the trait.”  And I said, 
“Huh?!”  She said, “Yeah, but he never had to go to the hospital.  What’s yours 
doing?”  I said, “I don’t have the trait, I have the full-blown disease.”  We got into 
the explanation of what’s going on with me, she said, “I remember when he was 
young and they told me he had the trait I didn’t know what that was.”  I was like, 
“Oh, okay.”   I slowly pushed that guy away. [PR: Why did you do that?] I never 
wanted to get so serious, married, and have a kid that went through what I went 
through.  You know what I mean?  I know what it feels like to sit there and have 
to get poked over and over again by somebody who missed your veins.   
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In this case, her boyfriend was either unaware of his trait status or had not disclosed this 
information to Pearl.  Upon learning of his status from his mother and based on the embodiment 
of the symptoms, she realized that she could not be responsible for someone else experiencing 
what she has been through.  This story shows the additional burden that accompanies the lived 
experience with disease symptoms that her boyfriend did not possess as an asymptomatic carrier. 
This is another example of the gendered burden of relationship formation and dissolution in that 
Pearl’s relationship formation was centered on her ability to identify a partner who did not have 
sickle cell disease or a carrier of the sickle cell trait and if he did to end that relationship.  Taking 
what she learned from this experience, Pearl was proactive and made sure her future partners 
were tested to determine whether they were a carrier of the sickle cell trait.   
Me and my dudes take two tests.  We take the AIDS test when we’re first getting 
to know each other and then as it’s progressing you take another one before you 
get next to me and you also take a sickle cell test too.  So in case something 
happens and I’m going to have kids or anything like that I didn’t want the babies 
to be born with sickle cell.  So he [her son] actually has C Trait, he doesn’t really 
have S in him at all and it’s because his father has nothing.  I’m real careful about 
that.  I don’t think we have the luxury of an “Oops” because an oops is what 
caused me the trauma that I have.  
 
Through her purposeful action, Pearl was successful in finding a partner without the trait. She 
was proud of her success in having her partner tested and ensuring her future children would be 
as healthy as possible.   
Nearly twenty years later, Pearl was pregnant again and was questioned by her providers 
about her partner’s sickle cell status during her initial prenatal visit. 
That was the first thing they asked me and I let them know he [the father of the 
baby] didn’t have it.  [PR:  Who asked you?]  The specialist, OB/GYN said, “Did 
my partner have the trait?” and “When the baby comes out they’re going to test 
him to see to see if he has sickle cell.” I let them know that, no, he didn’t.  I let 
them know that I had him tested before then.  They were like, “Oh, that’s really 
smart.”  I’m like, “That’s common sense.”   
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Although her second pregnancy was unplanned, the father of the baby had already been tested 
and was not a carrier of sickle cell trait.  Pearl’s response indicated she was offended by the 
suggestion that she may not have realized that getting her partner tested was the “smart” thing to 
do.  Pearl’s interaction with her provider suggests an awareness of the reproductive burden 
women with sickle cell disease possess—having to ask their partners to undergo testing.  
However in this case, her provider appeared not to acknowledge that Pearl would have been 
responsible enough to already have asked her partner to be tested before becoming pregnant. 
Pearl and Sophia illustrate the reproductive burden these women have in that they must 
make important reproductive decisions often independently based on what they feel is best for 
the future of their children.  Both women experienced an initial pregnancy with a partner who 
had not been tested beforehand and they later realized the implications this could have on their 
children.  These experiences provided the opportunity for them to give more thought into their 
future decision-making and did much to shape their reproductive and sexual lives.  Additionally, 
both Sophia and Pearl give examples of a gendered burden in that their partners were carriers of 
the sickle cell trait and either did not share this information or had not been tested even though 
they were in intimate relationships with women with sickle cell disease.  In Sophia’s case she 
shouldered the entire burden by even physically taking her fiancé to be tested at the SCDAA 
testing site.  
Like the participants above, Jewel’s first pregnancy was unplanned and she was unaware 
of the father of the baby’s sickle cell trait status.  
They [fathers of her children] had been tested.  Now the first baby father, I didn’t 
know if he had sickle cell or not.  I didn’t know.  But [the second child’s father], I 
asked him when we got really serious in the relationship. I asked him did he have 
sickle cell or sickle cell trait?  Was he normal?  He went and asked his mother and 
his mother said he didn’t have anything, but I wanted him to get tested anyway 
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because she [his mother] had one kid with the trait and everybody else was 
normal.  He didn’t have it and I was like, “Oh, that’s good.”   
 
From this experience, Jewel also became more proactive in ensuring her future partners were 
tested.   
Two other women in the study also had unplanned pregnancies with partners who were 
never tested.  In these two instances, both women were married and asked their partners to 
undergo testing instead of having to undergo prenatal testing themselves.  Katrina, a 31 year-old 
woman was offered, yet declined to have, an amniocentesis.   
[PR: Where you offered prenatal testing?] Yea, my doctor did because I have 
sickle cell.  So they [her doctor] wanted me to do the amniocentesis, but there was 
a risk [with the test] or whatever.  I just didn’t want to take any risks and I was 
like I’m just going to trust God that he’s going to be fine and he won’t have 
anything.  They said, “Well, do you want your husband to get tested?”  So I made 
sure that my husband was tested and then when he was fine I said, “Well, he’s 
fine.” Because then what?  You terminate the pregnancy?  No. I wouldn’t have 
done that.  
 
Katrina had already been labeled a high risk pregnancy and was approached about having 
prenatal testing but did not want to add any more risk to her pregnancy.  Instead she opted to ask 
her husband to be tested rather than “risking” her baby.  Katrina had already decided to continue 
the pregnancy regardless of the test results and once genetic testing determined that her husband 
was not a carrier of sickle cell trait she did not feel compelled to undergo additional prenatal 
testing. 
The father of Chloe’s children also underwent genetic testing while she was pregnant 
with two of their three children, in lieu of having the amniocentesis that was offered to her. 
[During the] first pregnancy they [her doctors] said, “Let’s do genetic testing.” 
[PR: How did he feel about that?] He was fine with it.  He understood it.  He 
knew it was to make sure that he was not a carrier.  I mean, had I been older and it 
was a planned thing, we would have did that beforehand, but I was already 
pregnant.  He did it twice–with the first and with the third one.  Because it was 
two different hospitals, two different doctors.  We just did it again so they could 
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have it on their record. He wasn’t a carrier.  Oh, I should mention this: my 
husband is the same father [of all three children].  So, once they found that he 
wasn’t [a carrier], the talk about an amnio and all that kind of ceased. For what? 
That was my response [to doctors asking about the amniocentesis].  For what?  I 
knew that without him being a carrier my kids would have the trait.  
 
In the instances of unplanned pregnancies, both Chloe and Katrina illustrated how partner 
testing during pregnancy can be used in lieu of prenatal testing.  Chloe and Katrina also illustrate 
that women do not always have their partners tested before pregnancy, even though they feel 
they should.  Chloe also acknowledged that her testing came a bit too late and the optimal time 
would have been before conception.  The participants highlighted above also show that 
regardless of having the belief that their partners should be tested before pregnancy, some 
partners still remain untested.  Chloe’s story shows that providers are very concerned about the 
transmission of sickle cell disease.  Even though all three of Chloe’s children had the same 
father, who had already been tested and found not to have sickle cell trait, testing was repeated 
when they encountered a different provider at a different health care system.  
Of the 22 participants who were proactive about asking their partners to be tested, several 
were older (N=8), had experience with unplanned pregnancies (N=6), already had a child with 
sickle cell disease (N=1), or had extensive family experience in this regard (N=4).  These stories 
show that participants did not necessarily begin their reproductive lives being proactive, but their 
agentic behavior developed over time in reaction to their initial experiences.  Sometimes it took 
experience with and knowledge of the potential of having a child with sickle cell disease before 
women took a stand in ensuring their partners underwent genetic testing. 
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Unwilling Partners 
Three women in the study indicated asking their partners to undergo genetic testing, yet 
they refused.  Hope, a 25 year-old mother who was currently pregnant with her second child, 
indicated that neither of her two sons’ fathers were willing to be tested.  
He wouldn’t let them test him because [boyfriend] says the trait don’t run on his 
side of the family. I’m going to still get him [her unborn baby] tested for sickle 
cell [disease] just to be on the safe side. Because nobody knows [for sure] because 
it skips generations.  So I’ll still get him [unborn baby] tested, just in case. [PR: 
Did your first son’s father get tested for the trait?]  No, he didn’t.  One thing I did 
was when [first son] was born was get him tested to see if he had it [sickle cell 
disease].  They said, “No, he don’t have it,” but automatically, “he do have the 
trait.”  I know this baby is going to have the trait too because [first son] has the 
trait.  
 
Hope was unsuccessful in having either of her sons’ fathers tested for sickle cell trait. She 
believed newborn screening was an effective method of determining whether her children had 
sickle cell disease.  However, because her sons had different fathers her unborn child may in fact 
have the disease, not the trait.  However. In the end, she accepted that her children would be 
carriers of the sickle cell trait.  Hope did not describe being persistent in either explaining to 
either of her boyfriend's why they should be tested, although she was concerned enough to 
inquire about her sons’ status after they were born.  This may indicate that while she did not 
think having sickle cell disease was a tragic fate, she wanted to be prepared to care for her 
children should they have sickle cell disease.  
Clem, a 32 year-old mother of three children, and Raven, a 39-year old mother of two, 
stated that the fathers of their children also refused to be tested.  
They [her partner and his family] talked about it in their family and they don’t 
have the sickle cell trait so…no choice but to go with that.  He wasn’t going [to 
get tested].  No, no, no, no.  When we was having the genetic testing he didn’t 
want to go.  He doesn’t like hospitals. [He said], “I will just tell you what you 
need to know.”  Well, I figure if he didn’t know in his own family he would have 
went. But he said they had talked about it and nobody has it, so I pretty much took 
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his word for it. I have no idea [what it would take]. I've thought about that for a 
while and you see, you are repeating from generation to generation. (Clem)  
 
Both of my sons have sickle cell anemia SS. Both of their fathers have sickle cell 
trait.  And [son’s] father, he swore to God he didn’t have no sickle cell trait, 
nothing.  He never went and got tested.  He just told me that he didn’t.  [PR: How 
about your other son’s father?  Did he ever get tested?]  He never got tested.  I 
just knew [son had the trait] when I had him.  I tried to get him to go to genetic 
counseling with me and he wouldn’t go.  (Raven)  
 
While Clem recognized the information genetic testing could provide and how the lack of this 
information may perpetuate sickle cell disease for future generations, she was unable to convince 
her partner to get tested and was forced to take his word that he was not a carrier of the trait.  Her 
partner relied on the absence of a family history with sickle cell disease as an indication that he 
was not a carrier.  None of her three children with this father had the disease, thus Clem was 
inclined to believe he did not have sickle cell trait.  Raven was also unable to convince either of 
her sons’ fathers to get tested.  Unlike Clem, however, both of Raven’s sons had sickle cell 
disease.  These stories show that regardless of the woman’s desires, there is no guarantee that 
their partners will get tested just because they are asked. Women then have very hard decisions 
to make.  They considered what was more important–the stability of their intimate relationship 
and respect for partners’ wishes, the desire to have biological children, or the need to prevent 
having children with sickle cell disease. 
 
Summary 
As shown in Chapter Five, over half of the participants were repeatedly told to ascertain 
their partner’s sickle cell carrier status prior to having children and, in some cases, to refrain 
from dating and reproducing with men with either sickle cell disease or sickle cell trait.  A few 
were simply told not to have children as well.  This instruction framed participants’ 
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understandings of the additional reproductive burdens and responsibilities they possessed 
because of their genetic condition.  This knowledge also caused them to be particularly mindful 
of the impact of their behavior on future generations.  
While women in the study were affected by the messages they heard from others, they 
also reported their own reasons for being motivated to have their partners tested, both to avoid 
having their children suffer as they did and their own mothers’ experiences of being unaware of 
partners’ sickle cell trait status.  The majority described feeling a great sense of responsibility 
when making reproductive choices, because they wanted to ensure that they did not pass the 
disease on to their children.   
With this sample, more participants whose partners underwent testing at their request 
were married or in long-term relationships, which may indicate both the intimate nature of a 
testing request and how important this testing is for relationships.  More of the partners of the 
women in the study with children agreed to undergo testing than disagreed.  Those who were less 
concerned about testing initially often became more interested after an unplanned pregnancy or 
pregnancy that concluded with the birth of a child with sickle cell disease.  Thus, experiences 
with the realization of almost having or having a child with the same disease also eventually led 
women to have a different perspective on testing.  Based on these data, then, it seems that 
relationship contexts, family contexts, and personal experiences with pregnancy and childbirth 
can impact women’s views of the importance of genetic testing. 
 
Decisions about Prenatal Genetic Testing 
Because of the genetic and health risks associated with pregnancy among women with 
sickle cell disease, they are typically offered prenatal testing and must make decisions about this 
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type of testing as well.  While partner genetic testing can occur before, during or after pregnancy, 
prenatal genetic testing is a method of providing pregnant women with in utero information 
about the health of her fetus, including the presence of fetal abnormalities and disease.  
Among the 17 participants who had ever been pregnant, 10 did not undergo testing: five 
declined, and five were not offered prenatal testing either because they miscarried or terminated 
early in the pregnancy, or their provider did not suggest the procedure (See Table 7).  Seven 
participants did undergo prenatal testing: six to discover the sickle cell status of the fetus and one 
because she contracted Cytomegalovirus (CMV) while pregnant (See Table 7).  Of the seven 
who underwent prenatal testing, only four participants did so even though their partners had 
already been tested for sickle cell trait–Zora and Gabrielle at the urging of providers, Vivian 
because she unexpectedly discovered her husband was a carrier while pregnant, and Sophia 
because her mother insisted.   
 
Prenatal Testing is an Unnecessary Test for Me 
Of the fifteen14 participants offered testing, five participants were offered and decided not 
to undergo prenatal testing. Three of these women intended to continue the pregnancy regardless 
of any abnormal results and two had their partners tested instead (e.g., Chloe and Katrina).  Pearl 
decided to forgo prenatal testing because she believed it was unsafe and unnecessary. 
I let her [health care provider who offered the test] know that whatever was going 
to happen, it was going to happen and that’s it. I didn’t want them digging around. 
What if they break it?  She explained the risks and I just declined, that was it.  I 
still don’t think that’s a good idea. [PR: Why not?]  It’s like, you’re looking at the 
answers to the questions on the test.  You know what I mean?  You’re cheating a 
little bit here. Then people will decide, “Well, this one might have something 
wrong with it we can get rid of that one.”  That’s awful to me.  I guess some 
people would think that’s more humane, but I didn’t and I still don’t.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14 Even after I explained the various testing procedures, two participants were unsure if they were offered prenatal 
testing. 
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In Pearl’s opinion, information about an unborn child should not determine the fate of 
that child.  Further, she saw little value in testing a fetus for abnormalities with the purpose of 
terminating the pregnancy.  Pearl’s mother also had sickle cell disease, which may have 
influenced her opinion about the value of those born with illness.  Perhaps Pearl was able to 
assert her decision to forgo prenatal testing with certainty because her son’s father had already 
been tested and was not a carrier of sickle cell trait.   
Raven, a 39-year old mother, was offered but decided to forgo prenatal testing.  
They just talked about ways of finding [out] if your child has sickle cell disease 
and stuff.  They just wanted to do an amniocentesis and I was like uh huh [no].  
They wanted to do an amniocentesis on me to see if [her 2nd son] going to have 
sickle cell disease or not. I’m like, “No, I’ll wait until I have him to find out.   It 
ain’t that serious to me to know if he got sickle cell.”   
 
Raven resisted prenatal testing and was comfortable waiting until delivery to find out her son’s 
sickle cell status.  Raven had sickle cell beta-plus thalassemia Hb-Sß+, which more closely 
resembles Hb-SC in terms of symptoms, and was not diagnosed until the age of 19 when her first 
son was born with sickle cell disease.  Having unknowingly lived with sickle cell disease for a 
large portion of her life (without any foreseeable health consequences) Raven’s disease status 
was not a major concern for her.   
While Joyce did not have children, she expressed a very strong opinion against prenatal 
testing. 
It doesn’t matter at that point, it’s [the baby] coming.  We’ll find out when it 
comes out.  I’m just saying, to me it’s an unnecessary procedure. Is there a way 
that you can go in there and correct it?  Can you change that?  Can you give me a 
shot and say, “Bam, your baby won’t have that!”  No.  It doesn’t work like that.  
It’s going to come out like that.  I would not give my baby up.  That baby would 
be born because I don’t believe in abortions because of religious purposes.   
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Joyce felt that prenatal testing was an “unnecessary procedure” because there was 
nothing that could be done to correct any abnormalities revealed.  Her explanations support 
comments made by other participants highlighted above, implying that if the underlying purpose 
of prenatal testing is to determine whether or not to terminate the pregnancy, then there was no 
reason to undergo testing.  Joyce, and most women in the study, firmly opposed termination.   
Furthermore, these three women and seven others suggested that if their already-conceived 
fetuses had abnormalities, then they (as parents) would learn how to deal with those 
abnormalities.  Here again, participants were considering their motherhood roles as well as what 
was best for their unborn and “unconceived” children. What these women described was similar 
to their experience having sickle cell disease which required that they learn to manage their 
symptoms, medications, provider interactions, participants also indicated that they would learn to 
manage having children with sickle cell disease if that situation arose 
 
Just Wanted to Make Sure Everything Was OK 
Of the seven women in the study15 who underwent prenatal genetic testing to determine 
the sickle cell status of their fetus, three participants agreed to undergo testing because of their 
mothers’ urgings, and two did so because of providers’ urgings (i.e., the latter group presented 
this testing as a form of safety for the fetus).  Another participant underwent testing after 
discovering her husband was a carrier of the sickle cell trait well into her pregnancy.  The 
decision of the last participant in this group was unrelated to sickle cell disease; instead she had 
contracted a serious virus while pregnant and her providers wanted to see if the fetus had any 
abnormalities other than sickle cell disease.   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  15	  Participants with multiple pregnancies may have had undergone prenatal testing with one or more, but not all of 
their children.	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Six of the seven women indicated the suggestion of prenatal testing arose solely because 
they had sickle cell disease, rather than age or previous miscarriage.  Sydney, a 24 year-old 
mother of one, was urged by her mother to undergo prenatal testing.  However, Sydney was 
unclear about the associating benefits or risks involved with the test.   
[PR: Let’s go back to the amniocentesis.  What did you understand the pros and 
cons of that test to be?] To tell you the truth I don’t even know. Back then I didn’t 
do anything for myself.  My mom was like my advocate.  Up until I want to say 
last year my mom was there, she went to all my doctor’s appointments.  [She] 
pretty much handled all my stuff.  I think it stopped because we were at the 
emergency room and the lady was just like, “Well, until you go get it in writing 
with a lawyer, she has to speak for herself.”  My mom talked to my doctors, filled 
out my papers, and just reported to me what was going on.  
 
I asked Sydney why she decided to undergo prenatal testing and she replied, “Well, we 
[she and her family] did. I needed to know because I’m sick and … you know, because they want 
you to get it to make sure they can know what to do.” Sydney’s comments suggest that she 
believed the test was being offered to allow providers the chance to adequately care for the baby 
upon delivery.  Sydney’s agreement to undergo testing appeared to be limited and mostly 
directed by her mother.  With the childhood onset of her illness, Sydney’s mother had been 
involved in her care since birth.  She perceived her mother’s involvement in her health care 
decisions very positively and saw her mother as an advocate. It was not until her mother’s 
involvement was called into question by a health care provider that her mother stopped making 
decisions for Sydney.  Sydney’s mother still had a strong influence on her decision to undergo 
prenatal testing, however. Sydney deferred to both her mother and her healthcare providers in 
making the decision to accept prenatal testing. 
Similarly, Sophia, a 35 year-old woman, also agreed to undergo prenatal testing at the 
urging of her mother.  
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I was scheduled for one. I just didn’t make it. [PR: Why did you decide to have the 
test?] Like I said, we're [she and her mother] very close and we discuss 
everything.  My mother, her thing was she wanted to make sure if it's sickle cell.  
She was like, “With you having sickle cell let's make sure there aren’t things that 
could be a problem.” I said, “Okay.”  
 
Sadly, Sophia’s pregnancy caused her to fall into a coma and lose her baby before the 
testing occurred.  However, she indicated agreeing to have prenatal testing to determine if the 
child would have sickle cell disease because her mother was concerned about making sure there 
were not “things” that could pose a problem.  At the time of this incident, the father of the baby 
was overseas in the military and therefore had little involvement in these decisions.  Her mother 
had previously expressed her concern about the pregnancy to Sophia because of her daughter’s 
illness. Sophia’s mother had also expressed guilt because Sophia had sickle cell disease and 
wanted to help prevent Sophia from having a child with sickle cell disease.  Sophia told me about 
her discussion with her mother:  
[My mother said,] “Well, because I felt bad that I had gave that to you,” and I 
said, “Why did you feel bad?”  She said, “I felt like you had this, you were 
hurting, because I had did this to you.  I didn’t want to do that to you.”   
 
Sophia’s mother’s concern for her daughter’s health and the positive sickle cell trait result for the 
father of the baby led to her trepidation about a future baby’s health.  
Gabrielle, a 36 year-old mother of two, described her regretful experience with prenatal 
testing while pregnant with twins.  With her first pregnancy, her ex-husband received a false-
negative test result, and he was in fact a carrier of the trait and her oldest son was born with 
sickle cell disease.  Because of this experience, she was adamant about having her next partner 
tested before becoming pregnant, and he did not have sickle cell trait or disease.  
I had an amniocentesis and I’m totally against those now.  They gave me an 
amino and they put something in [Nina] to shade her out so they could see [Tina].  
Well when I went back a week later, [Nina] was dead and [Tina] was fine.  But it 
was nothing wrong with her up until that point.  They were growing fine.  They 
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were the same size, nothing was wrong with her until after I had that amnio.  I 
think whatever solution they put in my stomach to make her dark so they could 
focus on [Tina].  I think that’s what killed her.  They told me I had sickle cell and 
it’s better to have an amnio to make sure the babies are safe.  I said, “Well, I 
know they’re safe and I’m keeping them anyway.”  You know, [I was] young; I 
was 23 [and they were] pressuring me so I just did it.  Not knowing any better, 
just doing what the doctor was saying opposed to researching things for myself 
and saying, “No, I won’t do this.”  But that’s why they wanted to have it [the 
amniocentesis] because it was a twin pregnancy and I had sickle cell.  That was 
their only reason.  
 
During her second pregnancy, Gabrielle felt confident that her twins were developing 
appropriately and, because the twin’s father had already been tested and found to not be a carrier 
of sickle cell trait, she was not concerned about genetic transmission.  Yet she clearly states that 
her providers only wanted her to undergo testing because she had sickle cell disease, which they 
presented to her as concern for the safety of the twins and she succumbed to having prenatal 
testing upon their urging.  Gabrielle attributed her acquiescence to testing to her provider’s 
insistence and to her age.  She became unwilling to follow her instincts.  In this case, Gabrielle 
suggested that along with age and experience comes the ability to stand firm and advocate for 
what she felt to be the best decision for her and her children.  Unfortunately it took the loss of 
one of the twins to get her to that point. Gabrielle also illustrates how through the pathologizing 
of pregnancy as a time of risk offers medical authorities additional control over pregnancy.   
Vivian was the one participant who underwent prenatal testing because she unexpectedly 
discovered her husband had sickle cell trait five months into her pregnancy.   
They took my blood, my families’ blood, his blood and sent it to John Hopkins 
University so they could tell me what type of S she was going to have. It came 
back from John Hopkins University inconclusive.  That was like…  I don’t 
understand that.  After the [blood] test came back inconclusive, they had me do an 
amniocentesis.  So I had that done and that’s when they said it was a female.  It 
was a girl.  I was 5 months pregnant at the time.  They said we really don’t know, 
we know [there is] an S there, but we don’t know what kind.  They said do you 
want us to go into the umbilical cord.  I was like, “No.” It’s another procedure 
where they can’t tell through the amino and they will go into the umbilical cord to 
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get this type of blood. I guess it’s more blood in the umbilical cord.  But she could 
be retarded, etcetera, etcetera, etcetera. I was like forget it.  I just have to have the 
baby.  
 
Originally, she had been told her husband was not a carrier of sickle cell trait and their first child 
did not have sickle cell disease.  However, after finding out suddenly her husband was a carrier 
of the sickle cell trait, she decided to undergo multiple tests to determine her baby’s sickle cell 
status.  The initial tests were inconclusive and when told that continued testing could cause harm, 
she stopped this pursuit.  Of note, this information was revealed when Vivian was five months 
pregnant and not much could have been done at this point, hence Vivian resolved within herself 
that she “just [had] to have the baby.”  Her daughter, Nia, was born with sickle cell disease and, 
as mentioned in Chapter 5, Vivian felt guilty about this. 
 
Summary 
The presence of risk during pregnancy opens the door for the medicalization–especially 
when matters of genetics are involved. Medicalization refers to the extension of medical 
jurisdiction or expansion medical experts influence over daily living about various forms of risks 
(Zola 1972).  Participants’ pregnancies were medicalized through attempts to compel them to 
conform to medical expertise and undergo testing. When presented with concerns for fetal risk, 
women can be placed in situations where they are viewed as either responsible or reckless as 
they make decisions to promote having a healthy baby and safe delivery. 
The women in the study who agreed to undergo prenatal testing viewed testing as a 
positive form of pre-birth information or opted for testing because of others’ urgings. The only 
other reason women noted when discussing why they agreed to testing was that it could be a 
source of knowing for themselves that their fetus was “Okay”.  Six of the seven participants who 
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agreed to have prenatal testing were also younger at first pregnancy and single at the time of 
their pregnancy and appeared to make this decision independently.  The participants who decided 
to forgo prenatal testing tended to hold more negative views of testing as a potentially harmful 
procedure, or their a priori opposition to abortion made them interpret the purpose of testing as 
only providing information about whether to continue or terminate their pregnancy.  The 
participants who declined prenatal testing were married and older at first pregnancy.  Perhaps 
more importantly, their partners had already been tested for sickle cell trait or were tested in lieu 
of prenatal testing; therefore they already had some certainty of their child’s sickle cell status.  
The uncertainty about whether their children would have sickle cell disease served as a strong 
motivator for women in the study to undergo prenatal testing if they did not have previous 
information about partners.  
 
Conclusion 
In Chapter Five I discusses the agency participants’ exercised to pursue their reproductive 
desires in the face of reproductive messages that they should not have children because of 
concerns about their own health and genetic transmission.  This chapter builds on participants’ 
responses to those messages by illustrating that thinking about genetic transmission is very much 
a part of living with sickle cell disease and reproduction and testing is an issue that they must 
confront.  Participants were repeatedly placed in situations that required reproductive decision-
making (e.g., whether to become pregnant, whether to ask their partner to undergo genetic 
testing, whether they themselves would undergo prenatal testing).   The three motivating factors 
for women asking their partners to be tested were, not wanting their children to suffer how they 
had, their mother’s lack of knowing her partner’s status and having an unplanned pregnancy in 
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which they were unaware of their partner’s sickle cell status. 
Women entered all pregnancies and all opportunities for conception (including intimate 
relationships) with information about their own genetic characteristics.  They also entered all 
pregnancies, opportunities for conceptions, and all relationships with some knowledge of their 
parents’ own decision-making and knowledge of what it was like to live with sickle cell disease. 
Within this context, they encountered the burdens of deciding whether to require partners to be 
tested, whether to end relationships if partners carried the trait, whether to engage in prenatal 
testing in the case of both planned and unplanned pregnancies. 
Many participants placed a self-imposed responsibility for not giving birth to a child with 
a serious illness that would cause children pain and suffering, through their decisions not to have 
children, asking their partners to be tested, or limiting their partners to men without sickle cell 
disease or trait.   Participants expressed a deep conviction to protect their future children from 
the illness itself and from the stigma and labeling that come along with sickle cell disease.  
Participants who experienced numerous symptoms of sickle cell disease provided a unique 
perspective and sense of urgency for “not passing it on” or not wanting my child to “suffer like 
me” and “go through what I went through.”  Their experience of living with and embodying the 
disease, the inclusion of much more than just the pain and treatments, and the awareness of 
sickle cell disease as an all-encompassing, physical, social, emotional, sometimes stereotype-
inducing, life-changing condition, dictated their attentions to genetic testing at least in part. 
Participants described not only the physical symptoms and accompanying hospitalizations but 
also the interactions and negotiations, worries and concerns, and strong medications that women 
with the disease have to manage.  Providers and women’s parents are actually concerned too, as 
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illustrated by participants such as Jada, Pearl, Sophia, and Nia but, for the most part, the 
participants themselves seemed the most concerned about not passing it on. 
In addition to partner testing, women in this study were confronted with genetic risk 
during pregnancy and had to make decisions about this type of testing as well.  Prenatal care has 
shifted from being a private concern to a social concern because of the fetus’ role as a future 
family member and member of the population.  This concern also gives rise to social norms 
devaluing of life those with illness.  
For women in this study, prenatal testing was not used for fetal decision-making, but 
instead for information.  In most cases, testing occurred as a means of uncovering sickle cell 
disease status.  Therefore, these women tell a fairly consistent story–that providers, parents, and 
participants themselves view both prenatal and partner testing as testing against the potential for 
genetic transmission of sickle cell disease and nothing else. 
Some participants whose partners were not tested before pregnancy opted to have their 
partners tested instead of undergoing prenatal testing as an alternative way of “knowing” their 
child’s sickle cell status before birth.  The uncertainty of whether their child would have sickle 
cell disease surfaced when the father of the baby varied (e.g., women with multiple children) or 
in the case of birth of their first child.  When the father of the baby was the same and it was 
confirmed–through genetic testing–that he was not a carrier, this offered some certainty that 
sickle cell trait was a possibility for the child.  For women in the study who already knew their 
partner’s sickle cell trait status and that their child would not be born with sickle cell disease 
prenatal testing was less of an issue. 
Participants gave more weight to partner testing than they did to prenatal testing.  Half of 
the participants’ partners were tested for the sickle cell gene and 40% participants’ underwent 
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prenatal testing.  These results may reflect participants’ views toward partner testing as proactive 
and prenatal testing as a sign they would terminate their pregnancies.  
In this study medicalization of the pregnancy experience emerged as more than just a 
matter of birth location or the gender of the provider, but the subjection to medical testing 
monitoring and surveillance during pregnancy.  Susan Sherwin (2001) argues that the 
medicalization of pregnancy elevates the importance of medical interventions and distances 
women from their own pregnancies; this distance increases their anxiety and causes women to 
rely even more on medical expertise to assure them that everything is progressing normally, thus 
reinforcing the cycle of dependence (Sherwin 2001).  The use of technology as a tool for routine 
care draws attention away from concern for the mother, and places more concern on the fetus as 
a future family member and member of society.   
In the end, participants carried with them the reproductive burdens due to gender and 
illness to disclose their own sickle cell status, inquire about partner’s sickle cell status, ask 
partners to be tested, sometimes even taking them to be tested. These activities were all part of 
their process for determining qualification for intimate relationships and eligibility for 
reproductive partners and their roles as bearers and carriers of children.  
In the next chapter I will discuss how participants managed their reproductive health, 
specifically gynecological care, contraception and pregnancy.  
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Table 7.  Partners’ and Participants’ Uptake of Genetic Testing 
Participant 
Partner Testing Prenatal Testing 
Partner 
Tested 
N=19 
Partner Not 
Tested 
N=9 
Prenatal  
Testing 
N=7 
No Prenatal 
Testing 
N=10 
PARTICIPANTS WITH PREGNANCIES (N=17) 
Chloe X   X 
Katrina X   X 
Pearl X   X 
Jada X   X 
Mya X   X 
Clem X   X 
Ivy X   X 
Zora X  X  
Sophia X  X  
Vivian X  X  
Gabrielle X  X  
Jewel X  X  
Sydney X  X  
Imani X   X 
Hope  X  X 
Tia  X X  
Raven  X  X 
PARTICIPANTS WITHOUT PREGNANCIES (N=11) 
Aja X   
Nia X   
Verlean X   
Joyce X   
Faith X   
Yvonne  X (N/A)  
Dana  X (N/A)  
Ebony  X (N/A)  
Lynn  X (N/A)  
Gina  X (N/A)  
Gwen  X (N/A)  
N/A – women who had not been in a relationship they felt warranted asking partners to be tested.  
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CHAPTER 7 
EXPERIENCES WITH REPRODUCTIVE HEALTH CARE 
 
Reproductive health is very important because I want to have a normal life as a 
woman.  I want to go through the normal cycles that women go through.  
Whether it is menopause or whether it is having a child.   
So it is important to keep all of that stuff intact. ~Faith 
 
In Chapter Five I described participants’ responses to discouraging messages and to the 
strategies they used to pursue their reproductive desires in the face of these messages. In Chapter 
Six I discussed participants’ perceptions of and decisions about genetic and prenatal testing 
within the context of sickle cell disease.  Currently little is known about the reproductive health 
care experiences of women with sickle cell disease.  Reproductive health reflects women’s health 
over their lifetimes and lays the foundation for the next generation (Roberts 1990, Rutherford 
1992).  Reproductive health includes a wide range of processes including contraception, 
menstruation, conception, pregnancy, childbirth, abortion, menopause, etc.   
This chapter describes how participants navigated their reproductive health care among 
providers with varying knowledge in caring for women with sickle cell disease. In particular 
participants described their attempts to: (1) maintain their gynecological health, (2) acquire 
appropriate contraception, and (3) garner quality care during pregnancy.  This chapter illustrates 
important gaps in providers’ knowledge about these normal reproductive events when dealing 
with patients with sickle cell disease.  At the time of the interview, nearly all of the women in the 
study (N=23) reported seeking reproductive health care within the past 12 months. Of these, 
most went for an annual pap smear (N=15), some for contraception consultation (N=6), and 
others for prenatal care (N=2).  Thus, most women in this sample had interacted with health care 
providers very recently about their reproductive health. 
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This chapter demonstrates that participants received reproductive health care from 
multiple providers, including: obstetrician/gynecologists, nurse practitioners, hematologists, 
emergency room physicians and primary care physicians.  Participants frequently heard 
conflicting medical advice and receiving conflicting treatments and diagnoses from these 
different providers.  Participants assumed these various providers held enough medical 
knowledge to recommend appropriate care and allowed these providers to influence their 
behavior and decisions.  Through interactions with multiple providers, however, participants 
found the gaps in providers’ knowledge. At times, participants’ race, gender and illness locations 
influenced their encounters with providers. 
 
Sickle Cell Disease & Gynecological Care 
They Know Their Field, but They Don’t Know Sickle Cell Disease 
Almost half of the women in the study (N=11) expressed their concerns about their health 
care provider’s clinical acumen for understanding the reproductive health needs of women with 
sickle cell disease.  Through their health care-seeking experiences, participants recognized that 
while providers may be adept in the field of reproductive medicine, not all are knowledgeable 
about providing reproductive health care to women with sickle cell disease.  Nia, a 23 year-old 
woman, felt her obstetrician/gynecologist was unable to provide adequate advice on recent 
medical developments.  
I do research and I found out that it’s an HPV vaccine.  I asked her [the 
OB/GYN], “Is it OK if I get that?”  She said, “Oh, yea.”  I’m thinking, Well, why 
didn’t you tell me about that?  I said, “What do you think about it?”  She said, 
“Well my daughter got it, so I would recommend it.”  I’m thinking, “Well if you 
would recommend it, why didn’t you tell me about it?”  I have to go in there 
being proactive and telling her what I’m going to do for her to react.  I didn’t 
think that was good.  Honestly I want to find a better OB/GYN.  With my 
OB/GYN, I think she’s a good doctor, but I don’t think she knows the 
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significance of sickle cell and the reproduction aspect of it. [PR: What makes you 
think that?]  Just the care that she did.  Because if she did I think she would have 
provided me with options.  I told her when I first started there [that] I had sickle 
cell.  I just feel like with sickle cell you have to be really careful. [PR: Careful 
with what?  What do you mean?]  With sickle cell you have to be cautious about 
everything, not just sickle cell, but even when you’re having sexual activities.  So, 
with me, with the certain vaccines out I want to be protected!  With me having 
sickle cell that I have to be a lot more cautious than the average person.  I think 
for an OB/GYN, I’m not going to say that every doctor should know what sickle 
cell is, but I feel that if you have a patient you need to make yourself more aware 
of sickle cell anemia, the causes, the outcomes, what could happen, what can 
coincide with it, different STDs.  Offer support to that patient and let them know 
something that they may have not known with being sexually active.  I feel that 
with sickle cell you need to become more aware of the whole package.  
 
According to Nia, her obstetrician/gynecologist failed to do all she could to ensure she was 
protected from common viruses, so Nia took the initiative to investigate matters related to her 
reproductive health on her own.  Nia was not doubtful of her provider’s ability to care for her, 
but she doubted her doctor’s awareness of how her illness might impact other aspects of her 
health.  She believed health care providers’ responsibilities were not limited to treating ailments, 
but included serving as a source of up-to-date medical information.  Nia also believed she was 
proactive and honest with her provider by providing as much information as possible and used 
this strategy to motivate her physician to be more engaged and provide the same level of 
information.  Nia’s expectations for the type of care and attention her providers should offer her 
derived from her interactions with health care providers over time and her exposure to the health 
care field as a nursing student.   
Like Nia, Joyce also felt that while her obstetrician/gynecologist was knowledgeable in 
her field, she did not possess sufficient knowledge of sickle cell disease.   
I have an OB/GYN [but] I don’t necessarily care for her.  [PR: Because?]  She’s 
just not with it.  She doesn’t understand sickle cell.  She understands her field, but 
sickle cell is not her thing.  Anytime I’m having a cycle and I’m telling you my 
cycle is putting me in the hospital and you ask me when am I going to have a 
child and that will stop my cycle that’s when I know you’re crazy.  Because if I 
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have a child I’m going to have all types of other health complications because of 
sickle cell.  [PR: What was her logic?]  To have a baby to cut my cycle off for 
nine months. I said, “How can I have a baby right now and I’m not married?”  
She’s like, “Oh, well you’re right.”  I’m like, “What?” I think that honestly they 
think any young, Black woman is automatically out here hoeing around.  No, 
that’s not going on.  I don’t plan on having kids until I’m at an appropriate stage 
in my life.  She said that to me when I was like 19.  So it resonated with me.  It 
was crazy. She is the doctor over my case, but they have nurse practitioners who 
really handle everything and they’re fine. [PR: They know about sickle cell?] 
They didn’t know about sickle cell, but more than her they were willing to learn.  
They were willing to research and say, “Joyce, I was up all night looking for this, 
this, and this.  I called this individual [and] this is what we are going to try.”   
 
Since menarche, Joyce experienced ongoing difficulties with her menstrual cycles causing 
frequent hospitalizations.  She originally received reproductive health advice from her 
hematologist, and after becoming sexually active moved her reproductive health care to an 
obstetric/gynecological practice.  In this practice, she had been seen by both the physician and 
nurse practitioners, and was able to make a clear comparison between these two points of care.  
Joyce preferred to be seen by the nurse practitioners, rather than the physician, because their 
approach was more patient-centered and they were willing to learn about sickle cell disease and 
make an effort to investigate potential solutions to her problem.  
Joyce resisted the physician’s recommendation that she have a baby out of wedlock as a 
resolution to her health problem and thus preferred to be seen by the nurse practitioners.  Joyce 
took particular offense to this recommendation because she held traditional values toward the 
appropriate context within which to have children. Further, she felt this comment was suggestive 
of her being promiscuous, a longstanding racist and sexist stereotype of African American 
women.  This stereotype has important implications for health care in that it justifies poor 
treatment from providers, jeopardizes health care, and exploits the reproductive behavior of 
African American women (Hill 2009).  In the United States, the low position that African 
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American women occupy in society is related to the fact that they are in a position of being 
subjected to both racism and sexism.   
Joyce and Nia both expressed their dissatisfaction with the care they received from their 
obstetrician/gynecologists.  Both had providers who were more doctor-centered and approached 
their care with an assumption that they were the final decision-makers without including the 
patient in the process.  Nia, as a nursing student, and Joyce, through her patient advocacy work, 
had clear expectations of quality health care.  They felt they were not receiving the best care 
possible due to their physicians’ lack of knowledge and interest to better understand sickle cell 
disease and the impact it could have on women’s reproductive health.  In response to their 
dissatisfaction, both women were compelled to consider finding another source for reproductive 
health care.  In Joyce’s situation, she opted to only see the nurse practitioners in the practice.  
Yvonne, a 23 year-old woman, through the suggestion of her hematologist, identified a 
provider whom she felt confident would have knowledge of both sickle cell disease and 
reproductive health.  
My periods were getting heavier; they were lasting longer.  My cramps were 
getting worse and most of all my sickle cell pain was starting to get out of control 
when I was on my period.  So that caused me to call up the gynecologist and say, 
“Hey, I need to figure out what’s going on because this period is causing 
problems elsewhere. I have sickle cell.” I figured that if I stop my period and 
completely get rid of it then maybe I wouldn’t have to deal with these cramps that 
spark up my sickle cell crisis. [PR: Is this a gynecologist you already had?]  No, 
it was the first time that I had been to a gynecologist. A friend, [name] [who also 
has sickle cell disease] talked to us about that [Depo-Provera] because she was 
having similar issues as well and told me that, “Hey, you know, you could try this 
[Depo-Provera].”  The gynecologist was telling me that Depo-Provera would 
probably be my best option because I didn’t want anything inserted in me, but I 
wanted to talk it through with Dr. [hematologist] and when he told me that he had 
a sickle cell gynecologist, I said, “Well, maybe it would be better to have her 
examine me and see what her options are.” [PR:  Why is that?]  Considering that 
she knows more about sickle cell than the regular gynecologist would, I just 
wanted to talk with my sickle cell specialist to get his opinion. [PR: Why is that?]  
Just because he’s my sickle cell specialist and he would know more about how 
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my period and the birth control would be and how it would benefit me as far as 
sickle cell. Because the other gynecologist, she doesn’t know anything about 
sickle cell, all she knows is about female issues. But they know about female 
issues and sickle cell so I thought that would be better finding out what they 
would advise rather than her.  
 
Yvonne was committed to maintain her virginity until marriage and therefore had not 
sought reproductive health care until now.  Yvonne reported16 having dysmenorrhea17−a painful 
gynecological condition that can interfere with daily activities−and concluded that her menstrual 
cycles were exacerbating sickle cell disease.  In her initial experiences of seeking reproductive 
health care and using contraception, Yvonne was unfamiliar with determining the validity of the 
information she received from the obstetrician/gynecologist she was originally seen by.  
Yvonne’s sources of information for her reproductive health not only included her 
obstetrician/gynecologist, but also included a friend with sickle cell disease and her 
hematologist.  Ultimately she preferred to receive her reproductive health care from a provider 
knowledgeable of both sickle cell disease and “female issues.”  Her decision to seek care from 
one provider rather than two separate providers would have reduced the burden of multiple visits 
to different locations, which may have increased the probability receiving comprehensive care.  
Nearly a year had elapsed between her deciding to seek care and then seeking care from the 
obstetrician/gynecologist in the sickle cell clinic which she attributed to “just me being sick and 
in the hospital like every month, so just it was me continuously being sick and not having the 
time to see another gynecologist.” 
It is also important for women with sickle cell disease to have providers who are 
knowledgeable about their disease since it is common for individuals with sickle cell disease to 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  16	  Yvonne did not indicate having received this diagnosis from a health care provider.	  17	  There are two types of dysmenorrhea: primary and secondary. Primary dysmenorrhea is defined as recurrent, 
crampy pain occurring with menses in the absence of identifiable pelvic pathology. Secondary dysmenorrhea is 
menstrual pain associated with underlying pelvic pathology such as endometriosis.  	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receive pain medications that render them unable to be fully present amid moments of important 
reproductive decision-making.  Aja passionately recounted a harrowing experience with a close 
friend whose reproductive capacity was jeopardized during a hospitalization.   
She was in the hospital because she was bleeding [vaginally] and the doctor just 
said, “We’ll take out your uterus.” She was 27 at the time and I’m like whoa.  I 
feel like a lot of that had to do with the fact that she was a Black woman, in a 
hospital that didn’t know anything about sickle cell.  It was a majority White 
hospital and they were just jumping to it, let’s just do what has to get done instead 
of taking the time to talk to her and say what’s going on.  I feel like a lot of that 
was just race-based because when I talked to her doctors, I was there being her 
advocate, I’m like, “Where’s this coming from? Do you do this for every sickle 
cell patient?”  They were like, “No.”  Then what is the problem?  Is it because 
she’s extremely dark-skinned and she can’t talk to you right now? To me they 
were being racist against us.  Because it [her bleeding] didn’t have anything to 
with sickle cell. [PR: Why do you think race had anything to do with them 
wanting to take out her uterus?]  I don’t know.  It’s just the way that they… You 
know how patient interactions, how when a person looks at you [made a face as if 
she was throwing up]…  It was partly because she couldn’t advocate for herself.  I 
don’t get it, but to me it’s like with racism, you see it, it’s hard to explain it.  But 
when you saw it, you were like immediately put off.  Like, he was doing this 
because why?  She had sickle cell?  Because it would help her sickle cell?  Do 
you see how that doesn’t make sense for somebody who is 27 and who has never 
had any children and has not been married?  [PR: What do you think they should 
have done?] Do some background.  Don’t just be like we’re taking her into 
surgery in five minutes to pull out her uterus.  Talk to her!  Wait until she can talk 
to you!  [PR: Your friend was unconscious when this decision was made?]  She 
was semi-unconscious.  She was under heavy narcotics at the time.  She couldn’t 
talk.  She couldn’t relay what she needed to say.  This was the on-call internist on 
the floor who was saying this is how we’re going to treat her sickle cell, by taking 
out this woman’s uterus.  
 
Aja believed this doctor prioritized addressing her friend’s physical symptoms over preserving 
her reproductive capability.  Specifically, she felt not enough consideration was given to the 
long-term consequences of this decision for a woman with these characteristics (age, marital 
status, and reproductive history).  As an on-call internist, Aja felt this physician did not possess 
the medical expertise to make such a permanent decision nor was he aware of her friend’s desires 
about the best strategy to resolve the bleeding.  With the numerous problems with this medical 
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encounter, perhaps most disturbing to Aja was her friend’s lack of informed consent for allowing 
this procedure to be performed.  Historically, women of color have been subjected to having 
hysterectomies performed on them for various reasons and frequently without their knowledge or 
consent (Roberts 1997; Nsiah-Jefferson 1989; Davis 1983).  This situation lends importance to 
Aja’s position as a patient advocate in times of her friend’s health crises–to ensure health care 
providers adhere to established medical and ethical guidelines.   
In addition to a lack of expertise and informed consent issues, Aja suggested that the 
provider’s decision was racially motivated and continuously questioned the medical necessity of 
this procedure.  Aja felt this particular situation was further fueled by the environment in which 
her friend was seeking care (e.g., a majority White hospital). Aja’s perception of racial 
discrimination was not only based on the racial discordance between patient and provider but 
also on the non-verbal cues she detected during her own interactions with providers.  Aja had 
also been semi-consciousness while hospitalized at times and also had a similar illness and social 
locations to her friend (e.g., similar race, gender, age, marital status, parity, and sickle cell 
identities).  Aja was able to empathize and step in to advocate for her friend because of a 
common identity.   
 
Summary 
Women in this study received care from multiple providers, which provided them with a 
unique perspective through which to gauge their providers’ levels of knowledge of sickle cell 
disease.  When participants described more negative interactions with their reproductive health 
care providers, they also described less confidence in their care.  In these instances they were led 
to use purposeful strategies to ensure their health was maintained, mainly giving preference to, or 
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involving, providers with familiarity with sickle cell disease in their care or expressed confidence 
in the care they received.  Participants also carefully considered the validity of medical 
information and recommendations they received with a degree of caution and, over time, became 
very proactive in pursing optimal care despite challenges of insufficient clinical acumen.   
Participants also emphasized that providers should have the knowledge and experience to 
know how best to incorporate sickle cell disease into their reproductive health care.  They noted 
that many providers prioritize the problem or condition identified at that time, without giving 
consideration to their reproductive desires or the larger social contexts surrounding the current 
problem or condition, particularly in times of sickle cell crisis.  Some participants felt that their 
care was influenced by their race, gender and illness locations, through providers’ adherence to 
long-standing racial and sexist stereotypes of African American women and ideas about sickle 
cell disease representing women’s primary concern.  As a result, participants were distrustful of 
providers’ recommendations.  
 
Sickle Cell Disease & Contraception 
One of the most frequently reported purposes for seeking reproductive health care among 
women in the sample was for contraception.  Nearly all participants in the study (N=25)18 had 
used contraception during their lifetime.  Of those, almost half (N=11) believed the contraception 
they were initially prescribed either exacerbated sickle cell disease symptoms (increased pain 
crises) or was a type not recommended for women with sickle cell disease.   
Contraception is a special circumstance for women with sickle cell disease since many of 
the side effects of hormonally-based contraception parallel the co-morbidities of sickle cell 
disease (heart attack, blood clotting, stroke, etc.).  Guidelines from the 2010 United States 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
18 Some women had used more than one type of contraception during their lifetime. 
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Medical Eligibility Criteria (MEC) for Contraceptive Use do not discourage the use of any 
contraceptive method for women with sickle cell disease (WHO 2010).  These guidelines do not 
restrict the use of progestin-only contraceptives (pill, injectable, and implantable) and suggest the 
use of combined hormonal contraceptive methods (a combination of pill, ring, and patch) 
outweigh the risks for women with sickle cell disease making them acceptable methods of 
contraception for this population (WHO 2010).  However, because the risks associated with 
combined hormonal contraceptive methods remain elusive, concerns and uncertainty regarding 
potential complications persist.  
Both Ivy, a 27 year-old mother, and Pearl, a 37 year-old mother, believed the form of 
contraception they were prescribed interacted negatively with sickle cell disease.  Participants 
drew these conclusions from their tracking of symptoms that coincided with contraceptive use.   
I was on the pills but that interfered with the sickle cell. [PR: When you say the 
pills interfered with the sickle cell, can you explain what you mean?]  I had more 
frequent sickle cell crises. [PR:  How did you decide to use the pills?] From their 
recommendation. That’s what they thought would be best so I just went along 
with it.  I got the pills was after I had my first child. Before [that] I wasn’t on birth 
control.  I was on that for a few years and I would have a crisis every month. (Ivy) 
 
They gave it [birth control] to me after that [miscarriage].  They said, “Well if you 
don’t want kids, take this.” [PR: Who gave it to you?] The people at [name] 
Hospital they assigned me an OB/GYN when I was in the hospital.  The OB/GYN 
that they assigned me at the time put me on the birth control pill that was too 
strong.  I ended up in the hospital for three weeks.  I stopped taking the pill.  They 
gave me another pill and I got real sick again.  I stopped [taking contraception] a 
long time ago because I kept having issues. (Pearl) 
 
Ivy gave birth and Pearl had a miscarriage, at the ages of 18 and 19 respectively.  Prior to 
their pregnancies, neither had used contraception.  Ivy had been told she could not have children 
and considered contraception unnecessary.  Pearl had never been educated about using 
contraception by her family or health care providers.  In both cases, the prescribing-provider was 
not someone with whom participants had an existing relationship and appeared unaware of the 
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unique circumstances of sickle cell disease and contraception.  Also, as their first experience 
with contraception, Ivy and Pearl were also unaware of any limitations on contraception use and 
experienced a doctor-centered approach to being prescribed contraception, with minimal if any 
input from the patient as to what would be best.  In addition to Ivy and Pearl, three other 
participants could have experienced potentially serious incidents due to their existing health 
issues and the side effects of contraception.   
Aja, a 30 year-old woman, was told by her hematologist that she had been prescribed a 
form of birth control that would interact negatively with sickle cell disease and immediately 
“pulled her off” of it.   
I went to Planned Parenthood when I was really young and thinking about having 
sex.  I remember them saying, “Well you can take anything that you want.”  Then 
actually I got up enough nerve to tell to my hematologist I was on the patch and 
him saying, “No, you can’t take anything you want because birth control will 
cause clotting.  It’s known that birth control can cause clotting when you already 
have a clotting disorder that if you clot it’s not very good, you don’t want to 
promote that.”  He’s like, “I don’t recommend this for you.  This has been known 
to cause really bad clotting.”  My hematologist told me “No” and he immediately 
pulled me off of that and told me I needed to go to the gynecologist.  
 
Aja was raised in a religious family in which conversations regarding reproductive health or 
sexual behavior were taboo. Instead she was given a book about “where babies come from.” 
Feeling unable to talk to adults in her life about becoming sexually active, Aja took the initiative 
to visit Planned Parenthood without realizing the restrictions on the type of contraception she 
was able to use because of sickle cell disease.  Being prescribed a potentially harmful 
contraceptive led Aja to question the knowledge some providers possess in relation to identifying 
reproductive problems among women with sickle cell disease.  
I guess my biggest concern would be how much they [obstetrician/gynecologists] 
know about sickle cell disease when they’re looking at everything.  Are they 
looking for the signs?  Because I don’t know all of these.  I don’t know what 
sickle cell can do to my reproductive health.  I don’t know how this [sickle cell 
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disease] is affecting my reproductive organs.  I know that it [sickle cell disease] 
wears on everything, but I’m not as educated in that area, so I want to make sure 
that they’re educated.  There isn’t a specialist who specializes in sickle cell 
reproductive health so you’re constantly hoping that they’re asking you the right 
questions and that your doctors are communicating.  You don’t want everything 
to go awry down there. I want my hormones to be halfway decent.  I may not 
want to go through menopause, but I want to able to have those changes naturally.  
 
Aja emphasized her desire to remain healthy and have reproductive bodily experiences naturally.  
She prided herself on her knowledge about sickle cell disease and recognizing the warning signs 
of potential pain crises and realized she did not possess the same knowledge when it came to 
how sickle cell disease may impact her current and future reproductive health.  Thus, she looked 
to obstetrician/gynecologists to have this expertise, although she remained apprehensive about 
how much they actually knew.  
Nia, a 23 year-old woman, actually experienced a negative reaction to the first form of 
contraception she had been prescribed.  
I started [using contraception] when I was 20.  I was on the patch, but I can’t use 
the patch because I’m allergic to it.  My OB/GYN prescribed the patch.  They ask 
you, “Do you want to do the pill, the patch, or…”  And I felt that I’m not good at 
taking pills consistently.  I said, “Let me do something that I can remember at 
least once a week.” I’m not taking anything right now because I just found out, 
less than a month ago that I’m allergic to it. I’m not sure if that coincides with the 
sickle cell or not.   
 
Nia viewed using contraception as sexually responsible behavior and based her decision on the 
type to use on what she knew about herself and taking oral medication.  From her description of 
the contraceptive consultation, she too was presented with various options without consideration 
of sickle cell disease.  Similar to Aja, she was unaware of the potential for a negative reaction to 
the contraceptive patch.  After three years of breaking out while using the patch and no guidance 
from her provider, Nia used her own trial and error process to deduce a relationship between this 
contraceptive method and her allergic reactions.  
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Jewel, a 41 year-old woman and Zora, a 37 year-old woman, used contraception before 
being told by a health care provider that it could potentially cause a health problem due to their 
medical history.  
I took the Depo shot.  Dr. [hematologist] told me that I should not have been on 
the shot.  [PR: Because?]  Because I had a stroke before and one of the side 
effects [of the shot] is a stroke.  With taking birth control, the side effects are 
heart attacks, strokes, so he felt like I should not have been on birth control and I 
was getting the shot.  I discontinued the shot.  [PR: Have you ever taken any other 
type of birth control, other than that?]  No, that was it. (Jewel)  
 
I'm on Tegretol and Keppra [medications] and my neurologist had said that you 
can't take any birth control with the Tegretol and it could have killed my brain.  
They don’t work together at all.  It could have killed me. When I had found out—
I was, “Oh, my goodness!” That’s what I said and I couldn’t just stop taking the 
Tegretol so I had to make a choice between the two. (Zora) 
 
These participants spoke to the potential errors that could have occurred because their medical 
history was not given sufficient consideration at the time of contraception prescription.  Again 
neither the prescribing provider nor the participants were aware of the potential harm hormonal 
contraception could cause.  In these instances, participants benefited from being followed by a 
provider who knew their medical history well enough to warn them about the potential harm 
contraception could cause.  Too often medical providers dispense medical advice in terms of a 
standardized model of care and when sickle cell disease is not brought into the equation, errors 
may occur.  
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Summary 
Since sickle cell disease is a blood clotting disorder and some forms of contraception are 
known to cause blood clotting−even among women without a serious health condition−the type 
of contraception prescribed to women with sickle cell disease is critical.   
Eleven participants indicated having been prescribed contraception that was potentially 
health harming.  This occurred either due to provider’s lack of knowledge of potential 
complications of sickle cell disease with some forms of contraception, or participants lack of 
introducing their disease during the conception consultation.  Unlike the above section of results 
in which participants describe situations in which providers gave too much consideration to 
sickle cell disease, often prioritizing it over participants’ reproductive desires, in these latter 
instances providers did not give sickle cell disease enough consideration, often leading to 
negative health experiences.  For example, Nia above where she specifically mentions she told 
her obstetrician/gynecologist she had sickle cell disease when she was first seen at the practice.  
However, participants like Aja who sought care outside the traditional health care system or who 
sought care at a young age may not have known to bring sickle cell disease into a reproductive 
health discussion.  In any case, participants looked to their providers to have the necessary 
expertise to prescribe the appropriate type of contraception.   Of note, women in the study whose 
first experience with contraception was for the purpose of contraception (rather than to remedy 
problematic menstrual cycles) were more likely to experience a negative interaction with sickle 
cell.  With these first experiences, participants may not have realized the importance of 
informing, or in some cases reemphasizing, that they have sickle cell disease with their provider, 
and this omission may have impacted the course of their reproductive health care.  
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Sickle Cell Disease & Pregnancy Care 
In addition to gynecological health and contraception, women in the study also 
emphasized pregnancy as another reproductive health event that required their providers’ 
knowledge of sickle cell disease.  Women with sickle cell disease face numerous pregnancy 
risks, complications and adverse outcomes (Barfield et al. 2010, Chase et al. 2008, Hassell 2005, 
Howard, Tuck and Pearson 1995, Smith et al. 1996).   
 
Be Sure To Get a Doctor Who Knows Sickle Cell 
Of the seven women in the study who emphasized the importance of having prenatal 
health care providers who are knowledgeable about sickle cell disease, six had been pregnant 
before the time of the interview.  Sophia, Katrina, and Chloe described varied levels of 
confidence in their prenatal care providers.  Chloe, a 31 year-old mother, specifically sought 
providers with experience caring for patients with sickle cell disease.  
They [providers] think I have the trait.  They always say, “You have the trait?” 
and I have to tell them, “Here’s the blood test.”   Then it’s like, “Oh, okay, you do 
have sickle cell.” It’s not like that as much [now that] I started working in health 
care.  I started picking doctors that came from [a medical center] that worked with 
the Black community and they are way more familiar with sickle cell.  But I 
didn’t learn that until I got into health care myself, to go with somebody that has 
dealt with patients that had sickle cell because they know a little bit more.  [PR: 
Did you have the same OB/GYN for all three children?] For the first two 
[pregnancies] I did that, but for the third one I had a different one, she 
[obstetrician/gynecologist] wasn’t as familiar, but one of her partners was very 
familiar so together they were fine.  With the third pregnancy I did experience a 
lot of pain.  I haven’t had that pain in so long that I didn’t know if I was having a 
crisis or not. [I said], “It’s unbearable pain and I’m functioning, and I’m talking 
so I don’t think I’m having a crisis.”  They didn’t feel like I was having a crisis.  
He [the partner] did some blood work and he said I was not having a crisis, but I 
was just having a lot of pain.  So they knew what to do.   
 
Chloe experienced few pain crises or other sickle cell symptoms (e.g., fatigue, lower 
hemoglobin, and stroke) during her life.  She had to constantly convince new providers that she 
	  	  
182 
had sickle cell disease because they mistook her for having sickle cell trait.  This frequent 
mistake, along with her professional experience as a nurse, caused her to be more diligent in 
selecting health care providers.  She applied this same approach to selecting providers for her 
prenatal care because it was even more important that her providers have this knowledge.  In her 
case, having providers who knew about sickle cell disease offered her peace of mind when she 
was worried she was having a crisis, because they knew how to care for her.  Chloe preferred 
providers who were more patient-centered and took her knowledge and experience into 
consideration.  
Sophia, a 34 year-old woman, emphasized how important it is for women with sickle cell 
disease to have a reproductive health care provider who understands their disease. 
Besides having a hematologist that takes care of the blood disorder, sickle cell, 
you also need to have an OB/GYN that understands that you have sickle cell and 
your reproduction and things like that because then you also have somebody to 
tell them that they need to be more cautious about becoming pregnant and things 
like that. [PR: What do you mean be more cautious?] My physician told me that 
because for some sickle cell patients it's a certain time that is right for them to be 
pregnant and most of the time when they're young, our bodies are still 
progressing, hormones are still going all over the place, and it's just not good.  
Actually, when you're older and your body has become more settled, it's best.  
She's been my primary OB/GYN since I was 18.  She's taken care of my whole 
family and she was really good. She was just one of those doctors, if she didn’t 
know about it she would look it up.  She was African American, she was very 
aware of African American care and sickle cell patients.  She had also taken care 
of sickle cell patients who’ve been pregnant and she was along for my pregnancy 
ride too.  
 
Sophia’s confidence in her obstetrician/gynecologist originated from the longevity of their 
relationship, the provider’s experience in caring for African Americans in general and women 
with sickle cell disease in particular, and her provider’s willingness to investigate health issues 
with which she was unfamiliar.  These qualifications gave Sophia confidence in her 
obstetrician/gynecologist’s ability to offer her advice about family planning and prepare her body 
	  	  
183 
for pregnancy and childbirth.  Also, having a provider that she felt had an intimate experience 
with people like her (i.e., with the same race, gender, and illness locations) offered Sophia 
comfort and reassurance.  
Since Sophia obviously expected this care not only for herself but also for other women 
with sickle cell disease, she passed her experience along to women she counseled at the Sickle 
Cell Disease Association of America. 
I usually tell them [women she counseled] if they can just hold out and wait [sic].  
But if you find somebody and you just can't wait, make sure that you're protecting 
yourself because it's a lot of other things out here, and [not] just you having to 
worry about sickle cell and a baby.  But if you do find yourself pregnant make 
sure that you do see your OB/GYN and you stick close to them.   
 
In contrast to Sophia and Chloe, Katrina, a 31 year-old mother, had an 
obstetrician/gynecologist who lacked knowledge of sickle cell disease and was unprepared to 
care for her during her pregnancy.  
I would suggest that women, if they are pregnant, they see an OB/GYN that is 
knowledgeable in sickle cell. My OB/GYN gave me iron pills because [when] 
you’re pregnant they think you need more iron and you need to take this prenatal 
vitamin.  Well my body didn’t take that.  As a sickle cell patient you already have 
a lot of iron so I had too much iron … iron overload.  Once I saw my 
hematologist, he said, “Oh no!”  Then my OB/GYN put me on something called 
Macrophine, but my hematologist felt like that was raising my bilirubin. She 
[OB/GYN] was putting me on this extra stuff not realizing what it was doing to 
the sickle cell.  By me seeing my hematologist, he was like, “Oh no, your iron 
numbers are too high.  Stop taking the iron. Don’t take this Macrophine because 
it’s raising your bilirubin.”  So I can’t take any vitamins to help the baby but folic 
acid, which I had already taken anyway.  The OB/GYN, she hadn’t really dealt 
with women that have sickle cell before so she must have searched sickle cell or 
something and felt like well because you have sickle cell your iron is going to be 
low because your blood is low so I’m going to give you more iron.  But she didn’t 
do good research.  She should have known that sickle cell patients have more 
iron, than less.  We have low blood but more iron. The sickle cell got terrible. The 
doctors really didn’t know what to do. Don’t take anything unless your 
hematologist has recommended it, because they are knowledgeable about sickle 
cell and have a relationship with you and know your body better.  
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Unlike Chloe and Sophia’s providers who had knowledge of sickle cell disease, Katrina felt her 
provider had limited experience caring for pregnant women with sickle cell disease.  Her 
obstetrician/gynecologist’s lack of knowledge led to two potentially health-harming 
recommendations and caused worsening sickle cell disease symptoms.  This situation required 
the expertise of different providers to keep Katrina healthy during her pregnancy.  Because 
Katrina continued to receive care from her hematologist throughout her pregnancy, she received 
advice on what was safe for her to take while pregnant that contradicted what her 
obstetrician/gynecologist recommended.  Consequently, Katrina found herself between these two 
providers, each using their own specialty to advise her.  The obstetrician/gynecologist focused on 
the pregnancy while the hematologist focused on the sickle cell disease.  Katrina was in a unique 
position to compare the care she received from her providers and believed the care she received 
from her hematologist was superior due to his knowledge of sickle cell disease and his 
knowledge of her body.  Therefore, she decided to follow his advice.   
 
Summary 
The women highlighted illustrate two key strategies they used for ensuring optimal health 
care during pregnancy: (1) identifying providers knowledgeable of both sickle cell disease and 
reproductive health care and (2) involving providers knowledgeable in sickle cell disease in their 
reproductive health care.  These strategies helped to ensure participants had providers with this 
knowledge during pregnancy as knowing how to manage their pain crises or other sickle cell-
related symptoms.  Again, not all participants’ providers possessed the same level of knowledge 
of sickle cell disease.  While Sophia and Chloe both had providers whom they felt were 
knowledgeable about their condition, Katrina did not share this experience.  Sophia and Chloe 
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expressed their confidence in the care and advice they received.  These participants felt that their 
providers gave special attention to understanding that sickle cell disease added a unique feature 
to their reproductive health care needs. 
 
Responses to the “High Risk” Pregnancy Label 
In addition to concerns of the lack of knowledge during prenatal care, participants also 
encountered risk discourse during their pregnancy.  To be without some element of risk is nearly 
impossible thus “individuals and populations are judged for degrees of risk–low, moderate, high–
vis-à-vis different conditions and diseases, which determines what is prescribed to manage or 
reduce that risk” (Clarke et al. 2003: p. 172).  Mary Douglas (1992) stated that “the word risk 
now means danger; high-risk means a lot of danger” (p. 24).  High risk is a label providers use to 
classify women who are likely to experience maternal or fetal complications during pregnancy 
(Douglas 1992, Heaman 1998).  As mentioned in Chapter Two, women with sickle cell disease 
face numerous pregnancy risks, complications, and adverse outcomes (Barfield et al. 2010, 
Chase et al. 2008, Hassell 2005, Howard, Tuck and Pearson 1995, Smith et al. 1996).  Prior to 
1972, maternal and perinatal rates averaged 4.1% and 52.7%, respectively, however these rates 
have declined and have been reported as averaging 1.7% to 22.7% (Powars et al. 2005).  The 
decreases in maternal and perinatal mortality may be the result of advances in medical care: 
improvements in transfusion medicine and more frequent prenatal care. All thirteen women in 
the study who carried pregnancies to term indicated they were categorized by their reproductive 
health providers as “high risk” or were in the “high risk” category.  The category of high risk 
suggests a deviation from the norm and an indication that medical expertise, surveillance or 
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regulation is warranted (Lupton 1999). In this section I explain the two disparate reactions 
women in this study reported after being categorized as high risk.  
 
Of Course I’m High Risk; I’ve Got Sickle Cell Disease 
Less than half (N=6) of the women in the study who carried their pregnancies to term 
took being told they were a “high risk” pregnancy in stride.  Katrina, a 31 year-old mother of one 
son with Hb-SS and Ivy, a 27 year-old mother of three children with Hb-SS, both felt being high 
risk was possible because they had sickle cell disease.  
I was considered high risk because of the sickle cell.  [PR: When they told you 
that you were high risk, what did that mean to you?] Nothing really. I have sickle 
cell. I have to be monitored a lot. (Katrina)  
 
I am considered high risk for the sickle cell. They [her doctors] basically said, 
“You are high risk so some things are going to be a little different.”  I kind of 
figured that I would be high risk because I do have sickle cell so that wasn’t really 
anything new.  They monitor the baby more closely with high risk mothers, I was 
getting an ultrasound at one month and I know with normal pregnancies they 
don’t do that. (Ivy)  
 
Both Katrina and Ivy easily accepted being categorized as high risk and perceived the additional 
prenatal monitoring as a consequence of having sickle cell disease.  For Katrina, the label held 
no meaning.  However, for Ivy the categorization did carry a meaning–additional medical 
attention and intervention–which she believed was different from the care other women having a 
“normal” pregnancy received.  By creating a dichotomy, by labeling herself as abnormal and 
others as normal, Ivy recognized that her reproductive experiences might not be quite the same 
as others. 
Hope, a 25 year-old mother of a two year-old son and currently pregnant with a second 
child and Hb-SS, described her experience with being categorized as high risk.  
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They [her doctors] put me as high risk because I have sickle cell.  That’s the only 
thing. I just figured that, “OK, I have sickle cell, I’m high risk, of course.”  I just 
left it at that.  I don’t know why I didn’t ask more questions about it.  I guess I 
was just like, “All right, I know I have sickle cell.  I know there are risks [that] 
can be involved like losing a lot of blood or passing out” and I left it at that.  I 
didn’t get too much details into it because I probably in a way didn’t want to 
know too much of the information because it would be in my head and I’d be 
panicking and I didn’t want to know.  
 
Hope was aware of the potential challenges she could encounter while pregnant and readily 
accepted being categorized as high risk as a consequence of having sickle cell disease.  This 
label held the potential to bring these challenges to the forefront; therefore Hope did not question 
the categorization or request additional information because she was concerned that an 
explanation or further details may have provoked her to worry about having a safe pregnancy 
and delivery.  To Hope, not knowing the details behind the categorization was a way of coping 
with the stress of potential complications she may face during pregnancy. Avoiding knowledge 
about the potential risks did not mitigate Hope’s fear about her risks.  Also, despite her concern 
about the associated risks, Hope still continued to pursue her reproductive desires and was 
currently pregnant with a second child. 
Zora, a 37 year-old mother of two children with Hb-SS, easily accepted the high risk 
label. 
Every last one of them [her doctors] came to me and told me they wished I had 
gotten my tubes tied. They said, “Do you know how scared we were for you?” 
They told me I was high risk.  [PR: When you heard that, what did that mean to 
you?]  You know what, I had been told I was high risk with everything since I was 
a little girl so words like that just rolled right off of me because that’s just the way 
I am. If you tell me I am high risk, I will pray about it and leave it there.  
 
For Zora, being labeled as high risk held little meaning because she had become accustomed to 
hearing such language throughout her life.  Like Hope, Zora did not feel it was necessary to 
inquire about the specifics surrounding the categorization and accepted it a consequence of 
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having sickle cell disease.  Each of the six women who accepted the “high risk” label in stride 
had the more severe form of sickle cell disease (Hb-SS) and they also had more frequent 
hospitalizations for sickle cell disease.  For these women, the lived experiences of sickle cell 
disease and previous health warnings they had encountered caused the high risk label to be less 
alarming and almost expected.   
 
What Do You Mean I’m High Risk? 
Conversely, several women in the study (N=7) were less accepting of the high risk label, 
because it did not parallel their past lived experience with sickle cell disease. Jewel, a 41 year-
old mother of four, interpreted the high risk categorization as an indication of danger.  
Everything about pregnancy with sickle cell is a precaution.  I was high risk 
because I was sickle cell.  Each time I went to the hospital for pregnancy, once the 
doctor found out that I had sickle cell they would take me off of their list and put 
me with the high risk doctors. [PR: What did that mean to you when they said you 
were high risk?] That meant to me, danger.  Whereas these other people, like a 
person without sickle cell, they have a greater chance on having a smoother 
pregnancy and they didn’t have to see a specialist and the whole nine yards, 
whereas I did.  I had to see a specialist for this, a specialist for that, every 
pregnancy it was the same.  Being high risk just sounds so serious.  Danger.  You 
know, that’s when somebody says high risk to me. That’s what makes me think 
you’re in a dangerous situation to be categorized as high risk.  [PR: Did you feel 
like you were in a dangerous situation?] Depending on what was going on, they 
would make you feel like you were in danger.  From the littlest thing as having a 
headache or your blood pressure is a little elevated.  Those are big alarms for 
them.  
 
As a woman with sickle cell disease, Jewel was prepared to have a “different” pregnancy 
experience than women without sickle cell disease.  However, she did not expect to be made to 
feel as if by being pregnant she placed herself in a dangerous situation.  Her lived experience 
with sickle cell disease brought about much more serious health concerns than high blood 
pressure and headaches.  For Jewel, who had a stroke during adolescence, these were minor 
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issues that did not warrant such a serious reaction.  Further, outside of the stroke, Jewel did not 
have any other health issues, reproductive events, or frequent pain symptoms. 
Similar to Jewel, being labeled as high risk made Tia feel uncertain about what was to 
come.  She stated that for her high risk meant “anything could happen.  You got to be extra 
cautious.  Any little thing it was a problem.  While I was pregnant, everything was normal, like 
regular pregnancies.”  Tia took the label of high risk, with both pregnancies, as a sign of caution.  
She felt as though her pregnancy was “normal”, yet her providers labeled her as high risk.  
Clem, a 32 year-old mother of three, suggested that hearing the high risk categorization 
with her first pregnancy “freaked her out”.   
It was like, “Okay, you are high risk; you fall into high risk category.” [PR: When 
they said that, what does that mean to you?]  I am like, “Oh my God! I have to be 
watched carefully.” It kind of freaked me out.  I was like, “Okay, where do we go 
from here?”  They [her doctors] said, “Okay, we are going to really watch you 
carefully when you come in for prenatal visits.  We will constantly watch your 
levels—just really specific.  You know, watching.”  They watched me more than 
other people.  Then as the pregnancy would get further along, they were giving 
me stress tests to make sure my stress levels were low and everything was going 
pretty normal.  They were never really specific about why I was deemed high 
risk; it was just like that was the procedure [for women with sickle cell disease].   
 
Clem’s surprise response originated from the fact that until the age of twenty-six she had been 
told she had sickle cell trait and had experienced very few sickle cell symptoms so to now hear 
she was high risk caused her to become uncertain about the future of her pregnancy.  During this 
pregnancy, while her providers were very specific about the health care plan, she did not feel 
they provided similar details about why this care was necessary.  She indicated that with each of 
her pregnancies “I didn’t really have too many complications” and “normal aches and pains” 
which may have caused her to not understand why she was being labeled high risk.  
Like Clem, Chloe, a 31 year-old mother of three, also experienced minimal sickle cell 
related symptoms during her lifetime.  She had Hb-SC, the milder form of sickle cell disease, 
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and had only had one pain crisis at the age of twelve, which led to her initial diagnosis.  For 
Chloe, being told she was high risk caused her to feel scared. 
I’m always a high risk pregnancy, because of the sickle cell, [but] I never did feel 
high risk.  The first time [I was high risk] it was because they [her doctors] told 
me that I was high risk. They just said, “You have sickle cell, you’re a high risk 
pregnancy because you’re going to have a crisis.”  Well I don’t have those and I 
tried to tell them that but they said, “Things get bad when you get pregnant.  If 
you have something it tends to get more severe when you’re pregnant.”  So I was 
scared.  I just went along with whatever they said because I did not know, 
especially with the first pregnancy. But the third time around I was a little more 
informed and I was more comfortable with staying with my doctors because that 
wasn’t a high risk clinic.  So I was more comfortable because I felt like I knew a 
little bit more.  The other two times I just kind of went along with whatever they 
said.  By the time I got to the third one, I kind of told them like, “Oh, here’s the 
deal.”   
 
It took having the knowledge and experience Chloe gained from two previous pregnancies 
before she spoke up about being referred to high risk obstetricians.  Prior to this, Chloe felt her 
categorization of high risk from her provider was unwarranted because it did not accurately 
reflect her past health experiences, yet she did not feel empowered to speak up.  This example 
illustrates how, in matters of pregnancy, health care providers are often considered the expert 
over the woman herself.  Although Chloe informed her providers that she did not have “typical” 
sickle cell disease symptoms, her providers proceeded to label her without considering that her 
experience with sickle cell disease was unique.  Initially, Chloe was unsure how her body would 
respond to pregnancy and therefore “went along” with the high risk label, even though she felt it 
was unwarranted.  However, after two pregnancies and not experiencing any disease-triggered 
symptoms, in her third pregnancy she was much more comfortable rejecting the high risk 
categorization and exercising agency by intentionally seeking prenatal care from providers who 
did not specifically provide care to women who were high risk.  
Gabrielle, a 36 year-old mother of two, also had the milder form of sickle cell disease.  
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In my case being pregnant actually helped me because my fetal hemoglobin 
mixed with the baby’s hemoglobin I was never sick.  I was high risk because they 
thought, “Oh she is going to be sick,” but I wasn’t.  I didn’t have one crisis, no 
pain, nothing.  I was healthier pregnant–much.   
 
Like Chloe, Gabrielle’s providers predicted being pregnant would aggravate her symptoms.  Yet, 
Gabrielle indicated feeling “healthier” when she was pregnant.  From the beginning of the 
interview, Gabrielle continued to reinforce that she was “totally different than any other 
‘sickler.19’  I’m tall, I’m fat and you don’t see that in most ‘sicklers.’” She also had not 
experienced frequent symptoms or hospitalizations.  Different from the women who took being 
labeled as high risk in stride, Jewel, Chloe, Clem and Gabrielle were among the seven 
participants who were less accepting of the label, and both groups’ attitudes were determined by 
their lived experiences of sickle cell disease.   
 
Summary 
The concept of high risk is applied to women in this study because of the potential 
complications associated with pregnancy and childbirth among women with sickle cell disease 
and gives rise to medicalization.  Pregnancy is an assumed time of risk and women should be 
motivated to avoid any type of risk and ensure they have a healthy pregnancy.  Therefore women 
are considered able to minimize the pregnancy risk through testing, monitoring, and regulation.  
However, participants based the meaning of being high risk in their lived experiences, rather than 
the fact that they had sickle cell disease.  Women with more symptoms and more sickle cell 
related reactions took the label in stride, while those with fewer symptoms and milder forms of 
the condition were less accepting of the label and suggested it did not reflect their experience.  In 
many of the scenarios described above, health providers positioned all pregnancies, included 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
19 A “sickler” is a slang term for a person with sickle cell disease or sickle cell trait and in some cases is a negative 
word to describe this population  
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uncomplicated pregnancies, within the disease model and categorized them as abnormal.  Under 
this guise, health providers, who have the skills and technology, gain authority to determine the 
type of pregnancy and undermine women’s knowledge and experiences of pregnancy.  Women 
who were less accepting of the high risk label indicated that having this categorization led them 
to fall under medical surveillance, receive additional and unwanted medical attention, and 
undergo increased interventions (e.g., frequent appointments, stress tests, prenatal testing, and 
ultrasounds).  Participants with limited pre-pregnancy medical experience were less welcoming 
of the increased monitoring and additional prenatal care.  
Participants’ stories highlight the medicalization of their pregnancies because of the 
providers’ disease orientations and expectations of increased illness-related symptoms.  This 
heightened perception of risk is caused in part by pre-established notions of pregnancy is a time 
of risk and danger and therefore already subject to medical surveillance (Parry 2008).  In this 
context the combination of the availability of medical technology (e.g., testing and monitoring) 
and women’s pre-existing disease classification create opportunities for professional dominance 
and the diminished importance of participants’ bodily experiences.  
The two groups are also distinguished by genotype, with the former group having the 
more severe type of the disease (Hb-SS) and the latter having the less severe type of sickle cell 
disease (Hb-SC). Ultimately participants who experienced more sickle cell symptoms (e.g., pain 
crises requiring frequent hospitalization) accepted the high risk categorization in stride compared 
to participants who experienced fewer sickle cell symptoms who were less accepting of the high 
risk label.  Even in this small sample, then, data indicate the variation in the sickle cell disease 
experience; not all women who have this disease have the same health trajectory. An implication 
of this variation is that providers need to assess more fully the exact nature of women’s sickle 
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cell disease and how it might impact their reproductive life courses.  Labeling all women “high 
risk” in pregnancy masks the severity of some women’s conditions and the more minor effect 
that sickle cell disease has on others.  Additionally, women who were less accepting of this 
categorization had a different outlook on pregnancy and pregnancy risk when compared to their 
providers. How provider and patients differing outlooks on pregnancy might affect patients’ 
perceptions of risk should be explored further.  
For women in this sample, sickle cell disease served as a context for providers to 
understand their pregnancy experiences.  However, simply having sickle cell disease did not 
always determine how participants would think about pregnancy.  Unlike in previous results 
sections in this chapter, here some participants did not understand the extra concerns their 
providers had that warranted high risk categorization.  These data further highlight the variation 
in women with sickle cell disease and that reproductive health providers should consider this 
when providing care.   
 
My Sickle Cell Disease Symptoms Don’t Stop Just Because I’m Pregnant 
Seven women in the study indicated they had experienced at least one pain crisis during 
their pregnancy, which required medical treatment from a health care provider.  In addition to the 
lack of clinical knowledge non-sickle cell providers may have about sickle cell disease, this lack 
of knowledge may also impact their interpersonal interactions with patients causing judgment 
and racially fueled beliefs.  Pain continues to be part of the pregnancy experience among women 
with sickle cell disease.  Mou Sun and colleagues (2001) found that women with sickle cell 
disease (Hb-SS) are significantly more likely to need antepartum hospital admission (62%; often 
as a result of sickle pain crises, pyelonephritis, and anemia).  Thus, as one of the primary 
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concerns among women with sickle cell disease, their reproductive health care providers should 
also be aware of this. Pearl, a 37 year-old mother, encountered disparaging remarks from a health 
care provider when she sought pain treatment while pregnant.  
When you have it [SCD] and you’re pregnant, that’s a whole ‘nother animal 
because people treat you like a dog.  You deal with a lot of prejudice when you 
have sickle cell.  I was like already stuck in this place and I will admit [hospital] 
is the nicest place to be stuck in because it’s like a hotel.  They have the 
refrigerator full of sodas and the TV, so that part was nice.   It’s just all the 
racism, [it’s] really hard.  They were really prejudiced.  They talked to me like I 
was a crack-head.  You know, some of the things they said to me were so hurtful, 
like I was a monster.  [PR:  Like what?]  Because I had a couple of pain crises 
[when I was] in the hospital.  [They asked me], “Why would you take Morphine?  
Your child knows what Morphine is.  You’re giving that to your baby now.”  Oh 
my God! I’m in here crying, screaming, biting a rag, that’s how bad I’m hurting. 
If this was the Old West give me a shot of whiskey to pull the bullet out.  You 
know what I mean?  Anything!  I’m dying in here!  That was very difficult. I had 
a very difficult pregnancy.  And then they’re telling his dad, “Well they both 
might not make it.  She’s actually really bad.”  And I had to have to have two 
blood transfusions.  This was the only time by the way I’ve actually had to have 
blood transfusions my entire life, when I was pregnant.   
 
Pearl was hospitalized for four months prior to the birth of her son due to preeclampsia and high 
blood pressure.  Having lived with sickle cell disease for over their years, this experience 
afforded Pearl the ability to contrast the treatment she received while pregnant to the care she 
received when she was not pregnant.  Pearl’s description of seeking treatment for pain while 
pregnant as “’nother animal” suggests that pregnancy caused a different response from providers 
regarding pain medication.  She felt that these providers were judging her as a bad mother 
because she decided to receive pain medication.  When the pain caused her to seek relief, 
providers responded with a lack of empathy.  Pearl attributed some of this experience to the 
setting, a hospital in a very affluent location. While she benefited from the amenities in this 
location, she believed that she was treated poorly because of it as well.  
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One of the medications individuals with sickle cell disease take to mitigate pain crises is 
Hydroxyurea.  As detailed in Chapter 2, Hydroxyurea is taken orally and stimulates fetal 
hemoglobin production, raises hemoglobin concentration, increases the size of the red blood cell, 
lowers white blood cell counts, and decreases red blood cell intracellular dehydration (Hankins et 
al. 2005, Steinberg et al. 2003).  However, Hydroxyurea is discouraged during pregnancy as it 
may increase the risk of adverse effects and fetal abnormalities (Brawley et al. 2008, Hassell 
2005, Lanzkron et al. 2010).  Tia, a 29 year-old mother, had taken Hydroxyurea but stopped 
taking it during pregnancy, which caused her to experience chronic pain and frequent visits to the 
hospital. 
I take Hydroxyurea, which is like a miracle drug for me.  That actually keeps my 
fetal cell count high so it made my cells round instead of sickle-shaped and it kept 
me out of the hospital a whole lot.  When I got pregnant, because it’s a chemo 
drug, I had to get off of it.  When I was pregnant and I came in [to the hospital] 
and I said, “I need Morphine.”  He’s [unknown provider] like, “Well you’ve been 
coming in for morphine quite a bit.  Before you weren’t really hospitalized and 
now you come in a whole lot, why is that?”   I said, “Because I’ve been more sick 
[sic].  I stopped my medicine.  I don’t understand why I have to explain this to 
you.  If I say I’m in pain you should treat me.”  He said, “I’m just saying I don’t 
want to be feeding your addiction.”  I said, “My addition?”  I said, “What do you 
mean my addition?  I’m not addicted to anything.  The only thing I’m addicted to 
is living my life.”  The world just seems so ignorant of sickle cell and it makes it 
harder to live.  
 
Similar to Pearl, Tia also felt judged by providers for requesting treatment for sickle cell pain.  
Tia’s more frequent hospital visits and the fact that pain is an invisible and subjective symptom 
created doubts about the credibility of her repeated complaints of pain. Pearl attributed her 
providers’ reactions to the setting. Tia attributed this judgment to the lack of public awareness 
about sickle cell disease and felt that if the public was better informed, stereotypes of patients 
with sickle cell could be lessened.   
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As health care providers themselves, two participants−Chloe was a nurse and Mya was a 
physician assistant−shared their insider experiences of witnessing negative encounters between 
providers and pregnant women with sickle cell who sought treatment for pain.   
I’ve been on the floor with sickle cell patients that [are] pregnant and the nurses 
don’t even want to give them their medicine.  These girls be screaming and 
shouting. (Mya) 
 
I’ve seen it [race] influence other people with sickle cell.  Women, or anybody 
with sickle cell, people think they are just drug-seeking.  I’ve seen that.  I’ve seen 
it.  And of course, I’m way more sensitive to that because I have it and I’m a 
woman.  But I have seen it happen, numerous times. I have met women [when] I 
worked in labor and delivery that have a problem with their sickle cell during 
their pregnancy.  They have crises and they’re ill and they’re bed-ridden.  I didn’t 
have that problem, but that’s what I’ve seen.  Some of the women got treated like 
they were drug-seeking when they were in fact in pain.  That was the issue I had 
working at that hospital.  You’re on this [side of town] and they’re racist and I 
just never could understand that.  How are you racist and you work here?  There it 
was pretty obvious. (Chloe)  
 
For Chloe, the providers’ reactions toward women in these instances were not due to a lack of 
knowledge or concern about the effects of pain medication on the fetus, but rather racist 
stereotypes and a belief these women with sickle cell disease were going to abuse pain 
medication.  Chloe acknowledged how her own race and illness identities made her more 
sensitive to these negative encounters but she believed that, because the hospital where she 
worked served a predominantly African American population, the staff should have been more 
sensitive to patients with sickle cell disease.  Chloe intentionally sought care from African 
American providers who served in an inner-city facility, believing she would receive better care 
with these circumstances. 
Black Feminist Standpoint Theory highlights how African American women occupy a 
unique standpoint based on their subjection to both racism and sexism (Collins 2000b).  
Through Joyce’s experiences as both a patient and a patient advocate, she gained insight into 
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how racial and illness identities intersect to influence the care patients with sickle cell disease 
receive. 
It’s much harder there [in the hospital]. Much harder because you’re dealing with 
a lot of racism and it’s hard in that aspect of it is hard for me.  The racism is hard. 
[PR: In your opinion is it race? Is it sickle cell?] It’s the combination.  What you 
have is a predominantly African American disease.  Having sickle cell is tough.  I 
mean it is really tough.  Being a predominately Black disease, it’s tough because 
you’re not treated fairly.  There are a lot of times that I’ve had to deal with 
racism. I know where it comes from.  America has had a very scattered history 
when it comes to race relations.  I understand that, but it’s difficult when you’re at 
your lowest point or at your sickest, [and] you are at times on your deathbed and 
you throw in the United States of America and our issues with race and 
stereotypes and you have a problem on your hands.  
 
Summary 
Maintaining their reproductive health is not something that can be accomplished 
independent of supportive family members, knowledgeable health care providers, and a non-
judgmental society. Some participants expressed their perceptions regarding providers’ 
judgments of drug-seeking due to racial and illness stereotypes during pregnancy.  For Pearl and 
Tia, they resolved these racial remarks as ignorance of sickle cell disease in society.  In the 
United States, sickle cell disease is closely associated with African Americans who are 
vulnerable to racial prejudice and stereotypical attitudes, causing the disease to be viewed 
through a negative racialized lens (Geller and O'Connor 2008, Nash and Telfair 1994).  During 
pregnancy, these stereotypes did not diminish but were intensified due to the impact of their 
decisions on the fetus.   
Participants discussed experiencing racialized situations with health care providers that 
they did not know or trust. These providers were often unfamiliar with participants’ medical 
histories. Especially in certain locations within the hospital setting (e.g., Emergency Room or 
inpatient locations), care is often administered by providers who are unfamiliar with the patient 
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and their medical history, causing providers to be more likely to be suspicious and less 
empathetic to complaints (Ratanawongsa et al. 2009, Shapiro et al. 1997). 
 
Conclusion 
This chapter illustrates the importance participants placed on identifying providers with 
knowledge about reproductive health care, particularly gynecological care, contraception and 
prenatal care.  Women in the study also felt it was important for their providers to be aware of 
the potentially health-harming effects of specific types of contraception for women with sickle 
cell disease.  Finally, participants wanted their providers to be able to provide care in times of 
pain crisis or other sickle cell-related symptoms and not pass judgment on them during 
pregnancy.  Participants were not always savvy in determining quality and competent care upon 
their initial introduction to reproductive health care (e.g., first pregnancy, first contraception use, 
etc.).  However, as participants aged and gained more exposure to health care providers, they 
adopted higher expectations for patient-centered and informed care that gives consideration to 
sickle cell disease.  Of note, participants often lacked this knowledge themselves, so they were 
dependent on their providers to advise and offer them safe care.  
Over time participants who described doctor-centered interactions about reproductive 
health care also eventually approached recommendations for contraception, prenatal testing, etc., 
with caution.   The doctor-centered approach is characterized as paternalistic and is based on the 
assumption that the physician as the medical expert and dominates decision-making (Byrne and 
Long 1976).  In doctor-centered interactions, little consideration was given to their status as 
women with sickle cell disease or to understanding how important sickle cell disease was as a 
context for reproductive health care (Mead and Bower 2000).  Hematologists often helped 
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participants understand how much standard reproductive care might conflict with their sickle cell 
needs.  Hayes-Bautista (1976) suggested that once a patient perceives the provider as providing 
inadequate treatment, the patient attempts to modify the situation (Hayes-Bautisa 1976).  
In these instances, participants developed strategies for mitigating medical errors and 
achieving optimal health outcomes, such as identifying and consulting with other providers they 
felt were more knowledgeable or doing their own research to ensure they remained healthy.  For 
example, some women in this study included hematologists or nurse practitioners (i.e., providers 
who might possess additional knowledge about their reproductive health care and/or be willing 
to seek it out) or discontinued receiving care from a provider who seemed unwilling to learn 
more about sickle cell disease.   
Participants whose reproductive health care was patient-centered described greater 
confidence in their provider’s knowledge and experience caring for women with sickle cell 
disease by acknowledging the illness into their care and recommendations.  The patient-centered 
approach to the medical encounter has been characterized as involving less provider-controlling 
behaviors and more sharing of power and responsibility between the patient and doctor. A 
patient-center approach also typically involves providers’ acknowledgements of the meaning 
patients attach to their illnesses, and providers’ attentions to both verbal and non-verbal 
communication from the patient (Byrne and Long 1976, Mead & Bower 2000).  In some 
instances a nurse practitioner or hospital staff member provided this care, not the physician.  This 
suggests that those most trained in a biomedical model may not be prepared to treat the 
“different” SCD case. Strict biomedical training may inhibit a patient-centered approach to 
reproductive health care. 
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Finally, this chapter highlighted the recommendations and advice participants received 
from numerous providers with different medical specialties and varied levels of experience with 
and knowledge of sickle cell disease.  The number and variation of providers consulted speaks to 
whom and what can influence women’s reproductive decision-making. Women in this study 
exist within a web of medical providers with varying levels of interest, knowledge and expertise 
about their reproductive health and disease status. Never quite knowing how much providers 
know about or have experience with sickle cell disease means that women receive reproductive 
health care in very complicated and piecemeal ways. There is considerable room for 
improvement of reproductive health care for women with sickle cell disease as a result.  
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CHAPTER 8 
CONCLUSION 
 
The specific aims of this study were to (1) explore and describe the reproductive health 
experience of women with sickle cell disease, (2) describe social, environmental, and cultural 
factors that influence their reproductive health experience, and (3) investigate the ways in which 
women with sickle cell disease manage their reproductive health.  Using a qualitative, 
phenomenological methodology, this study captured the authentic voices of 28 adult women with 
sickle cell disease and their perceptions and experiences of reproductive health and reproductive 
health care.  In the study I explored particular dimensions of reproductive health and health care:  
sexual health, intimate partner interactions, contraception, prenatal care, reproductive health 
screenings and genetic testing.  In this dissertation, however, I limit the focus of the findings to 
only three themes:  (1) participants’ resistance to discouraging reproductive messages, (2) 
participants’ perceptions of and decisions about genetic testing and prenatal testing, and (3) how 
participants navigate and secure reproductive health care.  Findings on other aspects of 
reproductive health will be reported elsewhere. 
Guided by the theories within literature on the Sociology of the Body this study explored 
the embodied reproductive health experiences of the women with sickle cell disease.  Within 
literature on embodiment, bodies are considered to be socially constructed rather than restricted 
to their biological or physical features.  Thus, participants’ bodies are not only understood via 
their physical existence (e.g., illness and symptoms) but also given meaning through the process 
of social interaction with others (e.g., family members, health care providers) (Waskul and 
Vannini 2006).   
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I approached data collection using phenomenological and Black Feminist Thought 
approaches, by placing participants’ experiences at the center of my analysis (Collins 2000b).  
These methodological approaches begin with the connected knowers, those who know from 
personal experience.  During the initial telephone conversation and during the informed consent 
process I assured participants that they were experts on this topic and I was hoping to learn all I 
could from them.  I wanted participants to know that I respected their vast knowledge of the 
topic up front, and was clear that I wanted to learn from them about reproductive health within 
the context of sickle cell disease.  Knowing this often motivated women to share very personal 
stories with me. 
This study investigated three specific research questions.  The first research question, 
“How do women with sickle cell disease think about and experience reproductive health?” 
focused on gaining an understanding of the reproductive health care participants received and 
how they thought about this care.  This question was answered by participants’ discussions of 
being questioned about their desires to have biological children, acknowledging their 
responsibility to avoid having children with sickle cell disease, asking their partners to undergo 
testing, making decisions to be tested themselves, and approaching uninformed and semi-
informed providers.  Participants were quite mindful of how their behavior would impact future 
generations or future children.  Participants also discussed approaching reproductive health care 
with trepidation and purposefulness to ensure they received safe and proper care.  These findings 
are described in Chapters Five, Six and Seven. 
The second research question, “How do race, gender, and genetic illness affect the 
reproductive lives of women with sickle cell disease?” focused on the ways in which 
participants’ believed their social identities impacted their reproductive lives.  This question was 
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only partially answered because the study was specifically designed for women with sickle cell 
disease, thus illness emerged as a as a primary social category as much as race or gender.  This 
illness identity also intersected and overlapped with gender and race contexts to create specific 
situations (i.e., a burden to get genetic testing and encourage partners to get tested, women's 
suspicions of incomplete/discriminatory care, etc.).  The intersecting categories of race, gender 
and illness influenced relationship formation and dissolution, decisions to have biological 
children and the types of reproductive conversations they had with potential intimate partners.  
These social identities also sometimes influenced their interactions with health care providers 
and the standard of care they received, particularly when they were in unfamiliar hospital 
environments or hospitals that served non-minority areas.  In these instances, participants were 
less trustful of providers’ recommendations and motives.  Only a select few participants believed 
that race shaped their medical treatment or interactions with hospital staff.  These findings are 
described in Chapters Six and Seven. 
The final research question, “What social, environmental, and cultural factors influence 
the ability of women with sickle cell disease to either seek or receive reproductive health care?” 
sought to uncover how these factors may influence how women with sickle cell disease come to 
understand reproductive issues.  This question was answered by data on participants’ perceptions 
regarding who should be able to reproduce and others’ willingness to provide reproductive health 
care to women with sickle cell disease or support women’s reproductive health decisions.  These 
beliefs emerged as a result of statements made by family members and providers discouraging 
them from having biological children.  Participants were faced with judgments of cultural norms 
on who should reproduce.  These findings are described in Chapter Five, Six and Seven.   
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Summary of Major Findings  
The findings that emerged in the analysis are often about embodied risk.  For participants 
in this study, risk of biological reproduction was established before pregnancy occurred (by 
family members, doctors, and women themselves) and reiterated during genetic testing 
situations, intimate partner selection and relationship dissolution, conception experiences, the 
initial prenatal visit, prenatal care, hospital stays, and throughout the duration of the pregnancy.  
These risks included risk to women’s bodies and health status during pregnancy and risk of 
genetic transmission to the fetus.  Thus, the notion of genetic risk interfaced with already 
established notions of maternal risk to creating a situation within which women received clear 
messages that embodying reproduction was risk-filled and (therefore) maybe not worth it (Katz-
Rothman 1993).  
Ulrich Beck (1992) argued that society is becoming increasingly vulnerable to scientific 
innovation.  This study showed how participants’ pregnancies were medicalized both through 
recommendations for prenatal testing and genetic testing, as a means of identifying the risk of 
fetal disease and potential harm to mother.  The main assumption behind the medicalization of 
pregnancy is that pregnancy and childbirth is a time of risk and danger (Parry 2008, Sagrestano 
and Finerman 2012).  By attaching the label of “high risk” to a pregnancy shifts pregnancy and 
childbirth from a natural and normal occurrence to one that requires scientific monitoring, testing 
and surveillance.  From a feminist perspective, the medical involvement of pregnancy can be 
seen as a form of social control and an interruption to women’s bodily autonomy that entitles 
medical professionals access to the body (Westfall 2006).  For example, even when participants 
expressed their resistance to the high risk label–because they felt that their bodily experience did 
not warrant the label–health care providers continued to assume authority over the pregnancy 
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experience.  Another example of medical surveillance is found in stories about participants being 
encouraged to undergo prenatal testing even after their partners had already been tested.   
Risk also caused participants to be discouraged from having biological children at times.  
Women were discouraged because their bodies posed a risk to themselves and to any children 
they might have.  Discouraging reproductive messages often came from close family members 
and health care providers.  Participants believed that the messages arose out of health concerns.  
In other words, others (often family members but also providers) believed that they were too sick 
to bear children, or that they would become sicker when pregnant.  However, participants often 
looked to their own embodied experiences of living with sickle cell disease to determine whether 
they were healthy enough for pregnancy and childbirth.  Barbara Rothman (1986) introduced the 
concept of the “tentative pregnancy” to describe the context for prenatal testing. In my study 
pregnancies were considered tentative by participants’ parents and providers at times, due to 
concerns about maternal risk and genetic inheritance, but participants were less likely to think of 
their own pregnancies as tentative.  Participants’ perceptions of their own risks were not static 
but, rather, changed over time however.  For the most part, participants’ views of the 
appropriateness of pregnancy was based on the fluidity of their individual health statuses as well 
as their feelings about their intimate partners and embodied disease experience. 
Faye Ginsburg and Rayna Rapp (1995) employed the term “stratified reproduction” to 
describe the conditions under which some categories of women are valued and supported in 
bearing and raising children while others are not.  Stratified reproduction illustrates how 
reproduction is structured across social and cultural categories, empowering, encouraging and 
resourcing privileged women and disempowering other women.  Some children are considered 
worthy of being born and efforts are made to ensure those births occur (e.g., assisted 
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reproductive technologies) (Ginsburg and Rapp 1995).  Women in this study were discouraged 
from giving birth to children who would be born with sickle cell disease, however. 
As Jada notes in Chapter 6, however, “We’re still normal, regular women in my opinion.”  
That participants often did not find themselves too sick to have children illustrates the 
importance of distinguishing between disease and illness and of recognizing that all women, 
regardless of what they specifically embody, may have reproductive desires.  While others 
considered participants to be in a constant state of sickness, participants understood themselves 
as women with life-long (“lived-with”) illness.  “Disease” is a biomedical concept based on 
empirical evidence of pathological abnormalities in the body, recognized by signs and symptoms 
which can be observed, measured, and analyzed using clinical standards (Eisenberg 1977, Idler 
1979).  “Illness” is a subjective phenomenon defined as a disturbance of social life preventing 
usual pursuits and activities within given social contexts (Conrad 1987, Idler 1979). Having a 
congenital, lived-with illness, participants did not view themselves as too sick to have children 
and, instead, allowed their own bodies to dictate their assessments of health status.  Nonetheless, 
embodying sickle cell disease meant having to deal with others’ perceptions of the debilitating 
nature of the disease, even if it was something that one learned to live with and adapt to.  This 
meant that women had to learn how to confront discouraging and often inconsiderate messages 
about reproduction and consistent suggestions about genetic testing while making their own 
decisions about whether and how to lead reproductive lives and navigate reproductive health 
care. 
Throughout their lives, many participants described resisting discouraging reproductive 
messages and exercising agency in making their own decisions.  Participants illustrated their 
abilities to negotiate their own reproductive desires with family and providers and respond to 
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external constructions about whether they should have children. Their behavior is best described 
as everyday acts of resistance in that their behavior may not be overt, but it is evidence of their 
ability and motivation to take control of their reproductive lives in small ways (Hollander and 
Einwohner 2004).  For example, much of this agency was via enacting specific strategies 
including seeking additional information, soliciting medical expertise from multiple sources, 
exercising their right to reproduce, becoming informed about their reproductive capabilities, and 
drawing upon personal experiences to make decisions rather than letting doctors or family 
members make decisions for them.  
Much of participants’ agency was possible because they believed that the outcomes of 
their child’s sickle cell status was within their control and based on their behavior (Rowe et al. 
2005, Wallston and Wallston 1978).  Of all of the questions I asked during the interviews, the 
question that elicited the most response was, “What kinds of conversations have you had about 
genetic testing?”  Nearly all women in this study acknowledged the risk of genetic transmission 
through their discussions of how to protect their future children from having sickle cell disease.  
Embodied risk establishes warnings about potential future illness for themselves and their 
children, susceptibility to the disease itself, and an awareness of the body as separate from the 
self (thus making desires for children separate from the reality of whether women can or should 
have children).  However, In the face of this embodied risk, participants exhibited strong 
orientations toward an internal locus of control by asking their partners to undergo testing 
(Wallston and Wallston 1978).  In regards to genetic risk that is constant, and particularly 
becomes more of an issue at times of reproduction, participants were more accepting of 
biomedical knowledge and knowingly carried the burden of trying to prevent the disease in their 
children.  Asking partners to be tested was action they felt they could and should take to prevent 
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having a child with sickle cell disease.  Additionally, several participants described having a 
spiritual locus of control, believing that whether they, or their children, would survive pregnancy 
and childbirth was in God’s hands (Debnam et al. 2012).  Through their own personal 
experience, participants were also committed to avoid “passing” sickle cell disease on to their 
children.  One motivation participants expressed was to prevent their children from “suffering” 
the way they had, both from the physical symptoms and social judgment that accompanies sickle 
cell disease.  Participants also viewed themselves as having the burden or responsibility of 
preventing this (as compared to someone who only carried the trait, for instance) because they 
knew the lived experience of having sickle cell disease.  Participants illustrated this 
responsibility through their conversations about disclosure of having sickle cell disease to 
partners, about relationship formation and dissolution, and about using genetic testing to find out 
their partner’s sickle cell trait status.  
As I discussed in Chapter Six, this reproductive burden is gendered because, although 
both parents have a role in heredity, as the bearers of children, women are considered the carriers 
of sickle cell disease. As women in this study hinted, male partners did not always bear the brunt 
of decisions about testing or conceiving with partners who might have sickle cell as well.  Male 
partners often took genetic testing less seriously or did not have as much information about 
testing as well. Thus, the responsibility for choosing to give birth to afflicted children (or, 
ultimately to confirm that this would not happen) falls on women alone (Caplan 1989, Ettorre 
2000).   
Additionally, participants gave consideration to both their own assessment of their future 
as a mother as well as to social perceptions of themselves as mothers.  In their considerations 
they speculated about whether they would carry parental guilt if they passed sickle cell disease to 
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their children and acknowledged that they would be blamed by society should their child be born 
with sickle cell disease.  Parental guilt is a common response to a child’s diagnosis with disease.  
For the most part guilt implies control over the situation and its occurrence (Kessler et al. 1984, 
Nixon and Singer 1993).  According to Jackson and Mannix (2004), mother-blaming is a term 
that describes how mothers are blamed and held responsible for the actions, behavior and health 
of their children.  Previous research supports these findings and indicates that mothers of 
children with sickle cell disease feel blamed for knowingly conceiving and giving birth to a child 
who suffers physically (Burnes et al. 2008, Hill 1994b).  Society deems the decision of these 
women to have children as irresponsible—especially in light of knowledge of their genetic 
risk—and judges parents’ who disregard genetic information as morally unacceptable.  Thus, if 
women wish to have children in what are considered as less than ideal conditions, attempts are 
made by different sectors of society to dissuade and/or prevent them from doing so (Phoenix and 
Wollett 1991).  Women can be viewed as both reckless and responsible in their responses to 
testing, because women who become mothers are viewed as bearing the burden of avoiding, 
reducing, or managing disability among her offspring (Lippman 1993). 
 
A Better Model for Reproductive Health Care 
The findings of this study demonstrate that a better reproductive health care model is 
warranted, one that includes individuals knowledgeable of sickle cell disease and one that 
provided an integrated system of primary and emergency care.  Over time participants enacted 
their own strategies for ensuring they received adequate reproductive health care by involving 
multiple providers in their care and identifying providers with sufficient knowledge to care for 
them.  Care for participants in the study appeared to be more thorough when it was delivered by 
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reproductive health providers (1) with existing knowledge of sickle cell disease (2) who are 
willing to learn more once they have a patient with the disease and/or (3) are in close contact 
with or in proximity to a hematologist who has specialized knowledge of sickle cell disease.  
Also, providers who acknowledge that, at times, sickle cell disease contexts are more important 
and that, at other moments, maybe those sickle cell disease contexts are less in important to 
women.   Both sickle cell disease and reproductive health can take precedence for women in 
different moments. 
Participants emphasized that they needed their providers to offer reproductive health care 
options and attention to them just as to any “normal” woman, acknowledge the context of sickle 
cell disease as a context for care delivery but not use that context to limit care, and use as a 
starting point where individual women are within their reproductive experiences and sickle cell 
disease experiences, and treat both experiences as important.  Also, the findings of this study 
suggest that closer attention should be paid to the offering of appropriate contraceptive methods, 
the meanings women give to genetic and prenatal testing, increased opportunities for patients to 
receive proper preconception counseling, and at base better understanding of the connections and 
overlaps between living with sickle cell disease and engaging in reproductive experiences.   
Because the actual experiences of women with sickle cell disease have been excluded 
from most reproductive health literatures, policies and guidelines that affect them may have also 
emerged mainly from entities external to and uninformed by their experiences.  Thus, an 
intended outcome of this study is to provide a better understanding of how women with sickle 
cell disease experience reproductive health care in order to inform clinical practice.   
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Study Contributions 
Results from this study make a contribution to the illness literature.  Peter Conrad (1987) 
suggested the following types of chronic conditions: lived-with, mortal, at-risk, terminal, 
stigmatizing and disabling illnesses.  Lived-with illnesses are non-life threatening conditions 
which a person is required to learn to live with, mortal illnesses are conditions that are life-
threatening, and at-risk illnesses are conditions that are contracted through predisposing, 
exposure, or hereditary pathways.  Sickle cell disease is a good example of overlapping 
categories as it has onset at birth, is genetic, life-long, and life-threatening.  Within the context of 
congenital conditions, no comparison of a past self or reference to a pre-illness state exists.  
Therefore, congenital illness can become as much a part of participants’ biographies as other 
social locations into which they were born (e.g., race or gender).  Further, this study adds to the 
literatures on women’s health and reproductive health in that research has only been completed 
on women’s perspectives on reproductive health when they develop a disease (e.g. breast cancer, 
Huntington’s Disease), rather than when they are born with a disease.  Simon Williams (2000) 
suggested that genetic conditions should be investigated because, “phenomenologically and 
existentially speaking, it remains the case that these biographies have not, in any real or 
significant sense, shifted” (Williams 2000: p. 50).  
Providers should also avail themselves of the nuances of this disease to be equipped to 
provide them with accurate and up-to-date information to maintain the gynecological and 
prenatal care.  The idea of integrated care is supported by the American College of Obstetricians 
and Gynecologists (ACOG) recently issued a practice bulletin on hemoglobinopathies in 
pregnancy and, in summarizing much of the literature presented above, advocated for a 
multidisciplinary approach in the management of pregnancy for women with sickle cell disease.  
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Specifically, they encourage an ongoing discussion between the obstetrician, hematologist, and 
anesthesiologist involved in the patient’s care during the perinatal period.  Given the probability 
for painful crises during this period and adverse pregnancy outcomes, the Association stresses 
the need for coordinated care (ACOG 2007). 
As discussed in Chapter Four, the fundamental tenet in Black Feminist Standpoint 
Theory suggests that alternative epistemologies are built upon lived experience, not upon an 
objectified position, and emphasizes the importance of giving voice to the lived experiences.  
This study gave that voice to African American women with sickle cell disease who have been 
silenced from bringing their reproductive health issues to the forefront in both medical and social 
milieus simply because researchers have not prioritized conversations with these women. 
Further, by placing these women at the center of this study, they were empowered through telling 
their own stories in their own word rather than victimized through the voices of others.  
This study may also give attention to the need for health advocacy and activism for 
women’s right to control their reproductive lives beyond the popular pro-life/pro-choice debates 
into other areas affecting sexual and reproductive health.  There is indeed a need for advocacy 
related to women’s equality and reproductive freedom focused primarily on women’s right to 
control their reproductive lives.  The findings of this study give attention to the reproductive 
discourse for women with illness and the ways in which illness can also influence women’s 
rights to bear children, particularly under a medical model that has the power to dispense 
judgment and medicine (including reproduction limiting procedures).  Particularly for this 
population, the autonomy for their own reproductive decision-making, the right to bear children, 
or forgo testing, regardless of concerns for health or genetic transmission, is especially relevant.   
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Study Limitations 
There were several limitations to this study.  First, the applicability of the study findings 
may be limited to those medically diagnosed with the sickle cell disease and not those with sickle 
cell trait.  The findings of this study may also be limited by self-selection bias.  Those who are 
talkative, critical or have a desire to share a particular life experience are more likely to volunteer 
than those who are private, quiet, or accepting of that experience (Rossi and Freeman 1989).  It is 
also possible that those who had more severe symptoms did not volunteer for an interview due to 
their illness identities, symptoms, or low energy levels.  It is also possible that those with more 
physical experiences with sickle cell disease symptoms may have given more thought and 
attention to the ways in which the illness impacted their lives.  While I attempted to minimize 
any form of social distance between me and my participants due to education or economic status, 
social distance may have still been present because I do not have sickle cell disease.  Snowball 
sampling may have increased trust levels between the participants and the researcher; however it 
may have also decreased the demographic variation (e.g., economic status, age, or education) 
within the sample.  Because sickle cell disease was so closely connected to race for women in 
this study, it was difficult to determine the exact source of instances of discrimination or 
prejudice.  Also, these findings are limited in that I did not ask specifically about care locations, 
race or gender of providers, or how long they had been seeing a particular provider, which may 
have also influenced participants’ perceptions of the care they received.  As previously 
mentioned in Chapter Four as well, the findings of this study may be limited to the sampling 
strategy from locations that either offer medical care or social support and education to women 
with sickle cell disease.  Another limitation is that, as mentioned above, health status is not static 
and may influence perceptions and experiences which may also change at different stages of life.  
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Thus, the findings of this study may also be limited because it captured participants’ perceptions 
of reproductive health at one time point rather than over their life course.  Also, because I used 
illness as the starting point of this study, it is of no surprise that illness emerged as the dominant 
identity.  
 
Policy Implications 
Two primary areas of policy are of importance for reproductive health for women with 
sickle cell disease.  First, it is critical that genetic testing be accessible for those who desire to 
undergo testing.  While prenatal and newborn screening have become commonplace in prenatal 
and postnatal care, genetic (partner) testing is not currently one of the services covered under 
The Patient Protection and Affordable Care Act (ACA).  The Genetic Services Policy Project has 
reported low utilization of genetic counseling and carrier screening by at-risk individuals and 
couples, and limited provider awareness/attention to carrier screening, especially in non-prenatal 
settings (Genetic Services Policy Project 2013).  Through the ACA, women can go directly to 
their OB/GYN without a referral, which may not only increase women’s access to reproductive 
health care, but also allow them to receive other care (e.g., screenings for domestic violence, 
HIV, etc.) through preventative services offered without copays or deductibles.  Due to the 
inherited nature of autosomal recessive genetic disorders, screening for these conditions is also 
frequently incorporated into routine obstetric care.  It is essential that these physicians accurately 
assess and communicate the risk of genetic disorders.  Also, continued support from the federal 
government (through legislation or research funding) for the Sickle Cell Disease Association of 
America will be important in future years.  This organization has done much over the past 40 
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years to increase public awareness in hopes of both mitigating illness-related stigma and the 
social fear of contagion and advocating for improved health care services.  
 
Directions for Future Research 
Since this research only collected the perspectives of women with sickle cell disease, this 
research could be expanded by investigating the perspectives of those delivering discouraging 
reproductive messages, such as health care providers and family members, in order to understand 
their rationale.  Once understood, information and education could be developed and offered to 
providers and family members to give them the opportunity to be more supportive.  Additionally, 
since males with sickle cell are also reaching reproductive age and experiencing urological 
problems (e.g., erectile dysfunction and priapism) that may influence their perceptions of 
reproduction, efforts should be made to incorporate their perspectives on reproductive health in 
order to capture uncover gender differences.  Also, because I was unable to examine in depth 
how race affects women with sickle cell disease, perhaps a better method of exploring these 
identities would be to use a more quantitative approach with validated instruments that might be 
better able to disentangle social identities and the influences they have on health and health care.  
Finally, because this research suggests participants’ decisions tended to be based on the 
embodied experiences of living with sickle cell disease, it would be helpful to compare attitudes 
of women with the disease to a sample of women with sickle cell trait who are asymptomatic.  
This would help us to comprehend the differences in women’s perspectives toward reproductive 
health and decision-making.   
The findings also support the concept of embodied knowledge in that participants used 
their own bodily experience (1) as a source of knowledge in reproductive decision-making and 
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(2) to define their own meaning of their reproductive risk.  Hopefully, this study will begin a 
discourse that includes the voices of the women affected by this condition and will serve to raise 
awareness and bring these voices to the forefront to improve reproductive health care for these 
women.  As Joyce put it, “We have to have these conversations… Knowledge is power. Talking 
and communicating is the only way that you can bridge the gap.” 
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APPENDIX A 
PRE-SCREENING QUESTIONS/SCRIPT 
 
Thank you for contacting me regarding your participation in this study.  The study is about the 
reproductive health experiences of African American women with sickle cell disease.  If you are 
eligible and choose to participate, you will be interviewed, in-person, for about 1-2 hours and 
asked to fill out a short survey. I will also ask that I be able to contact you after the survey in 
case I have further questions or need to clarify anything that was discussed during the interview.  
During the interview I will ask you questions about your experiences as an African American 
women with sickle cell disease.  I will also ask questions about contraception, pregnancy, 
motherhood and your interactions with family and health care providers.  
 
Are you interested in seeing if you meet the criteria to participate in this study? Do you have any 
additional questions before I proceed? 
 
Criteria #1 – Are you a female? 
If yes, continue with next question. 
If no, the person does not meet the study criteria. 
 
Criteria #2 – Are over the age of 18? 
If yes, continue with next question. 
If no, the person does not meet the study criteria. 
 
Criteria #3 – Are you African American? 
If yes, continue with next question, 
If no, the person does not meet the study criteria. 
 
Criteria #4 – Do you have sickle cell disease (NOT TRAIT)? 
If yes, continue with next question. 
If no, the person does not meet the study criteria. 
 
Criteria #5 – Are you willing to participate in a face-to-face interview? 
If yes, continue with next question. 
If no, the person does not meet the study criteria. 
 
If all the answers to the above questions are yes, proceed.  Great!  You are eligible.  Can we 
schedule the interview now?  When is a good time for you to have the interview?    
Day/date:__________________ Time: ___________________________ (am/pm) 
Location ________________________________ 
 
If it’s OK, I will call you the day before just as a reminder. Is this the best number to reach you, 
or do you prefer another phone number?  Preferred Phone Number: ______________ 
What is the best time to call?  Time(s): _____________ 
 
Thank you and I will call you the day before the interview. 
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APPENDIX B 
INTERVIEW GUIDE 
STUDY CODE # ______ 
RECRUITMENT SITE/METHOD___________________________ 
 
INTERVIEW GUIDE 
 
Tell me about your life with sickle cell? (school experiences, family experiences, friends, 
relationships) 
How did you first learn how to take care of yourself? 
Is there anybody you can call on to help when you don’t feel well? 
How do you think you first came to understand what it meant for you to have sickle cell?  
 
Are you open about having sickle cell?  I’m interested in understanding how people make 
decisions about whether and when to share with others that they have sickle cell? 
 Are there any situations that you found it easier or harder to discuss? 
 What leads you to tell people in the first place?  What causes you not to tell? 
 
Thinking back, how do you think you learned about what it meant to be a woman? What do you 
know about these things? Where or who did you get this information?   
What does it mean to you to be a woman with sickle cell disease? In what ways do you think 
you’re the same or different as other women? 
 
When you hear the term reproductive health, what things come to mind? 
Thinking back, how did you first learn about reproductive issues (periods, how babies are born, 
birth control, etc.?) 
What do you know about these things? Where or who did you get this information? 
In what ways do you think having sickle cell may impact any of these reproductive issues? 
If she says, her mother taught her…ask about the relationship with her mother? What is it 
like? 
 
PUBERTY 
When did you start puberty, developing?  Start your menstrual cycle? How did you feel about 
that? 
Had you already known what to expect before it happened? 
In what ways do you think your menstrual cycles may be affected by having sickle cell? 
 
Have you ever used BIRTH CONTROL 
What type?  How did you come to use birth control?  How did you come to use this TYPE of 
birth control? 
If no, why don’t you use birth control? 
 
MOTHERHOOD 
Do you have any children? 
Yes 
1. Before you had children, what were your thoughts about becoming a mother? 
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2. Take me back to when you first found out you were pregnant, what was that like? 
3. In ways might having sickle cell influenced your plans for becoming a mother? 
4. Tell me a little bit about your interactions and conversations with your doctor. 
5. In what ways do you think having sickle cell impacted your pregnancy? 
6. Do you think you were able to make the choices you wanted to about becoming a mother? 
7. What has it been like having children? 
8. Do you think you’ll have more children? 
 
No Children 
1. What are your thoughts about becoming a mother? 
2. In ways might having sickle cell influence your thoughts about becoming a mother? 
3. Do you think you are able to make the type of choices you want about becoming a mother? 
 
Do think you may have any difficulties with getting pregnant?  If so, would you consider 
infertility treatment or adoption? 
 
SEXUALITY 
Thinking back, how did you learn about sex?  Who or where did you get information from? (are 
they sexually active?) 
When you hear the term “safe sex” what comes to mind? 
In what ways do you think having sickle cell may influence your intimate relationships (either 
hetro- or homosexual..having boyfriends, etc.)? 
In what ways do you think having sickle cell may influence your sexual experiences (either 
hetro- or homosexual)? 
 
OTHER 
Do you see an OB/GYN?  How old were you the first time you went to see an OB/GYN.  What 
prompted the first visit?  Have you continued to see this person? 
 
Prenatal Testing 
What kinds of conversations have you had about prenatal testing/amniocentesis? 
Who?  What was said?  Did you understand it?  What did you think some of the pros/cons were?   
Do you think it is something you would consider doing? 
 
Genetic/Partner Testing 
What kinds of conversations have you had about genetic testing? 
Who?  What was said?  Did you understand it?  What did you think some of the pros/cons were?   
Do you think it is something you would consider doing? 
Would you feel comfortable asking your partner to get tested? 
 
What types of things do you consider when you are making these types of decisions?  Who do 
you look to for help when making these types of decisions? 
 
Specific Issues 
Have any of your providers ever asked you about depression?   
Have any of your providers ever asked you about domestic violence?  
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Have you ever been tested for HIV/STD?  If yes, what promoted the test? 
Would you say you feel more comfortable asking potential intimate partners about HIV/STDs or 
genetic testing? 
 
Let’s talk about your experienced with the health care system and providers. 
How many health providers do you have? 
What have your experiences been seeking health care? 
In what ways do you think your experiences may have been influenced by your race? 
In what ways do you think your experiences may have been influenced by having sickle cell? 
In what ways do you think your experiences may have been influenced by being a woman? 
What techniques do you use to make sure you get proper care? 
What recommendations would you have to health care providers about taking care of women 
with sickle cell disease? 
 
What does it mean to you to be a woman with sickle cell disease? In what ways do you think 
you’re the same or different as other women? 
What recommendations would you have to other women with sickle cell disease about any of the 
things we’ve talked about today? 
Are there any issues that I did not address that you consider important as a woman with sickle 
cell disease? 
Can I ask why you decided to participate in this research? 
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APPENDIX C 
DEMOGRAPHIC QUESTIONNAIRE 
 
STUDY CODE # ______ 
RECRUITMENT SITE/METHOD___________________________ 
 
Thank you for your participation in an interview today.  Please complete this short 
questionnaire.  Answers to this questionnaire will also remain confidential and does not include 
a request for any identifying information. 
Date: _______________ 
 
SOCIAL HISTORY 
What is your age?  ____________   In what year where you born? ___________ 
 
What is your martial status? Please check one. 
[1] £  Single, never married  
[2] £  Single, divorced 
[3] £  Widowed 
[4] £  Living with partner 
[5] £  Married  
[6] £  Other (please explain) 
_____________________ 
 
How do you identify your sexual orientation? Please check one. 
[1] £  Straight/Heterosexual 
[2] £  Gay/Lesbian 
[3] £  Bisexual 
[4] £  Prefer not to state 
[5] £  Other 
 
What is your highest educational attainment? Please check one. 
[1] £ No high school 
[2] £ Some high school 
[3] £ High school graduate or equivalent 
[4] £ Some college or associate’s degree 
[5] £ College graduate (bachelor’s degree) 
[6] £ Advanced degree (master’s or 
doctorate) 
[7] £ Other 
 
Have you ever been employed? 
[1] £ Yes   [2] £ No 
 
If yes, what is your current employment status? Please check one. 
[1] £ Unemployed 
[2] £ Employed part-time 
[3] £ Employed full-time 
[4] £ Retired 
[5] £ Other _______________ 
 
Are you currently receiving Supplemental Security Income (SSI)? 
[1] £ Yes   [2] £ No 
 
What is your average household annual income?  Please check one. 
[1] £ Less than $25,000 
[2] £ Between $25,000 and $49,999  
[3] £ Between $50,000 and $74,999  
[4] £ Between $75,000 and $99,999  
[5] £ Between $100,000 and $149,999  
[6] £ More than $150,000  
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In general, do you feel you have enough income to pay your basic expenses? 
[1] £ Yes   [2] £ No 
 
MEDICAL HISTORY 
What type of sickle cell do you have? 
[1] £ Sickle cell anemia hemoglobin S (Hb-
SS)  
[2] £ Sickle cell anemia hemoglobin C (Hb-
SC) 
[3] £ Sickle beta-zero thalassemia (Hb-Sß0) 
[4] £ Sickle beta-plus thalassemia (Hb-Sß+) 
[5] £ Other ___________ 
[6] £ Don’t know 
 
How many pain crises, requiring hospitalization, have you had in the last 12 months?  
[1] £ None (0) 
[2] £ 1-5 
[3] £ 6-10 
[4] £ 7-15 
[5] £ 15-20 
[6] £ 21 and up 
 
List any other medical conditions (list any condition regardless of relationship to SCD): 
             
             
 
What type of health insurance do you have?  Please check all that apply. 
[1] £ No insurance 
[2] £ Medicaid 
[3] £ Medicare 
[4] £ HMO insurance 
[5] £ Other private insurance 
[6] £ Other (please explain) 
___________________________ 
 
REPRODUCTIVE HISTORY 
Do you have an obstetrics/gynecology (OB/GYN) physician? 
[1] £ Yes   [2] £ No 
If no, why not?             
              
 
How many times within the last 12 months have you seen him or her?  
[1] £ None (0) 
[2] £ 1-5 
[3] £ 6-10 
[4] £ 7-15 
[5] £ 15-20 
 
What was the reason for your most recent visit to see your OB/GYN? 
[1] £ Annual pap smear 
[2] £ Pregnancy care and delivery 
[3] £ Miscarriage/abortion care services 
[4] £ Family planning services 
[5] £ Contraception consultation (to get             
contraception) 
[6] £ Sexually transmitted infection 
treatment and counseling 
[7] £ Other (please explain) 
___________________________________ 
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How old were you when you got your first period? __________ 
 
Do you have regular monthly periods? 
[1] £ Yes   [2] £ No 
 
Have you experienced menopause or early menopause? 
[1] £ Yes   [2] £ No 
 
What type of birth control method have you ever used/currently using? Choose all that apply. 
[1] £ Birth control pills 
[2] £ IUD (Intrauterine Devise) 
[3] £ Condom  
[4] £ Contraceptive Patch 
[5] £ Contraceptive Ring 
[6] £ Depo-Provera (the shot) 
[7] £ Rhythm Method 
[8] £ Norplant 
[9] £ None 
 
How often do you use condoms during sexual intercourse?  
[1] £  Never 
[2] £  Sometimes 
[3] £  Always 
 
When was the last time you used contraception during sexual intercourse 
[1] £ Never 
[2] £  0-3 months ago 
[3] £  4-6 months ago 
[4] £  7-9 months ago 
[5] £  10- 1 year 
 
If never, why have you not used contraception? 
[1] £  I am not sexually active 
[2] £  I want to have a child/get pregnant 
[3] £  I don’t believe I am able to conceive 
[4] £  I don’t like contraceptives 
 
Have you ever been pregnant?  
[1] £ Yes   [2] £ No 
If yes, how many times have you been pregnant? _____________ 
 
If yes, have these been planned pregnancies? 
[1] £ Yes   [2] £ No 
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Do you have any children? 
[1] £ Yes   [2] £ No 
If yes, how many children do you have? __________ Ages: ______________ 
 
What types of births have you had? 
[1] £ Vaginal birth 
[2] £ Cesarean section 
[3] £ Natural birth 
[4] £ Medicated birth (received pain medications during labor/delivery) 
[5] £ Other (please explain) ___________________________________ 
 
Did you breastfeed any of your children?  
[1] £ Yes   [2] £ No 
 If no, why not____________________________________________________________ 
 _______________________________________________________________________ 
 
Have you ever had an abortion/terminated a pregnancy? 
[1] £ Yes   [2] £ No 
If yes, how many have you had? ___________________ 
 
Have you ever had reproductive difficulties or other reproductive events?  Check all that apply. 
[1]   £ Dysmenorrhea (pain during menstruation that interferes with daily activities) 
[2]   £ Vaso-occlusive pain associated with menstrual cycles 
[3]   £ Miscarriage   If so, how many? ____________ 
[4]   £ Ectopic pregnancy 
[5]   £ Infertility 
[6]   £ Hysterectomy 
[7]   £ Unplanned tubal ligation (tubes tied) 
[8]   £ Endometriosis 
[9]   £ Cancer (ovarian/uterine/cervical/breast)[please circle all that apply] 
[10] £ Uterine fibroids 
[11] £ Ovarian cysts 
[12] £ Fibrocystic disease of the breast  
[13] £ Other reproductive difficulties (please explain) _____________________________ 
___________________________________________________________________ 
___________________________________________________________________ 
___________________________________________________________________ 
 
 
Thank you for participating in this study 
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APPENDIX H 
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Reproductive health among women with sickle cell disease remains a critical gap in the 
literatures on sickle cell disease, reproductive health, and women’s health.  Sickle cell disease 
(SCD) is a condition with a complicated clinical sequelae, accompanied by a myriad of health 
complications, unremitting, extreme pain, and frequent hospitalizations.  The purpose of this 
study was to explore the meaning and lived experiences of reproductive health and health care 
among women with sickle cell disease.  Using a qualitative, phenomenological methodology, 
this study captured the authentic voices of 28 adult women with sickle cell disease and their 
perceptions and experiences of reproductive health and health care.  Nearly all women in this 
study were advised to avoid having biological children because of the concerns for their health or 
that they would have a child with sickle cell disease.  Despite this recommendation, participants 
exercised agency and looked to their embodied experience living with sickle cell disease when 
determining whether they were healthy enough for pregnancy and childbirth.  Participants also 
described carrying a reproductive burden due to their genetic characteristics to ensure they did 
not “pass” sickle cell disease on to their children.  Their motivations were derived from their 
desire to prevent their children from “suffering” the way they had, both from the physical 
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symptoms and social judgment that accompanies sickle cell disease.  These findings illustrate the 
need for women with sickle cell disease to receive reproductive health care that takes into 
consideration their particular health characteristics in regards to gynecological care, 
contraception and prenatal care to avoid potentially health-harming recommendations that may 
exacerbate sickle cell disease symptoms. 
This study extends existing ideas concerning the embodied risk and reproductive health 
from women who develop or contract risk, to those who were born with it.  This information 
may also encourage more appropriate reproductive health care, and improve the understanding 
regarding the significance of reproductive health in general and within the context of illness 
among health care providers. 
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